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ABSTRACT 
Adenoviruses have been used as a model system for understanding gene 
expression, DNA replication, gene delivery and other molecular biological phenomenon. 
In this project, adenovirus was used as a model to study exogenous gene expression in 
mammalian cells. More specifically, several adenoviral components were identified to 
enhance gene expression together with components needed for viral DNA replication. 
The adenoviral elements that enhance gene expression were assembled in an expression 
vector (pEl). These include the viral inverted terminal repeats (ITRs), the El region, the 
major late promoter (MLP) and the tripartite leader sequence (TPL). The green 
florescence protein (GFP) was used as a reporter gene. Various aspects of gene 
expression were examined including DNA delivery and stability inside the cells as well 
as mRNA transcription and protein expression. 
First, the effect of DNA quality on its delivery, stability and expreSSIOn III 
mammalian cells was studied. Five different conditions of the major DNA contaminants 
were used in this investigation including ethidium bromide (EtBr) , cesium chloride 
(CsCl), EtBr/CsCl, endotoxins and ethanol. CsCl, EtBr/CsCl and endotoxins affected the 
delivery process while EtBr affected the expression process but not the delivery. The 
used EtOH had no significant effect on both. In addition, the effect of all the 
contaminants was reversible. 
Next, we looked at the factors that enhance mRNA transcription and translation 
levels. Three approaches were tested, the first was the co-transfection of pEl and a 
plasmid that contains adenoviral genes involved in replication (PE2: contains E2 and 
viral protease). The second was the establishment of a cell line expressing these 
adenoviral genes involved in replication and the third approach was the super-infection 
with the wild type adenovirus. The co-transfection did not show any significant increase 
in gene expression or vector stability. On the other hand, the construction of CHO-E2 
cell lines yielded five cell lines but none of them showed expression of all the integrated 
adenoviral E2 genes or enhancement of stability. 
Adenoviral super-infection enhanced gene expression. CHO cells showed higher 
enhancement in intensity and time than human embryonic kidney (HEK) 293 cells. In 
addition, such enhancement was dependent on the multiplicity of infection (MOl). 
Finally, this study emphasizes the importance of DNA quality on gene expression. 
However, the use of adenoviral elements to enhance exogenous gene expression is 
II 
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successful only when the complementary viral proteins and sequences are present. Active 
expression of the adenoviral proteins does not depend on a few major elements, but 
depends on the combination of different elements that work in cis or trans to activate 
gene expression. 
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INTRODUCTION 
Since the introduction of the central dogma of molecular biology by Crick (1958 
and 1970), gene expression has gained increasing attention. Scientists have tried to 
understand the regulatory mechanisms of the different processes involved in gene 
expression as well as gene function. Modem recombinant DNA technology made it 
possible to clone, manipulate and deliver DNA constructs into various cells to study the 
expression of recombinant proteins out of their natural environment. This is called 
exogenous gene expression. The progress in this field has grown rapidly to match the 
scientific needs for recombinant proteins as tools not only for molecular biological 
research but also as tools in diagnostic and therapeutic applications. 
It has been nearly forty years since Paul Berg and co-workers (Jackson et al., 1972) 
reported the engineering of the first recombinant DNA molecule. It took nearly 10 years 
to produce the first recombinant human insulin (Humulin), the first genetically 
engineered human recombinant therapeutic protein used to treat diabetes (Goeddel et al., 
1979). Since that time, hundreds of genetically engineered human recombinant 
therapeutic proteins were developed in different gene expression systems. This 
introduction will discuss recombinant protein expression in mammalian cells with the 
main focus on the adenovirus serotype 5 (AdS) genome and regulatory sequences and 
elements that control gene expression. 
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1.1- RECOMBINANT PROTEIN EXPRESSION 
1.1.1- Ectopic gene expression in prokaryotes and in eukaryotes 
Both prokaryotes and eukaryotes are used to express exogenous genes. Prokaryotes 
and eukaryotes differ in the physical separation of the expression process. In prokaryotes, 
transcription and translation are simultaneous, while the two processes are separated in 
the eukaryotes by the nuclear membrane. The prokaryotic expression machinery and its 
regulators are very simple relative to eukaryotes. They have only one RNA polymerase 
to transcribe all the RNA species and they lack the post-transcriptional modifications. 
Also, they do not facilitate many post-translational modifications that are important for 
imparting biological activity to many complex proteins (Lodish et al., 2007). 
Generally, prokaryotes are the preferred host for recombinant protein expression 
because they produce a high yield of protein in a short period of time and they are easy to 
manipulate. However, most of the post-translational modifications are not available in 
bacteria, making them unfavourable for the expression of many pharmaceutical proteins 
that require accurate protein structure (Verma et ai., 1998 and Hunt, 2005). 
Eukaryotic organisms range in complexity from simple unicellular organisms, such 
as yeast, to multicellular complex organisms such as mammals. These organisms differ 
mainly in their growth rates and the complexity of their growth conditions. Also there is 
variability in their ability to perform complete and accurate post-translational 
modifications (Hunt, 2005 and Lodish et ai., 2007). Three RNA po1ymerases are 
involved in the transcription of their different RNA species. Most transgene constructs 
use promoters recognized by RNA polymerase II, responsible for mRNA transcription, 
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although some expreSSIOn cassettes make use of promoters recognized by RNA 
polymerase III and these are used mainly for the expression of short mRNA or micro 
RNA (miRNA) (Lodish et al., 2007). 
1.1.2- Eukaryotic expression systems 
Various eukaryotes have been used for trans gene expression, including yeast, insect 
and mammalian cells. Generally, exogenous DNA is cloned in plasmids which can be 
delivered into these cells by different methods. Pichia pastoris is the most commonly 
used yeast strain for exogenous protein expression. Although it is harder to handle 
relative to bacteria, it is still more favourable than higher eukaryotes due to their 
expression yield (Boettner et al., 2002). The Pichia system was used to express a variety 
of proteins from many different organisms, including humans. DNA topoisomerase I, 
Serum albumin and Granulocyte-macrophage colony-stimulating factor (hGM-CSF) are 
examples of human proteins that were successfully produced using this system (Bushell 
et al., 2003, Wu et al., 2003 and Yang et al., 2004). However, they still have a major 
drawback with the glycosylation of their proteins. When used for immunization, 
glycosylated proteins expressed in Pichia can invoke an improper response, making them 
unsuitable for these applications (Macauley-Patrick et al., 2005). 
The most widely used insect cell expression system is the baculovirus-based 
system. Baculoviruses have a circular double stranded DNA and infects mainly insects, 
making them safer relative to other mammalian systems that use mammalian or human 
viral infections (Granados & Federici, 1986; Groner, 1986; Kang, 1988 and Luckow & 
Summers, 1988; Miller, 1988; Maeda, 1989 and Kost et al., 2005). The virus produces 
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polyhedra which consist of the polyhedrin protein. The promoter of this protein is usually 
used to drive high transcription efficiency leading to high expression of the trans gene 
(Miller, 1988 and Maeda, 1989). In addition, insect cells can recognise the secretion 
signal of mammalian proteins (Oker-Blom et aI., 1989). 
Although insect cell expression systems have high efficiency of recombinant 
protein expression, they still have some drawbacks in the quality of the produced 
proteins. Insect cells, similar to yeast systems, have N-linked glycosylation problems. 
They can perform the N-linked glycosylation since they have the processing sites. 
However they cannot complete the process to same diversity of glycosylation as 
mammalian cells (Hseih & Robbins, 1984). 
Mammalian cell lines are the most favourable host in the production of complex 
recombinant proteins because they can perform all the post-translational modifications 
and can recognize the correct signals for synthesis, processing and secretion. The major 
drawback of the mammalian systems remains their low protein yield and their complex 
handling procedures compared to the other systems (Wurm, 2004 and Hunt, 2005). The 
maximum protein amount produced in mammalian cells is about 5 giL, which is almost 
one third of the production efficiency of bacteria or yeast (Anderson & Krummen, 2002; 
Gemgross, 2004 and Baez et aI., 2005). Mammalian cells can carry on complete 
proteolytic processing, phosphorylation, both O-linked and N-linked glycosylation and 
amino acid modifications. 
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1.1.3- Gene expression in cultured mammalian cells 
Expression of trans genes in mammals has gained more attention than all the other 
expression systems due to the quality of the expressed proteins. Mammalian cells 
complete all the post-translational modifications and provide the correct folding of any 
protein molecule as their expression machinery is more advanced than the other 
eukaryotic expression systems (Makrides, 1999; Kaufman, 2000; Butler, 2005 and Hunt, 
2005). The expression of protein with the right post-translational modifications and 
folding is important for the biological activity and hence the functionality of proteins. 
The first step in designing a mammalian trans gene expression system is the 
construction of the expression cassette. This includes choosing the appropriate promoter 
and poly(A) signa1. Other elements might be included to fulfill specific functions that 
enhance the system stability or efficiency. Different methods are used to deliver the 
trans gene into mammalian cells. These include the use of viral or non-viral vectors and 
will be discussed later. 
Different mammalian cells are used, among them are: baby hamster kidney (BHK) 
(Wurm & Bernard, 1999), mouse myeloma (NSO) (Dinnis & James, 2005), African green 
monkey kidney (COS) (Blasey et ai., 1996), human embryonic kidney 293 (HEK 293) 
(Jordan et ai., 1998) and Chinese hamster ovary (CHO) cells (Preuss et ai., 2000). Cells 
can be grown as a monolayer by the cellular adhesion to the surface of culture plates or 
in suspension using special culture bottles or containers. Transgenes can be integrated in 
the genome of the cell to form a stable cell line expressing the recombinant protein. 
However, the process of mammalian cell line construction is both time consuming and 
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labour intensive. Another alternative method is to express the recombinant protein from a 
transient vector to obtain a good yield in a short period of time (Hunt, 2005). 
CHO cells were the first mammalian cells used to express recombinant proteins, 
and they are currently being used to express the majority of therapeutic proteins 
expressed in mammalian cells (Wurm, 2004). They have been used to express many 
human recombinant proteins including the 21.5 kDa myelin basic protein and proteolipid 
protein (Jaskiewicz et aI., 2005), the bone morphogenetic protein 2 (Zhang et at., 2006) 
and the CDl4 monoclonal antibody (Tang et at., 2007). 
Transgene expression in mammalian cells is characterized by its low protein yield. 
To enhance trans gene expression levels, scientists make use of viral expression vectors. 
Among these systems is the poliovirus which uses its new genomic RNA molecules as 
templates for protein expression (Wimmer et at., 1993 and Xiang et at., 1997). The 
presence of different non-coding mRNA sequences in the viral mRNA increases its 
stability and enhances its translation. An example is the internal ribosome entry site 
(IRES), which was identified from poliovirus (Pelletier & Sonenberg, 1988; Jang et at., 
1989 and Molla et at., 1992) and was used to enhance the binding of viral mRNA to the 
ribosomes. In addition, viruses use other regulatory elements that interfere with the 
cellular translational machinery to enhance viral translation. 
1.2- CONTROLLING EXOGENOUS GENE EXPRESSION IN MAMMALIAN 
CELLS 
The control of gene expression in mammalian cells has been studied on different 
levels, from gene to protein. This includes transcription, post-transcription, translation 
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and post-translational levels. Two additional factors are involved only with exogenous 
genes: the first is the delivery of DNA and the second is the stability of exogenous DNA 
in the host cell. 
1.2.1- Delivery of DNA 
The first step in expressing any transgene is the successful transfer of the DNA into 
the nucleus of the host celL Different methods are being used to deliver trans genes into 
mammalian cells. The efficiency of DNA delivery depends on the methods used as well 
as the type of cells. These methods have been classified according to the nature of the 
transfer process, either viral (infection) or non-viral (transfection). Non-viral DNA 
delivery has been further classified, according to the agent or technique used, into 
physical or chemical (Chou et al., 2004 and Liu et al., 2004). 
1.2.1.1- Viral delivery 
Viral delivery has the advantage of its high delivery efficiency and the ability to 
target specific cells or tissues and is being used intensively in gene therapy. Five major 
viral vectors are being used in the delivery of DNA both in vitro and in vivo, including 
adenovirus (Douglas, 2008), adeno-associated virus (Coura Rdos & Nardi, 2008), 
lentivirus (Philpott & Thrasher, 2008), herpes simplex virus (Burton et al., 2002) and 
retrovirus (Tai & Kasahara, 2008). The pros and cons of these viral delivery vectors 
mentioned above are summarized in Table 1.1 and reviewed in Nuno-Gonzalez et aI., 
2005 and Worgall, 2005. 
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Table 1.1: Characteristics of the most commonly used gene transfer vectors (modified from 
Worgall,2005). 
Vector type 
Transgene 
Advantages Disadvantages 
capacity 
- Easy to produce at high titres - Host immune and 
- High expression levels inflammatory response 
Adenovirus 7.5 kba - Almost all cell types transducible - Transient expression 
- Infects replicating and non-replicating cells - Instable genome 
- Cell targeting possible 
- Almost no immunogenicity - Difficult to produce at high 
Adeno- - Non-pathogenic in humans titres 
associated 4.5 kb - Infects replicating and non-replicating cells - Small trans genes 
virus - Site-specific, stable integration - Late onset of expression 
- Long-term expression 
- Non-immunogenic - Insertion mutagenesis 
- Stable integration in dividing cells - Low titres 
Retrovirus 8 kb 
- Cell type retargeting possible - Infects only proliferating 
cells 
Lentivirus 8 kb 
- Non-immunogenic - Safety concerns 
- Stable integration - Possible mutagenesis 
Herpes - Good persistence in selected cell-types - Toxicity and 
simplex 10-40 kbb - Large expression cassette immunogenicity 
virus 
. . 
a CapacIty for helper-dependent (gutless) vectors contammg no vIral genes IS approxImately 36 kb . 
b Herpes virus vectors 10 kb, herpes virus replicons 40 kb. 
1.2.1.2- Non-viral delivery 
Although they have lower efficiencies when compared to viral-based delivery, non-
viral DNA transfer methods are immunologically safer with faster and easier DNA 
preparation (Zhang et aI., 2004). Non-viral transfer is performed either by using a 
physical transfer method or by a chemical agent although both have smaller gene size 
limitations. The physical methods are based on using physical forces to insert DNA into 
cells or tissues. On the other hand, the mechanism of the chemical delivery is based on 
8 
I ntroauction 
the interaction between the chemical compound and the DNA and their interaction with 
the cellular membrane. (Chou et ai., 2004). 
1.2.1.2.1- Physical delivery 
Physical methods can be used with a wide range of cells and tissues. One of the 
commonly used physical methods is electroporation, where an electrical pulse is being 
used to disturb the balance in the cellular membrane charge. This creates membrane 
pores through which the DNA can enter the cell. This method is being used with a 
variety of cells and tissues, both in vitro and in vivo, and also for single cell and adherent 
cells transfection (Olofsson et al., 2003 & 2007 and Rabussay, 2008). Transgenes can 
also be delivered by capillary microinjection, where a single cell can be injected by the 
trans gene (Graessmann & Graessmann, 1983 and Zhang & Yu, 2008). 
Another method is the gene gun which bombards microscopic-size tungsten or gold 
particles carrying the transgene into the cytoplasm (Yang et ai., 2001 and Chou et al., 
2004). Finally, ultrasound has been used to enhance the chemical transfection by 
liposomes (Unger et at., 1997 and Koch et at., 2000). Ultrasound can be used on its own 
to deliver DNA into cells, although the delivery mechanism is still unknown (Frenkel et 
al., 2002 and Deshpande & Prausnitz, 2007). Despite their efficiency and suitability to a 
wide range of cells and applications, physical methods are limited by their specific tools 
and apparatuses (Chou et al., 2004). In addition, the application of physical force can 
reduce cell survival or damage them. For instance, electroporation at high voltages can 
increase cell death or induces apoptosis at lower voltages (Matsuki et al., 2008). 
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1.2.1.2.2- Chemical delivery 
Different chemical compounds are used in DNA transfection, including 
diethylaminoethyl dextran (DEAE-dextran), calcium phosphate and cationic polymers 
(Liu et al., 2004). DEAE-dextran aggregates with DNA or RNA and forms a positive 
charged mixture that binds to the plasma membrane and is then internalized by 
endocytosis. The transfection efficiency is dependent on the cell type and can reach up to 
80% (Onishi & Kikuchi, 2003; Liu et al., 2004 and Onishi & Kikucchi, 2004). 
Cationic polymers are another family of chemical reagents used in transfection and 
characterized by their high water solubility. Polyethyleneimine (PEl) is the most 
commonly used cationic polymer for gene transfer (Boussif et a!., 1995 and Abdallah et 
al., 1996). PEl has two types, linear and branched, the latter is used in transfection and 
was used to transfect different cells in vitro and in vivo (Godbey et a!., 1999; Lemkine & 
Demeneix, 2001; Schatzlein, 2001; AsIan et a!., 2006 and Ahn et al., 2008). When used 
in excess amounts, PEl forms a cationic complex with DNA that can bind to the cell 
surface and is internalized afterwards in an endosome from which it can break away into 
the cytoplasm (Boussif et al., 1995; Kichler et al., 1995; Behr, 1996 and Labatmoleur et 
a!., 1996). However, the high cytotoxicity of PEl is the major disadvantage that limits its 
use with several cell lines (Moghimi et al., 2005). 
Graham and van der Eb introduced the calcium phosphate transfection early in 
1973 and since that time, the method has been used in the transfection of various cells. 
The transfection method is based on the precipitation of DNA as a calcium phosphate-
DNA complex. The precipitate is then adsorbed on the cell surface and subsequently 
enters the cell by endocytosis (Loyter et al., 1982 and Orrantia & Chang, 1990). 
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In 2002, Grosjean et at., studied calcium phosphate transfection in CHO cells and 
found that the process is more efficient during cell division. Calcium phosphate 
transfection efficiency varies between the different cells and depends on the quality and 
size of the formed precipitate and can reach 50% of the initial used cell count (Liu et at., 
2004). 
Cationic lipids are another family of transfection reagents and was introduced by 
FeIgner et at. (1987) when they used N-(2,3-dioleyloxypropyl) N, N, N-· 
trimethylammonium chloride (DOTMA) in a lipofection process to transfect DNA. In 
1989, the same reagent was used to transfect RNA into different cells including mouse, 
rat and human (Malone et at., 1989). Many different cationic lipids are being used today 
for transfection and all have the same basic structure that consists of a head, a linker and 
an anchor. The head contains nitrogen atoms to give the head its positive charge and 
hydrophilic nature, while the anchor is hydrophobic since it consists of one to three 
hydrocarbon chains. Both the head and the anchor are essential for the mechanism of 
transfection mediated by cationic lipids (Gao & Huang, 1995; Dalby et at., 2004 and Liu 
et at., 2004). The major classes of cationic lipids are reviewed by Balaban & Hies (2001). 
Due to their amphiphilic nature, cationic lipids form liposomes in aqueous 
solutions. DNA interacts with the positively charged head and forms complexes called 
lipoplexes, which can then interact with the negatively charged cell membrane and 
deliver the DNA into the cell (Liu et at., 2004). Lipofection is used for DNA, RNA and 
small interfering RNA (siRNA) delivery both in vitro and in vivo (FeIgner & Ringold, 
1998 and Pautz et at., 1993). Although the transfection efficiency depends mainly on the 
structure of the cationic lipid, there are other factors that affect the efficiency including 
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the cell type, DNA size and the ratio between the cationic lipid and DNA (Liu et ai., 
2004 and Recillas-Targa, 2004). 
1.2.2- Transgene stability 
The physical presence of the transgene and its activity directly affects gene 
expression efficiency. After the delivery of the transgene into the nucleus of the host cell, 
two possible pathways can take place. The first is the episomal presence of the 
exogenous DNA with no integration into the genome of the host cell and is called 
transient transfection. However in the second pathway, the transgene integrates into the 
genome to form stable transfected cells. 
1.2.2.1- Transient transfection 
The transgene is present in an episomal form, with no integration in the genome, 
and will last for a period of time that depends on its degradation rate and its ability to 
replicate. Usually, high degradation levels are common in transient transfection and 
about 50% of plasmid DNA is degraded within one to two days post-transfection 
(Recillas-Targa, 2004). For this reason, various attempts have been carried out to 
increase the stability of episomal trans genes inside the cell by using viral replication 
elements. Among these viral replication origins are: the SV 40 (Stillman, 2005), the 
bovine papillomavirus (BPV) and the human papillomavirus (HPV) (Chow & Broker, 
1994). 
The introduction of the first human artificial chromosome (HAC) in 1997 was a 
promising step to enhance the stability of gene expression from episomal DNA 
(Harrington et ai., 1997). HACs can be obtained by two techniques; the first method is 
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the top-down and is based on the use of a complete chromosome and its size reduction 
(Farr et al., 1992). The second is the bottom-up method where the chromosome is a 
combination of different DNA fragments (Basu & Willard, 2005). The utilization of 
HACs is limited due to their low stability and their high integration probability into the 
cellular genome (Lipps et al., 2003; Conese et al., 2004 and Basu & Willard, 2005 and 
Glover et a!., 2005). 
1.2.2.2- Stable transfection 
The integration of the transgene into the host cell genome will generate a stable cell 
line which can express the integrated trans gene. The establishment of stable cell lines is a 
time consuming and labour intensive process. In addition, different factors affect the 
expression of the trans gene from the new cell lines. The integration site and the integrity 
of the trans gene together with its copy number are the most important factors (Recillas-
Targa, 2004). 
The integration site of the transgene in a stable cell line has a major effect on its 
gene expression efficiency (Grosveld et al., 1987; Phi-Van et al., 1990 and Chung et a!., 
1993). Upon transfection, the transgene integrates either in the euchromatin or the 
heterochromatin. Since the majority of the genomic DNA is heterochromatin, transgene 
integration most likely will lead to its silencing and transcription repression. 
Alternatively, an integration site within the euchromatin will guarantee the active 
transcription of the trans gene (Dillon & Festenstein, 2002 and Dillon, 2004). Various 
methods have been attempted to protect transgene against the epigenetic effects that can 
repress trans gene expression. The two main strategies used for such protection are 
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modifications performed on histones or by incorporating protective sequences into the 
transgene. 
Transgene copy number is a very important factor in enhancing its expression. To 
increase the copy number, a classical method based on the tandem cloning of multiple 
copies of the trans gene in the same vector can be used, however this strategy leads to 
transgene silencing upon integration (Garrick et al., 1998). Another more sophisticated 
strategy is based on gene amplification which can be described simply as in vivo PCR. 
The dihydrofolate reductase (DHFR)/methotrexate system is the most well understood 
and used method for gene amplification and has been used to express different proteins 
(Monaco et al., 1996; Peroni et aI., 2002 and Chung et al., 2003). 
1.2.3- Transcription 
Choosing an active and appropriate promoter is essential for maximizing gene 
expression. In addition, the incorporation of enhancers and transcription factors can 
further improve expression levels. 
1.2.3.1- Promoters 
Promoters are DNA sequences where the different transcriptional elements, 
including the enhancers, transcription factors and RNA polymerase interact to initiate the 
transcription process (Huang et aI., 1996; Goodrich et aI., 1996 and Novina & Roy, 
1996). Promoters recognized by eukaryotic RNA polymerase II are predominantly used 
in trans gene expression since this polymerase is responsible for mRNA transcription. 
The T ATA box, in addition to an upstream element, such as a CAA T box or dc boxes, 
are the essential components of most eukaryotic promoters although some promoters do 
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not have a TATA box (Kollmar et a!., 1994 and Boam et a!., 1995). Transgenes designed 
for expression in mammalian cells should include a promoter compatible with the 
eukaryotic transcription machinery (Kaufman, 1990 and Kriegler, 1990). Promoter 
strength has a direct effect on ultimate protein production (Yew et a!., 1997). Both viral 
and eUkaryotic promoters can be used, however viral promoters are characterized by their 
high efficiency due to the nature of the viral infection. Active and high levels of viral 
protein production are required for the completion of the viral life cycle. Therefore, the 
most commonly used promoters in trans gene expression are of viral origin and these 
include the cytomegalovirus immediate early (CMVie) promoter, the AdS major late 
promoter (MLP), the SV40 promoter, Rous Sarcoma virus promoters and the murine 3-
phosphoglycerate kinase promoter (Markrides, 1999 and Papadakis et al., 2004). 
Some promoters show different efficiencies, either lower or higher activity, In 
different tissues. For instance, the CMV promoter, which is known for its high 
efficiency, has lower activity in hepatocytes (Najjar & Lewis, 1999). Other promoters 
exert their activity in a tissue-specific manner and are particularly important in gene 
therapy to control the site where the therapeutic protein will be expressed. The major 
difficulty in achieving high and localized trans gene expression is the weakness of tissue-
specific promoters. For that reason, efforts are being made to enhance the promoter 
strength by different methods including the positive feedback loop (Nettelbeck et al., 
1998), the two step amplification method (Iyer et a!., 2001) and the Cre-loxP method 
(Kaczmarczyk & Green, 2001 and Nakamura et al., 2008). 
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1.2.3.2- Enhancers 
Enhancers are DNA sequences that increase mRNA transcription regardless of their 
distance or orientation. Their activity can be limited by insulators which were first 
defined as enhancer blockers. The first enhancer was found in the SV 40 virus while the 
immunoglobulin heavy-chain locus contained the first identified human enhancer 
(Banerji et aI., 1981; Banerji et aI., 1983; Atchison, 1988 and Lee & Young, 2000). 
Enhancers contain transcription factors binding sites (TFBSs) that allow the interaction 
with transcription factors to enhance the transcription process. They are similar in their 
function to the upstream promoter elements that also contain TFBSs and enhance 
transcription. However, enhancers are more flexible in both distance and orientation 
(Maston et al., 2006). They can work from a long distance through DNA looping to bring 
both the promoter and the enhancer close to each other. This action will allow the 
recruitment of the general transcription factors at the TFBSs and the creation of the 
transcription pre-initiation complex (Szutorisz et al., 2005 and Vilar & Saiz, 2005). 
The incorporation of enhancers in the integrated trans gene prevents its silencing, 
however rapid decrease and loss of expression from integrated transgenes was reported 
when the enhancers were deleted (Walters et al., 1995 & 1996 and Sutherland et aI., 
1997). This anti-silencing effect is mediated by the ability of enhancers to guide the 
transgene to integrate away from heterochromatin. This prevents its silencing and 
maintains the active transcription state (Francastel et al., 1999). 
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1.2.3.3- Transcription factors 
Transcription factors are proteins that interact with RNA polymerase to initiate or 
enhance the transcription process. Factors related to the RNA polymerase II can be 
subdivided into two types; general factors and promoter-specific factors. General factors 
are essential for transcription initiation; they interact with the TATA box and the RNA 
polymerase. Promoter-specific factors vary between the different promoters; they interact 
with specific DNA sequences in the promoter to enhance the transcription process 
(Weaver & Hedrick, 1992). 
Although not essential for transcription initiation, promoter-specific transcription 
factors play a role in enhancing trans gene expression. Similar to enhancers, the 
incorporation of a transcription factor in the trans gene is determined by the degree of 
enhancement and the spacing considerations. However, transcription factors differ from 
enhancers in that they are proteins that interact with cis-acting DNA motifs of about 10 
bp. The coding genes of these factors can be placed, if their expression is required, either 
in cis or in trans from the trans gene. Therefore, the presence of these small motifs in the 
promoter used for transgene expression has an additional enhancing effect. They can 
normally be present in the promoter or they can be inserted during promoter design and 
construction (Papadakis et al., 2004). Examples of these transcription factors are the zinc 
finger proteins, homeodomains and leucine zippers. While the majority of transcription 
factors perform their function by protein-DNA interaction, some factors, such as the AdS 
EIA protein, do not interact directly with these DNA motifs but instead interact with 
other proteins that can bind specific DNA (Liu et al., 1994). 
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When their binding DNA motifs are engineered correctly in a trans gene, over-
expression of transcription factors can efficiently increase transgene expression. Over-
expression of the zinc finger transcription factors MAZ and Sp 1 increased expression 
from the adenovirus MLP in HeLa cells. This expression was increased to about 200-fold 
in the presence of adenovirus E lA proteins (Parks & Shenk, 1997). 
1.2.4- Post-transcription 
The control of trans gene expressIOn on the post-transcriptional level includes 
different events. Since the nuclear envelop acts as a physical barrier between the nuclear 
and cytoplasmic environments, scientists have divided these post-transcriptional control 
events into post-transcriptional modifications, mRNA transport and mRNA stability. 
1.2.4.1- Post-transcriptional modifications 
The majority of mRNA transcripts in eukaryotes undergo a capping process to 
protect the 5' end from cellular exonucleases (Furuichi et al., 1977 and Shatkin, 1985). In 
addition, this capping enhances the transport of mRNA from the nucleus to the 
cytoplasm and is essential for the interaction between the mRNA molecule and the 
ribosomes in the first step of the translation process (Banerjee, 1980; Rhoads, 1988; 
Hamm & Mattaj, 1990 and UUu & Tschudi, 1991). These modifications can be done in 
vitro through the incorporation of an mRNA cap using modified cap nucleotides 
(Stepinski et aZ., 2001). However, no cap modifications have been applied on transgene 
mRNA capping since no DNA sequence can alter the process. 
Polyadenylation is the addition of a non-coding poly(A) tail to the 3' end of the 
mRNA molecule, a process that takes place mostly in the nucleus (Birnstiel et aZ., 1985 
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and Carter et al., 1993). The length of the tail varies between different organisms, 
ranging from 70-90 nucleotides in yeast and 200-250 nucleotides in mammalian cells 
(Jacobson, 1996). The polyadenylation process includes two steps, first a clipping 
enzyme cleaves the newly synthesized premature mRNA molecule at a specific site, and 
then the poly(A) polymerase starts to add the tail (Wahle & Ruegsegger, 1999; Zhao et 
al., 1999; Edmonds, 2002; Hall, 2002; Wu & Alwine, 2004 and Clark, 2005). This tail 
protects the 3' end from degradation by an exonuclease and is also involved in the 
regulation of the translation (Brawermann, 1981; Bernstein & Ross, 1989 and Gallie et 
al., 1991). Both the poly(A) tail and the cap are needed for mRNA transport and they 
efficiently enhance gene expression (Bechler, 1997). In addition, longer poly(A) tails are 
translated more efficiently than shorter tails and yield more protein (Mockey et al., 
2006). 
Therefore, the incorporation of a suitable polyadenylation signal downstream of the 
gene in trans gene design is very important for accurate mRNA production and 
processing. In fact, the signal specifies the cleavage site for the clipping enzyme. This 
signal should be recognizable by the transcription machinery of the used cell or 
organism. In mammalians, the polyadenylation signal has three elements in its core 
sequence, starting with a highly conserved AAUAAA sequence, then the cleavage site 
(downstream by 10-30 nucleotides) and ending with a conserved region rich in GU or U 
nucleotides (Chou et aI., 1994; Chen et aI., 1995; Graber et al., 1999 and Hans & 
Alwine, 2000). 
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1.2.4.2- mRNA transport 
After the post transcriptional modifications, mRNA is transported to the cytoplasm 
where the translation can start. While still in the nucleus, mRNA interacts with proteins 
to form mRNA-protein complexes called ribonucleoproteins (RNPs). These complexes 
are then exported through the nuclear pore complexes (NPCs) in a process that requires 
energy and is regulated by transport factors-mediated recognition (Mattaj & Englmeier, 
1998; Gorlich & Kutay, 1999; Conti & Izaurralde, 2001; Reed & Magni, 2001 and Reed 
& Hurt, 2002). 
The mRNA transcribed from transgenes is being transported under the same 
conditions and mechanism as cellular mRNAs. No reported sequences or genes encoding 
nuclear localization signals (NLSs) and/or nuclear export signals (NESs) were 
incorporated into trans genes to facilitate the transport process. On the other hand, a few 
viruses have a more complicated system since some of their proteins can act as NLSs 
and/or NESs. These proteins interact specifically with viral mRNAs and guide them 
through the transport process. One example is the active transport of the adenovirus late 
mRNA mediated by the interaction between the EIB 55k protein and the E4 orf6 
proteins with viral mRNA (Horridge & Leppard, 1998). 
1.2.4.3- mRNA stability 
The net balance between rates of mRNA synthesis and degradation determines 
mRNA accumulation. One side of the balanced equation is more controllable on the 
transgene design level and contains all the aforementioned factors that affect the 
transcription efficiency. The other side of the equation contains the factors that affect 
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mRNA stability and unfortunately are less controllable. In general, mRNA stability is 
determined by the different elements that confer resistance to degradation and it plays an 
important role in gene expression regulation (Coller & Parker, 2004). 
The degradation of mRNA starts with poly(A) deadenylation which indicates the 
importance of the tail in protecting the molecule (Fort et aI., 1987; Peppel & Baglioni, 
1991; Shyu et at., 1991; Bernstein et at., 1992; Lieberman et aI., 1992 and Parker & 
Song, 2004). The length of the poly(A) tail is another stability determinant. Since 
poly(A)-binding protein (PABP) has a high affinity in binding poly(A), longer poly(A) 
tails allow the binding of more P ABP which protects the tail from the degradation by 
exonucleases or by other complex interactions (Bernstein et at., 1992; Gorlach et at., 
1994 and Rowlett et at., 2008). The presence of a stable poly(A) tail will not only 
increase the accumulation of mRNA in the cytoplasm, but will also enhance mRNA 
translation (Bernstein & Ross, 1989; Sachs, 1990; Patel & Butler, 1992; Peltz & 
Jacobson, 1992 and Sachs, 1993). 
The presence of the 3' untranslated region is another element to determine mRNA 
stability since this region commonly contains signals for mRNA decay (Chen et at., 
2001; Wang & Kiledjian, 2001 and Mukherjee et at., 2002). Examples of these regions 
are the Histone mRNA 3'-terminal stem-loop (Marzluff & Pandey, 1988 and Schumperli, 
1988) and the AU-rich elements (Caput, et at., 1986 and Shaw & Kamen, 1986). Some 
proteins bind to the 3' untranslated region to cover and shield their mRNA decay signals 
(Caput, et at., 1986; Shaw & Kamen, 1986 and Ross, 1995). The endonuclease site 
within the 3' C-rich sequence of the globin mRNA is used for regulating mRNA decay 
and therefore globin gene expression. The poly(C)-binding protein can shield this 
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endonuclease site and is believed to be regulated by a cellular signalling pathway that 
controls the binding affinity of the poly(C)-binding protein to the C-rich sequence (Wang 
et aI., 1995; Weiss & Liebhaber, 1995 and Waggoner & Liebhaber, 2003). 
As previously mentioned, the 5' cap protects the mRNA and is important for its 
translation initiation. Decapping of the mRNA might add another regulatory pathway 
since cap-containing mRNAs are at least four times more stable than cap-lacking 
mRNAs (Furuichi et ai., 1977; Shimotohno et ai., 1977; McCrae & Woodland, 1981 and 
Peltz et aI., 1987). In addition, some 5' untranslated regions can enhance mRNA stability 
several fold and control its localization and translation efficiencies (Pesole et aI., 2001). 
For instance, the tripartite leader sequence (TPL) in adenovirus mRNA increases its 
stability by five folds (Moore & Shenk, 1988). 
1.2.5- Translation 
The final destination of the mRNA molecule is to bind to the ribosomes and then 
initiation of the translation. The process is regulated by different mechanisms during the 
initiation and the elongation steps (Jefferson & Kimball, 2003). The initiation step starts 
with the formation of the pre-initiation complex by the assembly of three main 
components; the mRNA, 40S ribosomal subunit and the methionine-tRNA. The 
formation of this complex is mediated by different factors called the eukaryotic initiation 
factors (e.g. eIF4F). The different factors interact with the three main components and 
bring them into close proximity to form the initiation complex (Klann & Dever, 2004). 
The control of the translation initiation step is mediated mainly by the 
phosphorylation performed on some of the eukaryotic initiation factors or their binding 
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proteins. Translation is suppressed by the phosphorylation of eIF2, which can be 
controlled by different stimuli of cellular kinases. This includes the stimulation of the 
double-stranded protein kinase RNA-activated (PKR) by viral double-stranded RNA 
(dsRNA) (Kaufman, 1999 and Hinnebusch, 2000), dimerization disruption (Lee et a!., 
1994 and Gale et a!., 1997, 1998 and 1999) and blocking the interaction between PKR 
and its substrate (Beattie et a!., 1991; McMillan et al., 1995; Brand et a!., 1997 and 
Kawagishi-Kobayashi et al., 1997). Similarly, phosphorylation ofeIF4E binding protein-
1 will prevent binding the eIF4E which then allows its function in the initiation step to 
occur (Ptushkina et al., 1999). On the contrary, phosphorylation of eIF4G enhances its 
binding potential to the initiation complex (Bolster et al., 2004). 
Transgene translation usually undergoes the same cellular regulatory mechanisms 
that are based on the cap binding and the formation of the pre-initiation complex. 
However, some mRNA sequences can enhance the translation process and they can be 
incorporated or optimized during the trans gene design and construction. This includes 
the kozak sequence, the stop codon, the codon usage and the IRESs. 
1.2.5.1- Kozak sequence 
The sequence that flanks the AUG initiation codon is defined as a consensus 
sequence of CC(A/G)CCAUGG and was named as the Kozak sequence. In addition to 
the AUG, AlG at the -3 position and the G at the +4 are the most important two 
nuc1eotides in the sequence. The presence of this sequence enhances the recognition of 
the translation initiation codon by eukaryotic ribosomes (Kozak, 1987 and 1997). The 
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incorporation of the Kozak sequence upstream of the gene was found to increase gene 
expression. 
In vitro expression of the human serum albumin gene in different horse cells was 
enhanced by the kozak sequence (Olafsdottir et aI., 2008). Du et al. (2008) investigated 
the effect of A or G nucleotide at the +4 position of the kozak sequence on green 
fluorescence protein (GFP) expression in HEK 293 cells. They reported that using G at 
+4 enhances GFP expression by 4 fold providing that the -3 nucleotide is a purine (A/G). 
This +4 G enhancement effect is more related to the presence of alanine (GCN) and 
glycine (GGN) in the second amino acid position (Xia, 2007). 
1.2.5.2- Codon usage 
Codon usage and optimization can enhance translation since mammals have more 
than one codon for each amino acid and some organisms favour one codon over the 
others (Ikemura, 1985 and Nagata et al., 1999). Some poorly translated poxvirus and 
human papillomavirus genes, expressed transiently in mammalian cells, showed 
improved translation efficiencies upon codon optimization (Disbrow et aI., 2003; 
Mossadegh et al., 2004 and Barrett et al., 2006). The optimization of Aequorea victoria 
GFP (A vGFP) increased its expression in mammalian cells by four to ten fold and also 
enhanced its fluorescence (Yang et al., 1996 and Zolotukhin et al., 1996). Similarly, 
expression of human erythropoietin in'mammalian cells was enhanced by more than 13 
fold after codon optimization (Kim et aI., 1997). Even the choice of the stop codon 
(VAA, VGA or VAG) and the adjacent nucleotides affects the translation termination 
efficiency (Cassan & Rousset 2001, Namy et aI., 2001 and Sun et al., 2005). 
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1.2.5.3- IRES 
The expression of some viral proteins under cellular translation suppreSSIOn 
attracted scientists to investigate the mechanisms and sequences used to escape from the 
cellular translation regulation. One interesting sequence is the IRES, used by the 
ribosomes to bind within the mRNA molecule, although not from the 5' end, and start the 
recognition and subsequent translation from the AUG codon downstream from the IRES. 
It was first identified from poliovirus (Pelletier & Sonenberg, 1988) and named by Jang 
et al. (1989) after a study on encephalomyocarditis virus RNA and confirmed from 
poliovirus by Molla et al. (1992). 
Different viral and cellular IRESs have been isolated and function to allow the 
ribosomal attachment and translation of an internal gene without the need of the cap-
binding initiation mechanism (Jang et al., 1988; Pelletier & Sonenberg, 1988, Jackson & 
Kaminski, 1995 and reviewed in Baird et al., 2006 and Martinez-Salas et aI., 2008). This 
mechanism, together with the absence of tissue specificity, allowed the incorporation of 
IRES sequences in transgenes design to transcribe bicistronic mRNA. Expression from 
this mRNA occurs with cap-dependent translation of the first gene and IRES-mediated 
translation of the second gene (Lucas et al., 1996 and Shaw-Jackson & Michiels, 1999). 
1.2.6- Post-translation 
Although some sequences can be incorporated in a trans gene to guide the protein 
secretion, other elements are less controllable and rely on the cellular ability to perform 
accurate post-translational modifications. As mentioned earlier in this chapter, transgene 
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expression was upgraded from simple prokaryotes to complex mammalian cells to match 
the increased requirement for efficient and accurate post-translational cellular machinery. 
Various post-translational modifications are performed on the primary polypeptide 
chain to form the final protein molecule in its active form. Among these modification 
reactions are acetylation, acylation, adenosine diphosphate-ribosylation, amidation, y-
carboxylation, ~-hydroxylation, disulfide bond formation, folding, glycosylation, 
phosphorylation, proteolytic processing and sulfation (Walsh & Jefferis, 2006). Despite 
the fact that mammalian cells can perform all of these modifications, the efficiency and 
accuracy of these processes is encountered by other reactions or drawbacks such as 
glycosylation variation, methionine oxidation, asparagine and glutamine deamidation and 
protein misfolding and aggregation (Jenkins et aI., 2008). 
Viral expression systems are used as a model to understand gene expression in 
mammalian cells. In this study, different genes and sequences that are thought to enhance 
gene expression were used from the Ad5 genome to study gene expression in mammalian 
cells. 
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1.3- ADENOVIRUS 
The adenovirus, named after its first isolation from adenoidal tissue in 1953 (Rowe 
et aI., 1953; Hillemann & Werner, 1954), is considered the most extensively used viral 
model for gene delivery and expression studies. The virus is widely used in molecular 
biology research and is well understood on both the structural and genetic levels. The 
adenovirus was used the research model where RNA splicing was first established. 
Among the different isolated types of adenoviruses, human serotype 5 remains the 
workhorse in the majority of research and applications. The virus does not induce human 
cancer, which makes it the most favourable viral gene delivery vector for mammalian 
cells, especially in gene therapy. 
1.3.1- Classification 
Adenoviruses belong to class I viruses (double stranded DNA viruses) according to 
the Baltimore classification system. They are grouped in the family Adenoviridae and 
subdivided, according to their host, into four different genera: Atadenovirus, 
Aviadenovirus, Mastadenovirus, and Siadenovirus (Figure 1.1). Human adenoviruses are 
members of the genus Mastadenovirus, and they are sub-grouped, according to different 
properties including their nucleotide sequence and hemagglutination, into six subgroups 
(A to F). The types of the different groups are distinguished by their serological 
differences and are known as serotypes. The collective serotype numbers in the six 
groups of human adenoviruses is fifty-one (Benko et al., 1999 and Lichtenstein & Wold, 
2004). 
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B), Human (A-F), Murine, Ovine 
(A, B), Porcine (A-C), Tree shrew, 
unclassified Simian & unclassified 
Mastadenoviruses 
[ Human adenoviruses 
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Serotypes: 12, 18, 31 3,7,11,14,16,21, 1,2,5,6 8-10,13,15,17,19, 4 40,41 
34,35,50 20,22-30,32,33,36-
39,42-49, 51 
Figure 1.1: Taxonomic structure of the family Adenoviridae (reproduced from the National 
Center for Biotechnology Information (NCB!) taxonomy browser: http://w~:yw.ncbi.nlm''!'uih.gov 
lTaxonomy/Browser/wwwtax.cgi?id= 1 0508). 
1.3.2- Genome 
Human adenoviruses have a linear double stranded genome of 35-38 kbp. The 
genome is characterized by its inverted terminal repeats (ITRs) and the 5' terminal 
protein which are essential for viral genome replication (Rekosh et aI., 1977 and Hay et 
aI., 1995). Adenovirus genes are divided into early and late genes according to the stage 
of their transcription within the viral life cycle. All the adenoviral mRNAs are 
transcribed by RNA polymerase II except the virus-associated RNA (VA RNA) which is 
an RNA polymerase III transcript (Shenk, 2001). Viral transcripts and their protein 
products are shown in Figure 1.2. 
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Figure 1.2: Transcription of the Ad5 genome. Early and late transcripts and their direction are 
indicated by arrows. The major late promoter (MLP) and the tripartite leader sequence (TPL) are 
indicated. 
1.3.3- Life Cycle 
A copious amount of information is available on every gene and the relationship to 
the other viral and cellular genes. This review will be limited to those genes directly 
related to this study. Adenovirus life cycle can be divided into two distinct phases: early 
and late. The early phase starts upon the entry of the virus into the cell and ends just 
before viral DNA replication starts. Then, the late phase begins and lasts until cell lysis 
and the release of the new viruses. 
1.3.4- Early region 
Early genes are the first genes transcribed and expressed during viral infection, 
after the delivery of the viral genome into the nucleus. Early genes include four cassettes 
and are subdivided into immediate early (E I A) genes, and early genes that include E 1 B, 
E2 (E2A and E2B), E3 and E4. All these genes have mainly a regulatory function in the 
viral cell cycle and viral-host interaction. 
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1.3.4.1- The Immediate Early Genes (EIA) 
Gene products of the E1 region are divided into E1A and E1B. Two major mRNA 
transcripts are produced from E1A early after infection, the 13S and 12S which are 
named according to their sedimentation coefficient or 289 and 243, according to the 
length of their amino acid residues (Shenk, 2001). An additional three mRNA transcripts 
of 9S, lOS and lIS are produced from E1A in the later stages, however their function is 
unknown (Stephens & Harlow, 1987 and Ulfendahl et al., 1987). Transcription of these 
mRNAs is driven by a common promoter and they share the same 5' and 3' terminal 
sequences since they are produced by differential splicing. The E IA regions of most of 
the human adenoviruses share three conserved regions (CR1, CR2 and CR3) (Figure 
1.3). 
13S mRNA ______________ --' ~-----------An 
188 
13S Protein N 
~ __ -A~~~ ____ ~~ 1"'"--____ ---', C 
CRI CR2 CR3 
12SmRNA _____________ ~~~ ___________ An 
139 
12S Protein NI L.. __ ~~~.:!o.-'W. __ __J;::~= '--_____ ----', C 
CRI CR2 
Figure 1.3: ElA major mRNAs and their encoded polypeptides. 13S and 12S mRNAs are 
represented in lines; exons are represented by horizontal lines and introns are the caret symbols 
and (An) is the poly A sequence. Polypeptides are represented by triangles, conserved regions 1 
to 3 (CR1, CR2 and CR3) are shown on the Figure (Shenk, 2001). 
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E1A protein products have different functions. They regulate the expression of the 
other adenoviral proteins (early and late). Viruses with a mutated or deleted E1A region 
are replication incompetent since they cannot activate the expression of viral proteins 
(Berk et aI., 1979; Jones & Shenk, 1979 and Shenk et aI., 1980). The HEK 293 cell line, 
which contains the integrated adenovirus El region, can be used to grow these replication 
incompetent viruses (Graham et at., 1977). 
Other functions of the E1A 12S and 13S protein products include the stimulation of 
cell division and growth (Keblusek et at., 1999). They play an important role in 
activating the expression of adenoviral E2 proteins and other cellular S-phase proteins. 
E1A proteins also have the ability to bind and inactivate the retinoblastoma (Rb) tumour 
suppressor proteins. This binding will release the E2F which is the transcription factor of 
E2 and S-phase protein expression (Brehm et at., 1998). The release ofE2F will stabilize 
the p53 tumour suppressor protein. This action is mediated by the induction of the human 
pl4ARF which in tum will bind the mdm2 oncogene and alter its ability to bind and 
inactivate p53 (Lowe & Ruley, 1993; Querido et at., 1997b; Bates et at., 1998; Prives, 
1998 and Zhang et at., 1998). 
In spite of the unique presence of CR3 in the 13 S, the lack of this region in the 12S 
does not affect its ability to mediate cellular transformation. Only CRI and CR2 are 
responsible for cellular transformation (Whyte et at., 1989 and Stein et at., 1990). 
However, the CR3 region has its own functions. CR3 has the binding site of the TATA-
box binding protein (TBP), thus it has an advantage in transcription regulation. The CR3 
also contains a zinc finger domain involved in its binding site with TBP (Culp et at., 
1988; Horkoshi et aI., 1991; Lee et aI., 1991; Webster & Ricciardi, 1991 and Webster et 
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at., 1991). It also mediates transactivation of the activating transcription factor (ATF) 
family of proteins. The interaction of CR3 with ATF-2 and ATF-a is through their 
leucine zipper-dependent activation (Chatton et aI., 1993 and Liu & Green, 1994) or a 
CR3-dependent activation (Flint & Jones, 1991). 
Zinc finger domains of E1A 13S and its ability to interact with the TBP are 
important to increase the late protein expression. E1A increases the expression from the 
adenovirus MLP 4 to 10 fold. On the other hand, MLP activity increases 200 folds when 
both E1A and either MAZ or Sp1 transcription factors are present (Parks & Shenk, 
1997). 
1.3.4.2- E1B 
Unlike E1A which activates p53-mediated apoptosis, E1B proteins inhibit 
apoptosis and antagonize the effect of E1A. Two major protein products are expressed 
from E1B, 19k and 55k, and both function as apoptosis repressors to reverse the action of 
EIA, but via different methods (Rao et at., 1992; Debbas & White, 1993 and Acheson, 
2007). Both proteins share a single mRNA which is 22S, but they have different AUG 
codons for their translation initiation. Despite the overlap in their mRNA sequence, there 
is no homology in the amino acid sequence of both proteins due to the different codon 
positions (Esche et at., 1980; Bos et aI., 1981 and Montell et at., 1984). 
E1B 55k blocks the p53-dependent apoptotic pathway by the direct binding ofp53 
(Samow et at., 1982 and Roth et aI., 1998). The complex ofEIB 55K-p53 is co-localized 
in the cytoplasm (Grand et at., 1999). This interaction is important for viral mRNA 
transport and viral replication (Ridgway et at., 1997 and Horridge & Leppard, 1998). E4 
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orf6 protein has a similar function in binding and inactivating p53 (Dobner et aI., 1996 
and Nevels et al., 1997). The presence of both 55k and E4 orf6 proteins cause a marked 
reduction in p53 production (Querido et al., 1997a and Steegenga et aI., 1998). 
The 55k protein also has important functions during the late phases of t~e viral cell 
cycle. It binds to the E4 orf6 protein product and the new complex plays the main role in 
active transport of the TPL-containing mRNA from the nucleus to the cytoplasm (Babiss 
& Ginsberg, 1984; Babiss et al., 1985; Halbert et al., 1985; Pilder et al., 1986a,b; 
Williams et al., 1986; Leppard & Shenk, 1989 and Bridge & Ketner, 1990). 
The complex ofEIB 55k and E4 orf6 is present in the viral transcription sites in the 
nucleus (Gonzalez & Flint, 2002 and Omelles & Shenk, 1991). Evidence suggests that 
viral mRNA interacts with this complex through the ability of EIB 55k to bind RNA 
(Horridge & Leppard, 1998) and facilitates its transport to the cytoplasm using the E4 
orf6 proteins nuclear localization and transport signals (Dobbelstein et al., 1997). This 
complex also enhances late viral mRNA accumulation in the cytoplasm and its 
subsequent translation (Imperiale et al., 1995). Cellular mRNA transport to the 
cytoplasm and synthesis of cellular proteins are blocked by the same complex (Beltz & 
Flint 1979 and Flint & Gonzalez, 2003). 
The smaller E 1 B protein, the 19K, is more efficient than the 55k in repressing 
apoptosis (Rao et al., 1992) and it is a member of the BCL-2 death antagonists family 
(Chao and Korsmeyer, 1998). The 19k protein represses apoptosis by binding to Bax and 
inhibiting the activation of caspases (Han et al., 1996 and Sabbattini et aI., 1997). EIB 
19k viral mutants have several viral DNA and host cell degradation and low viral 
production (Pilder et al.; 1984 and white et al., 1984). 
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1.3.4.3-E2 
The expression of the EIA genes activates expression of E2 proteins as well as the 
S-phase cell cycle proteins and this prepares the cell for viral DNA replication (Hay et 
al., 1995). E2 gene products are related directly to genome replication and are subdivided 
into E2A and E2B. Three proteins are produced from the entire E2; DNA binding protein 
(DBP) from E2A in addition to viral DNA polymerase and precursor terminal protein 
(pTP) from E2B. 
Two promoters drive expression from the E2 region; one during the early phase of 
the cell cycle (E2 early promoter) and the second is active during the late events (E2 late 
promoter) (Swaminathan &Thimmapaya, 1995). The E2 early promoter has two sites for 
transcription factors, one for ATF-2 and the second is for E2F. Activation of both sites is 
mediated by EIA proteins (Shenk & Flint, 1991; Swaminathan &Thimmapaya, 1995 and 
Brehm et al., 1998). The binding ofE2F on the E2 early promoter is enhanced by the E4 
orf6/7 19k protein (Neill et aI., 1990 and Helin & Harlow, 1994). 
The DBP is a 59k protein that has a high binding affinity for DNA and fulfi1e 
different functions (van Breuke1en et al., 2003). It protects against in vitro DNA 
degradation by inhibiting the DNase-mediated hydrolysis (Nass and Frenkel, 1980). It 
binds cooperatively and non-cooperatively with single stranded DNAs and double 
stranded DNAs, respectively (Dekker et al., 1997). DBP has a major role during viral 
replication to unwind DNA and to stabilize the single stranded DNA during elongation 
(Brenkman et al., 2001) and its flexibility is important for its unwinding function (van 
Breukelen et al., 2000). In addition, it has an important role in replication initiation by 
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enhancing the binding of the viral DNA polymerase to the origin of replication (van 
Breukelen et al., 2003). 
DBP enhances transcription, mRNA stability and assembly of the new viral 
particles (Nicolas et al., 1983; Cleghon et aI., 1989 and Zijderveld et aI., 1994). 
Transcription from most of the adenoviral promoters, except the E4 promoters, is 
activated by DBP (Chang and Shenk, 1990). In addition, the binding of the upstream 
stimulatory factor 1 (USFl) to the MLP is enhanced by the DBP (Zijderveld et al., 
1994). 
Adenovirus DNA polymerase and pTP are produced from E2B and together initiate 
viral DNA replication through a protein-priming mechanism (Parker et aI., 1998). 
Adenoviruses cannot use cellular DNA polymerase for its genome replication and instead 
use the viral DNA polymerase, since it has the ability to interact with pTP and initiate the 
process. Adenovirus polymerase works in the 5' to 3' direction and it has 3' to 5' 
exonuclease activity which is important for proofreading during the replication process. 
Both the polymerase and exonuclease activities decrease upon their binding to pTP (Field 
et aI., 1984 and King et al., I 997a,b). 
The adenovirus replicates its genome through a strand displacement mechanism. 
ITRs are about 100 bp at the left and right ends of the viral genome and they serve as an 
origin of replication. Only the terminal 20 bp from each ITR are needed to initiate the 
process (Brenkman et al., 2002). The first step is the binding of pTP to the viral 
polymerase to form the pTP-polymerase complex which binds to nucleotides 9 to 18 on 
the replication origin site (Temperley & Hay, 1992). pTP contains a serine residue which 
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binds to a dCTP and plays a key role in the priming activity of the protein (Lichy et al., 
1981 and King et aI., 1994). 
Some cellular transcription factors are involved in the process, such as nuclear 
factor I (NFl) and Oct-1 (also called nuclear factor III). They enhance viral replication by 
binding to specific regions on the ITRs and then function to guide and stabilize the pTP-
polymerase complex at the ITRs (O'Neill et al., 1988; Bosher et aI., 1990; Mul et al., 
1990 and Berk, 2007). A specific protein-protein interaction appears between NFl or 
Oct-1 and the pTP-polymerase complex. NFl is activated by DBP and it binds to the 
polymerase, however Oct-1 binds to the pTP part of the complex (Cleat & hay, 1989; 
Chen et al., 1990; Stuiver & van der Vliet, 1990; Mul & van der Vliet, 1992; van 
Leeuwen et al., 1997 and Botting & Hay, 1999). The presence of these two transcription 
factors is not essential to initiate the replication process, however they increase the 
replication activity by 200 fold (Hay et al., 1995; van der Vliet, 1995 and de Jong & van 
der Vliet, 1999). 
The sequence of the first four nucleotides of the 3' end of both the adenoviral 
genome strands is 3' G'T2A3G4 5'. The fourth nucleotide on the viral template (G) directs 
the binding between pTP and the dCTP in a reaction activated by the viral DNA 
polymerase. The polymerase will continue to add another two nucleotides to form an 
intermediate of three nucleotides (CAT) bound to the pTP-polymerase complex. Then, 
the 3' end of the viral template pairs with the intermediate nucleotides to form the 
primers and the viral DNA polymerase dissociates from the pTP-CAT. This process 
continues to the elongation step and a new complementary strand is synthesized (King & 
van der Vliet, 1994 and King et aI., 1997a). 
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According to the different probabilities in the initiation of the replication process, 
there are two types of adenoviral replication as illustrated in Figure 1.4, both types will 
end up with the formation of two viral genome copies. Type I replication is the 
synchronized replication at both ends of the viral genome yielding two genome copies, or 
the one end replication initiation to yield one genome copy and one single stranded DNA 
(ssDNA) copy. However, type II is the replication of the ssDNA templates to form the 
complete double stranded genome (Shenk, 2001). 
In type II replication, the presence of ITRs allows the ssDNA to form a panhandle 
structure that is stabilized by DBP. ITRs of the panhandle structure function as the origin 
of replication for the synthesis of the complementary strand (Lechner & Kelly, 1977 and 
Berk, 2007). Then, the viral protease cleaves the pTP while attached to the genome, 
yielding its mature TP form (Smart & Stillman, 1982). 
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Figure 1.4: Adenovirus genome replication (reproduced from Shenk, 2001). 
1.3.4.4-E3 
The control of the various host immune responses is the main function of the E3 
genes (Horwitz, 2001). This region is not important for viral growth in cell culture and is 
deleted in most adenoviral vectors. E3 encodes for several proteins including adenovirus 
death protein (ADP), gp19K, receptor internalization and degradation (RID)a, RID~ and 
14.7k proteins. It also encodes for another two proteins with unknown function referred 
to as 12.Sk and 6.7k (Russell, 2000). 
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J.3.4.5-E4 
The E4 region encodes several proteins that are named according to their open 
reading frame (orf) position within the region. Different E4 orfs were found in the Ad5 
including orf! to orf4, orf6 and orf6/7. Early studies on adenovirus 2 revealed that E4 
products are generated from a single mRNA of about 2800 nucleotides, driven by the E4 
promoter which undergoes differential splicing to generate about 18 mRNAs with 
common 5' and 3' terminal sequences (Herisse et aI., 1981; Freyer et aI., 1984; Virtanen 
et aI., 1984; Gilardi & Perricaudet, 1986 and Watanabe et aI., 1988). Protein products of 
the multiple orfs have different functions, mainly auxiliary to other proteins such as the 
EIB 55k protein. These proteins work during the different stages of the viral life cycle 
including early events and replication as well as late protein expression and inhibition of 
cellular expression (Halbert et aI., 1985). 
1.3.5- The major late transcriptional unit 
The major late transcription unit (MLTU) contains five families, called Ll to L5, 
that are expressed under the control of one promoter, the MLP (Figure 1.5). The MLTU 
contains all of the structural proteins that are needed for the assembly of the new viral 
capsids with a primary transcript length of about 29 kbp (Evans et at., 1977; Ziff & 
Evans, 1978 and Nevins & Darnell, 1978). Five different poly(A) sites are present inside 
the ML TU and they are used to subdivide the unit into the five families. About 18 
proteins are being produced from the MLTU by differential splicing (Chow et aI., 1977; 
Nevins & Darnell, 1978 and Ziff & Fraser, 1978). During the early phase of viral 
infection, transcription from the ML TU is weak as the MLP is not fully active and it 
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drives low levels, mainly from the LI (Shaw & Ziff, 1980 and Nevins & Wilson, 1981). 
Once replication is initiated, MLP and hence the ML TU gains its full activity and 
expression proceeds from LIto L5. 
_ ......................................... ................................................ 29kbp ..................................................... .................................. ~ 
L2 L3 L4 L5~ 
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Figure 1.5: Ad5 major late transcription unit. L I to L5 are the late adenoviral genes. MLP is the 
major late promoter and TPL is the tripartite leader sequence. 
Late protein expression in adenovirus infection is very efficient. The production of 
the viral proteins is accompanied with an increase in the cell dry weight and cell size; 
HEK 293 cell diameter increases 13% after infection (Nadeau et al. , 2000a,b). The 
plaque assay determined that 7000 to 12000 plaque forming units (PFU) were formed per 
cell from adherent cells, and 5000 PFU/cell from cells growing in suspension (Nadeau et 
al., 2001 and Nadeau & Kamen, 2003). This indicates the abundant amount of 
production particularly when considering that the plaque assay measures only the 
infectious particles not all the produced particles and that the protein content of each 
particle is 87% (Russell, 2000). 
Two main components within the ML TU are responsible for the efficient 
adenovirus protein production; the first is the promoter (MLP) and the second is the TPL. 
Both are located at the beginning of the transcription unit and work together to ensure 
high transcription and translation levels of the viral late proteins (Figure 1.4). 
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1.3.5.1-MLP 
The major late promoter gains its full activity during the late phase of infection 
(Ziff & Evans, 1978). This activity is the driving force of transcription from the five late 
families (LI to LS) and at the same time, efficient transcription levels. The MLP of AdS 
is 217 bp in length and is recognized by the cellular RNA polymerase II. The activity of 
this promoter can be understood by examining its structure as well as the viral and 
cellular proteins that contribute to its activity. 
Promoters recognized by the RNA polymerase II have a typical structure consisting 
of the T AT A box in addition to one or more upstream elements. Both of these are very 
important for the activity of the promoter since they act as recognition sites involved in 
the direct interaction with the transcription factors and/or the RNA polymerase II itself. 
In the SV 40 early promoter, the upstream element consists of three pairs of GC boxes 
located between -103 and -40 and each pair is about 21 bp. Another pattern for the 
upstream elements appears with the herpes simplex virus (HSV) thymidine kinase 
promoter which has a CAAT box flanked with two GC boxes (Weaver & Hedrick, 
1992). 
MLP has an interesting structure that is believed to be related to its high activity. It 
has a TATA box from -31 to -25, a CAAT box at -70, and a binding site for an USF 
called the major late transcription factor (ML TF) at -50. The MLP also has a downstream 
binding site (DBS) that binds to a complex of cellular and viral proteins. The structure 
around the TAT A box is unique, since it is flanked with two GC-rich sequences located 
at -36 and -18 (Figure 1.6) (Shenk, 1996; Song et aI., 1996, Parks & Shenk, 1997 and 
young, 2003). 
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The presence of these different elements in the MLP enables its interaction with 
different viral and cellular proteins. MAZ and Sp 1 are examples of cellular transcription 
factors that interact with and enhance the activity of MLP. Among the different sites 
within the promoter region, MAZ binds strongly to both -36 and -18 GC-rich regions 
located around the TA TA box and close to the transcription initiation, and increases the 
MLP activity by 40-50 folds. However, Sp 1 binds only to the -18 GC-rich region and 
provides four to ten folds increase in MLP activity (Parks & Shenk, 1997). Another 
cellular factor that activates MLP is the major late transcription factor which binds to the 
-50 site (Miyamoto et al., 1985). 
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Figure 1.6: Architectural elements of SV40 early promoter, HSV thimidine kinase promoter and 
the adenovirus MLP (Weaver & Hedrick, 1992, Parks & Shenk, 1997 and Young, 2003). 
Different viral proteins have a positive effect on MLP activity. The E 1 A 13S 
protein product activates the MLP through its zinc finger domain and enhances its 
activity by four fold, this activity increases 200 folds in the presence of either MAZ or 
Sp 1 (Parks & Shenk, 1997). Protein IX and protein IVa2 are expressed in large amounts 
during the events of MLP activation after initiation of viral genome replication to induce 
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the activity of MLP (Lutz & Kendinger, 1996 and Lutz et aI., 1997). IVa2 forms a 
protein complex with cellular proteins; this complex can bind to the DBS of the MLP 
(Shenk, 1996). 
1.3.5.2 TPL 
The TPL is a 5' end untranslated RNA sequence of 201 nucleotides present in all 
the late viral mRNA. As indicated from its name, the TPL originates from three exons on 
the adenoviral genome (Berget et aI., 1977). The primary TPL transcript is 3685 bp, 
since it contains two introns of 1021 bp and 2461 bp (Alignment of the TPL sequence 
obtained from Zhang et al. (1989) and Ad5 genome obtained from the National Center 
for Biotechnology Information (NCB!) genome browser, accession number: 
AC _ 000008). During the post-transcriptional modifications on the viral late mRNAs, the 
two introns are removed and only 201 bp, resembling the exons, are joined together to 
form the mature TPL (Figure 1.7). The TPL introns are not important for its function 
however, they are important for the MLP activity since the first intron contains the 
majority of the DBS (Mansour et al., 1986). 
The TPL facilitates late mRNA transport and accumulation in the cytoplasm and is 
responsible for the selective translation of the late viral proteins instead of the cellular 
proteins (Logan & Shenk, 1984; Berkner & Sharp, 1985 and Zhang et aI., 1994). 
Adenovirus EIB 55k and E4 orf6 play the main role in the active transport of viral late 
mRNA, containing the TPL, from the nucleus to the cytoplasm (Babiss et al., 1985; 
Halbert et al., 1985; Pilder et aI., 1986a,b; Williams et aI., 1986; Leppard & Shenk, 1989 
and Bridge & Ketner, 1990). The viral transcription sites in the nucleus contain a 
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complex of E 1 B 55k and E4 orf6 (Omelles & Shenk, 1991 and Gonzalez & Flint, 2002). 
Viral mRNA interacts with this complex through the ability of E 1 B 55k to bind mRNA 
through the TPL (Horridge & Leppard, 1998) and facilitate its transport to the cytoplasm 
using the E4 orf6 proteins' nuclear localization and transport signals (Dobbelstein et al., 
1997). Cellular mRNA transport is blocked by the same complex (Flint & Gonzalez, 
2003). 
During the late phase, viral mRNA is translated with high efficiency while the 
translation of cellular genes is shut off (Beltz & Fl int, 1979; Babiss & Ginsberg, 1984 
and Halbert et al., 1985). The adenov irus exerts this regulatory effect by giving 
translation priority to its structural genes. The cap-binding protein complex (eIF-4F), 
needed for mRNA binding to the ribosomes and hence translation, is inactivated through 
blocking its phosphorylation. Dephosphorylation of the eIF-4F appears with the 
activation of the MLP at the beginning of the late phase. 
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Figure 1.7: TPL architecture on genomic DNA and late viral mRNA. Size and location of the 
exons and introns were determined by aligning TPL sequence obtained by Zhang et al. (1989) 
with that of human AdS obtained from the National Center for Biotechnology Information 
(NCBI) genome browser (accession number: AC_000008). Ex: exon and In: intron 
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The viral regulatory element that mediates eIF-4F phosphorylation inhibition is the 
lOOk late protein. It is encoded by L4 and produced at the beginning of the late phase 
(Bablanian & Russell, 1974 and Oosterom-Dragon & Ginsberg, 1980). This protein 
binds and blocks a site on the elF -4G that is needed for the kinase MnK1 to bind to and 
start its function in phosphorylating the cap-binding protein (Cuesta et aI., 2000). In 
addition, the lOOk protein has an RNA-binding domain that interacts with the 
cytoplasmic mRNA, specially the TPL sequence (Adam & Dreyfuss, 1987 and Riley & 
Flint, 1993). The formation of the 100K-TPL complex and then its binding to the eIF-4G 
will facilitate ribosome shunting and hence translation of the late viral mRNAs (Xi et al., 
2004 and 2005). 
Upon inactivation of the eIF-4F, cellular mRNAs are unable to attach to ribosomes 
and therefore, cannot initiate translation. However, only late viral mRNAs will be able to 
initiate translation, since the TPL binding to the ribosomes is eIF-4F-independent (Dolph 
et al., 1988). The relaxed secondary structure of the TPL facilitates its function in 
translation initiation even when eIF-4F is inhibited (Dolph et al., 1990). The TPL allows 
ribosome shunting, in a similar manner to the IRES recognition, which avoids the 
scanning mechanism that is needed for cellular mRNAs and the required cap-binding 
(Yueh & Schneider, 1996 and 2000). 
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The aim of this study was to investigate the effect of various factors on gene 
expression in mammalian cells. The following four factors were examined: 
1- The effect of DNA quality on DNA uptake and gene expression. More specifically, 
the effect of Ethidium bromide, Cesium Chloride, endotoxins and Ethanol on calcium 
phosphate-mediated transfection into CRO cells and the expression of LacZ gene. 
2- The effect of adenoviral major late promoter and tripartite leader sequence exons on 
gene expression. Also, the effect of the adenoviral E 1 genes and the cellular 
background was studied. 
3- The effect of adenoviral DNA replication genes on the copy number and the 
expression efficiency of the transgene. This involves the construction of a cell line 
expressing these viral replication genes and allows the replication of the ITRs-
containing expression vector. 
4- The effect of wild type adenoviral super-infection at different multiplicity of 
infections (MOls) on exogenous gene expression in mammalian cells. This involves 
the study of the expression under super-infection in CRO and REK 293 cells. 
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2.1- BACTERIAL CULTURE 
2.1.1- Bacterial strain 
Plasmid DNA cloning and propagation was carried out in Escherichia coli DH5a, 
with the following genotype: F-, <1>80, olacZ, ~M15, ~(lacZY A-argF), U169, deaR, 
recA1, endA1, hsdRI7(rk-, mk+), phoA, supE44, thi-1, "A-, gryA96, relAl (Woodcock et 
al., 1989). 
2.1.2- Bacterial culture and colonies maintenance 
Bacterial cultures were grown and maintained at 37°C in Luria-Bertani broth (LB: 
1 % (w/v) bacto-tryptone, 0.5% (w/v) bacto-yeast extract, 1% (w/v) NaCI, sterilized by 
autoclaving). For growing bacterial colonies, LB-agar plates were prepared by adding 
2% (w/v) agar to LB. After autoclaving, the solution was cooled down to 45°C and 0.1 
mg/mL ampicillin was added for selection purposes. Twenty millilitres of the LB-agar 
solution was poured into 10 mm Petri dishes then let stand to solidify and stored at 4°C. 
2.1.3- Competent cells 
Competent cells were prepared from a stock cell population (New England 
Biolabs), according to Inoue et al. (1990). A single colony was obtained from an 
antibiotic-free LB-agar plate and inoculated into 2 mL of antibiotic-free LB. After an 
overnight incubation at 37°C in a shaking water bath, the inoculum was transferred to 
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250 mL of SOB medium (2% (w/v) bacto-tryptone, 0.5% (w/v) bacto-yeast extract, 10 
mM NaCI, 2.5 mM KCI, 10 mM MgCh, 10 mM MgS04, 20 mM glucose) in a 2 L flask 
and grown with vigorous shaking (250 rpm) at 18°C, to mid-log phase (OD6oo=0.6). The 
culture was then placed on ice for 10 minutes and centrifuged at 3000 x g in a Beckman 
GPR centrifuge for 10 minutes at 4°C. The supernatant was discarded and the pellet was 
resuspended in 80mL of ice-cold transformation buffer (TB: 10 mM Pipes (or Hepes), 55 
mM MnCh, 15 mM CaCh, 250 mM KCI, pH 6.7) and placed on ice for 10 minutes. 
Cells were centrifuged again at 3000 x g for 10 minutes at 4°C. The supernatant was 
discarded and the pellet was resuspended in 12-15 mL of ice-cold TB. Dimethyl 
sulfoxide (DMSO) was added with gentle swirling on ice to a final concentration of 7% 
and then kept on ice for 10 minutes. Competent cells were then ali quoted and frozen 
immediately in liquid nitrogen. Cells were transferred to -80°C for long-term storage. 
2.1.4- Transformation 
Plasmid DNA was resuspended into a 20 ilL volume of water or TE buffer (ImM 
ethylene diamine tetra-acetic acid (EDTA), 10mM Tris-HCI), prior to transformation into 
competent cells. Frozen competent cells were thawed on ice and then used to inoculate 
the plasmid DNA. The mixture was incubated on ice for 30 minutes and then subjected 
to a heat shock at 42°C for 45 seconds. After the heat shock, the cells were put 
immediately on ice for 2 minutes and 700 ilL of antibiotic-free LB was added to the 
transformation mixture and incubated with shaking at 37°C for 45 minutes. 
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2.1.5- Bacterial selection 
The ampicillin gene was used as a selection marker in all the constructed plasmids, 
therefore LB-agar plates with 2X ampicillin (0.1 mg/mL) were used to grow and select 
the positively transformed colonies. Plates were incubated overnight at 37DC and the 
selected colonies were picked and inoculated into 2 mL of LB with 2X ampicillin and 
shaken overnight at 37DC. In addition, X-gal (5-bromo-4-chloro-3-indolyl-beta-D-
galactopyranoside) was used for blue and white screening when cloning was performed 
inside the ~-galactosidase gene. When used, 0.8 mg (40 ~L from a stock of20 mg/mL) of 
X -gal was added to the surface of an LB-agar plate prior to the spreading of transformed 
bacteria. 
2.1.6- Small-scale plasmid DNA preparation 
Small-scale plasmid DNA isolation and preparation was carried out either by the 
alkaline lysis procedures (Cohen et al., 1972 and Sambrook et al., 1989), or by the 
Plasmid DNA MiniPrep Kit (Norgen Biotek Corp.) according to the manufacturer's 
instructions. The obtained plasmid DNA was stored at _20De. 
2.1.7- Endotoxin-free plasmid DNA preparation 
Endotoxin-free plasmid DNA preparation for cell culture experiments was carried 
out using the Endotoxin-free DNA MaxiPrep Kit (Norgen Biotek Corp.), according to 
the manufacturer's instructions. 
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2.1.8- Large-scale plasmid DNA preparation 
The preparation of large-scale plasmid DNA starts with the pre-inoculation of 10 
ilL of the desired frozen plasmid culture into 10 mL of LB medium supplemented with 
2X ampicillin (0.1 mg/mL) and incubated at 37°C with shaking. When the OD600 of the 
growing culture reached 0.4 to 0.6, the pre-inoculated culture was inoculated into 1 L of 
LB medium supplemented with 2X ampicillin and incubated overnight (16 h) with 
shaking at 250 rpm. The growing culture was harvested by centrifugation in 1L 
centrifugation bottles at 4,560 x g for 1 hour at 4°C in a JS-4.2 rotor using a Beckman J-
6B centrifuge. 
After decanting the supernatant and drying the bacterial pellet for 5 minutes, the 
cells were resuspended by gentle vortexing in 50 mL of resuspension solution (50mM 
Tris, 10 mM EDTA pH 8.0 and 0.1 mg/mL RNase A) and incubated at room temperature 
for 5 minutes. The resuspended cells were lysed by adding 50 mL of lysis solution (1 % 
sodium dodecyl sulfate (SDS) and 0.4 M NaOH) and mixing by inversion 10 times and 
incubated at room temperature for no more than 5 minutes. Fifty millilitres of the 
neutralization solution (3M Sodium Acetate pH 4.8) was added immediately and mixed 
by inversion 10 times followed with incubation at 4°C for a minimum of 30 minutes. 
The bacterial lysate was then transferred to 250 mL centrifugation bottles and 
centrifuged at 30,100 x g for 30 minutes at 4°C in a JA-14 rotor using a Beckman J2-MI 
centrifuge. The supernatant was filtered into a clean 1L bottle using eight-micron filter 
paper (Whatman). The filtrate was treated with 5 units/mL RNase T1 (Cedarlane 
Laboratories Ltd., Worthington) and incubated at 55°C for 30 minutes. Then, 2.5 
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volumes of ice-cold 95% ethanol was added to the filtrate and incubated overnight at -
20DC or -70DC. 
The next day, the precipitated plasmid DNA was harvested by transferring the 1L 
bottle contents into several 250 mL centrifugation bottles and centrifuging at 30,100 x g 
for 20 minutes at 4 DC. The supernatant was discarded and the bottles were dried, after 
which the precipitated DNA in the 3 or 4 bottles used was dissolved in 5 mL of TE 
buffer (10 mM Tris-HCl and 1 mM EDTA, pH 7.5). The harvested DNA was confirmed 
by restriction enzyme digestion before proceeding to cesium chloride banding. 
2.1.9- Cesium chloride gradient 
The density of the harvested large-scale plasmid DNA was adjusted to 1.57-1.59 
g/mL using CsCI (about 1.01 g of CsCl is used per 1 mL of plasmid DNA). The 
harvested and density-adjusted DNA from 1 L culture was adjusted to S.7 mL using TE-
CsCl (density of 1.59 g/mL). Two mg ethidium bromide was added (200 J.lL from a stock 
of 10 mg/mL) and mixed by inversion. The contents were transferred into S.9 mL 
Beckman OptiSeal ultracentrifuge tubes and sealed with the tube stopper. The tubes were 
then placed in a type 70.1 Ti rotor and centrifuged in a Beckman LS-SOM ultracentrifuge 
at 246,960 x g for 22 hours at 22DC. 
The resultant lower supercoiled plasmid DNA band was extracted from the banding 
tube using an IS gauge needle assembled to a 1 mL syringe and transferred into a 15 mL 
Falcon tube. The extracted DNA was then cleaned to remove the ethidium bromide by 
repetitive mixing with isoamyl alcohol saturated with CsCl. To enhance the phase 
separation, the well-mixed contents were centrifuged for 5 minutes at 2,000 x g in a 
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Beckman GPR centrifuge equipped with a JS-42 rotor. After centrifugation, the upper 
isoamyl alcohol layer was aspirated from the tube. This was repeated several times until 
the pink color disappeared. The cleaned DNA liquid phase was then transferred into 
Spectra/Por 7 dialysis tubing (Spectrum Laboratories, Inc.), pre-heated at 65°C for 10 
minutes and sealed with clips. The filled dialysis tube was dialyzed against 10 L of TE 
buffer at 4°C, with continual changing of the buffer every 16-24 hours for three times (a 
total of 30 L). Plasmid DNA was collected afterwards and stored at -20°e. 
2.2- MAMMALIAN CELL CULTURE 
2.2.1- Cell lines and maintenance 
The Chinese hamster ovary (CHO) cells utilized in this study were the subclone K1 
(ATCC CCL-61) derived from the parental cell line initiated by Puck et at. (1958) and 
were obtained from Dr. Andrew Rainbow (McMaster University, Ontario, Canada). Cells 
were maintained as a monolayer in Petri cell culture dishes and cultured in advanced 
Dulbecco's Modified Eagle Medium (Advanced D-MEM: Invitrogen Corp., Gibco), 
containing 5% (v/v) fetal bovine serum (FBS, PAA Laboratories Inc.), 1% (v/v) 
penicillin/streptomycin (Invitrogen Corp., Gibco) and 1 % (v/v) glutamine (Invitrogen 
Corp., Gibco). Growing cells were incubated in a water-jacketed incubator (Fisher 
Scientific, Pittsburgh PA) at 37°C with 96% relative humidity and 5% C02. 
At 90% confluencey, cells were passaged by using EDTA-trypsin solution (0.53 
rnM tetras odium EDTA, 0.05% (v/v) Trypsin). The used volume is determined by the 
size of the cell culture plate, for a 150 mm plate, a 4 mL volume was used. After 
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aspirating the media, cells were washed with 6 mL phosphate buffered saline (PBS), pH 
7.4. Upon removal of the wash by aspiration, EDTA-trypsin was added to the monolayer 
for two minutes, and then cells were lifted by gentle tapping of the side of the dish. Six 
millilitres of the culture medium was then added to the cell suspension with pipetting to 
split the cells. Four milliliters of the cell suspension was added to a new culture plate and 
the volume was completed to 20 mL with new culture medium and the cells were 
incubated at 37°C. 
Maintenance of human embryonic kidney (HEK) 293 cells (Graham et at., 1977; 
Microbix Inc., ATCC CRL-1573) was done using similar handling to the CHO cells but 
with different media components and solutions. The medium used was autoclavable 
MEM (Invitrogen Corp., Gibco) supplemented with 3% (v/v) sodium bicarbonate 
(Invitrogen Corp., Gibco), 1 % L-glutamine (Invitrogen Corp., Gibco), 10% (v/v) FBS 
(PAA Laboratories Inc.) and 1% (v/v) Antibiotic-Antimycotic (10,000 units/mL 
penicillin G sodium, 25 Ilg/mL amphotericin B, and 10,000 units/mL streptomycin 
sulphate, Invitrogen Corp., Gibco). Saline citrate was used to wash and lift the cells and 5 
minutes of incubation at 37°C was used for the lifting step. 
2.2.2- Cell freezing and thawing 
Cells were grown to the late log phase (about 90% confluencey) and then lifted 
using EDTA-trypsin for CHO cells or Saline citrate for HEK 293 cells. Cells were 
centrifuged at 670 x g for 5 minutes at 4°C (Beckman Spinchron Centrifuge). The 
medium was aspirated and the CHO cell pellet was resuspended in 4 mL of ice cold new 
growth medium with 10% (v/v) DMSO, however the HEK 293 cell pellet was 
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resuspended in FBS with 10% (v/v) DMSO. Cells were then transferred to 1 mL sterile 
cryogenic tubes (Sarstedt), and frozen slowly by wrapping them with insulating paper 
towel in a Styrofoam container and stored in a -70°C freezer. 
Cell thawing was done by hand rubbing the frozen cryogenic vial and pouring the 
contents into 150 mm cell culture dish containing 20 mL of preheated (37°C) growth 
medium. The medium was changed within 24 hours to remove DMSO and changed 
every other day thereafter. 
2.2.3- Cell counting 
Cells were lifted from the plate and transferred to a microcentrifuge tube. A 20 ilL 
volume of the sample was placed on the notch of a hemocytometer covered with a cover 
slip. A light microscope was used to visualize and count the average cell number in the 
defined fields of the hemocytometer. The total number of cells could then be calculated 
in the original sample. 
2.2.4- Calcium phosphate transfection 
Calcium phosphate transfection was carried out according to the optimized protocol 
done by Jordan et al. (1996) based on the method created by Graham & Van der Eb 
(1973). On the day prior to transfection, cells were split in a 6-well plate and allowed to 
attach overnight. The amount of cells used was optimized so that the confluencey would 
be 60-70% at the transfection time. Two hours before transfection, the medium was 
replaced with 2 mL fresh medium. Transfection solutions were warmed up to room 
, temperature prior to use. The transfection mixture was made by diluting 5 Ilg plasmid 
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DNA into 90 J..lL TE buffer (pH 7.6). A 10 J..lL volume of 2.5 M CaCh (filter sterilized) 
was added to the DNA-TE slowly with swirling followed by gentle vortexing for 
complete mixing of components. Next, 2X HEPES (140 mM NaCl, 1.5 mM Na2HP04, 
50 mM HEPES, pH 7.05, filter sterilized) was placed in a 1.5 mL Eppendorf tube and 
vigorously shaken on a vortex while adding the DNA-TE-CaCh slowly and dropwise. 
This mixture was let stand for 30 seconds and then mixed well by pipetting to split the 
aggregates. The solution was added evenly and dropwise on the medium surface. Cells 
were then incubated at 37°C and the medium changed 6 hours post-transfection to reduce 
cytotoxicity. The transfection efficiency was tested 21 hours post-transfection. 
2.2.5- Lipofectamine 2000 transfection 
Lipofectamine 2000 (Invitrogen) was used to transfect plasmids DNA into 
mammalian cells. The confluencey of the monolayer was ensured to be at least 70% at 
the transfection time. The culture medium was replaced prior the transfection with 2 mL 
of antibiotic-free medium. The transfection mix for each well (of a 6-well plate) was 
prepared in 500 !1L by mixing plasmid DNA and Lipofectamine 2000. First, 5 J..lg 
plasmid DNA was diluted in a total volume of 250 J..lL using Opti-MEM I Reduced 
Serum Medium (Invitrogen Corp., Gibco). Similarly, 5 J..lL Lipofectamine 2000 was 
diluted in 250 J..lL total volume by using Opti-MEM. Both the diluted DNA and 
Lipofectamine 2000 were incubated at room temperature for 5 minutes then mixed 
together and incubated at room temperature for additional 20 minutes. The 500 J..lL 
transfection mixture was added dropwise onto the well and shaken to distribute the 
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mixture evenly. Finally, the plate was incubated at 37°C for 6 hours before changing the 
medium with the regular, antibiotic-containing, medium. 
2.2.6- LacZ activity assay 
Positive LacZ transfected cells were stained and visualized under a light 
microscope. The medium was aspirated 21 hours post-transfection from the 6-well plate 
followed by 2 washes with 1 rnL PBS. A 1 mL volume of 4% paraformaldehyde (pH 7.2) 
was added to each well and incubated at 37°C for 2 minutes. The cells were then washed 
twice with 1 mL PBS. A 2 mL volume of X-gal stain (35 rnM K3Fe(CN)6, 35 rnM 
KtFe(CN)6, 1 rnM MgCh, in PBS; pH 7.4, supplemented with 1 mg/mL of X-gal) was 
added and the cells were incubated overnight at 37°C with 96% relative humidity. The 
next day, the number of blue cells was counted to determine the transfection efficiency. 
2.2.7- G418 selection 
G418 (Bioshop Canada) was used for selecting or maintaining mammalian foci 
positively transfected with the neomycin resistance gene. A concentration of 0.5 mg/mL 
of the culture medium was mixed freshly and added to the cells under-selection. The 
G418-containing medium was replaced every other day during the selection period 
(about two weeks). 
2.2.8- Adenovirus infection 
The adenoviral infection of mammalian cells was carried out in 6-well plates by 
using a volume of the viral stock equivalent for the required multiplicity of infection 
(MOl). This viral volume was mixed with PBS++ (0.01% CaCh.2H20 and 0.01% 
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MgCh.6H20 dissolved in PBS) in a total volume of 500 flLlwell and then added to the 
cell monolayer (after aspirating the medium). The 6-well plate was then incubated for 1 
hour at 37°C with 96% relative humidity and 5% CO2, with swirling the plate every 15 
minutes. After that, 2 mL of the culture medium were added to each well and the plate 
was returned to the incubator. 
2.2.9- Trypan blue staining 
Cell vitality was investigated by using trypan blue staining. First, cells were 
collected by centrifugation at 2000 rpm for 5 minutes and resuspended in PBS. Then, 10 
flL of cells were mixed with 10 flL of trypan blue and counted under a light microscope 
using a hemocytometer. Live cells appear bright under the microscope while dead cells 
appear blue. 
2.3- DNA MANIPULATION 
2.3.1- RNA/DNA isolation 
DNA and RNA were isolated, all from the same sample, using the 
RNA/DNA/Protein Purification Kit (Norgen Biotek Corp.), according to the 
manufacturer's instructions. 
2.3.2- DNA quantification 
DNA was quantified using a spectrophotometer after dilution with water. The 
absorbances were measured at wavelengths 260 nm (A26o) and 280 nm (A28o) and the 
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DNA concentration was then calculated according to the following fonnu1a (Sambrook et 
at., 1989): 
(A26o) x (dilution factor) x (50 ng/ flL) 
1000 
The value A26o/A2so was used to detennine sample purity. If the value was between 
1.8 and 2.1, the samples were considered pure. 
2.3.3- Endotoxin preparation and quantification 
A freshly prepared E. coli culture, grown overnight, was centrifuged at 3000 x g in 
a Beckman GPR centrifuge for 30 minutes. The supernatant was then filtered through a 
sterile Acrodisc® 25mm syringe filter with 0.2 flm HT Tuffryn® membrane (PALL, Life 
Sciences) to eliminate any bacteria left from the centrifugation step and the collected 
supernatant was used as a source of endotoxin. The level of endotoxin in the supernatant 
was quantified by measuring the endotoxin units (EU) per mL using the Limu1us 
Amebocyte Lysate (LAL) Endochrome Kit (Charles River Laboratories), according to 
the manufacturer's instructions. 
2.3.4- DNA cleaning 
DNA was cleaned using the C1eanAll Kit (Norgen Biotek Corp.), according to the 
manufacturer's instructions. 
2.3.5- DNA extraction from agarose gel 
After eXCISIOn from an agarose gel, DNA was cleaned usmg the DNA Gel 
Extraction Kit (Norgen Biotek Corp.), according to the manufacturer's instructions. 
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2.3.6- Cleaning of PCR amplification Product 
PCR amplification products were cleaned using the PCR Purification Kit (N orgen 
Biotek Corp.), according to the manufacturer's instructions. 
2.3.7- Restriction enzymes digestion 
All of the restriction enzymes that were used were obtained from either New 
England Biolabs (NEB) or MBI Fermentas. Digestion and heat inactivation were carried 
out according to the manufacturer's instructions. In digestion preparations used for 
agarose gel electrophoresis, 0.5 to 5 ~g of DNA was digested using one to ten units of 
restriction enzyme in a 20 ~L reaction volume for two hours. However, larger volumes 
or longer incubation times were used for other digestion applications. When needed, 
enzyme inactivation was performed by heating up the reaction to 70°C or higher for 20 
minutes, if recommended by the manufacturer. 
Multiple restriction enzyme digestion was required to obtain some fragments 
needed for downstream cloning purposes. In most cases, a one step digestion with 
multiple enzymes was used with the most suitable buffer, with attention to the enzymes' 
activity. Equal amounts of restriction enzymes were used and the extent of digestion was 
determined with agarose gel electrophoresis. When incomplete digestion was 
encountered, the enzyme amount and digestion time were adjusted. In some cases, 
sequential digestion was used with incompatible restriction enzymes. 
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2.3.8- DNA ligation 
DNA fragments were ligated in a 20 ilL reaction using 400 units ofT4 DNA ligase 
(New England Biolabs), according to the manufacturer's instructions. The reaction was 
performed at room temperature for 2 hours when ligating sticky ends and 8 hours for 
blunt end ligation. If necessary, heat inactivation was carried out at 65°C for 20 minutes. 
2.3.9- Oligonucleotides phosphorylation 
An amount of 150 pmol of each of the oligonucleotides was phosphorylated in a 25 
ilL reaction using five units of T4 polynucleotide kinase (New England Biolabs), 
according to the manufacturer's instructions. The reaction was at room temperature for 
30 minutes followed by heat inactivation at 65°C for 20 minutes. 
2.3.10- Oligonucleotides annealing 
Oligonucleotides that were used for generating multi-cloning sites or constructing 
DNA fragments were mixed and annealed by using the iCycler PCR machine (Bio-Rad). 
The oligonucleotide mixture was heated to 94°C followed by lowering the temperature in 
decrements ofO.5°C every 10 seconds. When the temperature reached 18°C, the mixture 
was cooled down directly to 4°C. 
2.3.11- Adjacent oligonucleotides ligation 
Ligation of the annealed adjacent oligonucleotides is carried out to form a 
phosphodiester bond between the neighbouring 5' phosphate and 3' hydroxyl terminal 
ends, in a process similar to nick-closing. The reaction was performed in a 20 ilL 
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volume, using 40 units of Taq DNA ligase (New England Biolabs), according to the 
manufacturer's instructions. 
2.3.12- DNA sequencing 
DNA sequencing was performed at York University Core Molecular Biology and 
DNA Sequencing Facility. Cycle sequencing reactions were carried out with Bigdye 
Terminator chemistry on the Applied Biosystems 337 DNA Sequencer, using the 
appropriate primers. 
2.3.13- peR 
Polymerase chain reaction (PCR) (Mullis et aI., 1986) was carried out according to 
the polymerase manufacturer's instructions. The used of forward (F) and reverse (R) 
primers, ordered from Sigma Genosys, for all of the PCR reactions are listed in Table 
2.1. Primers were dissolved to a concentration of 50 ~M using dH20 and stored as 
aliquots at -20cC. The iCycler PCR machine (Bio-Rad) was used to perform the 
reactions. A 20 ~L reaction mixture was made as follows: 1 ng of less of DNA template, 
0.12 ~L of each primer (50 ~M stock), 0.2 ~L deoxynucleotide triphosphates (dNTPs) 
(10 mM), 2 ~L of the supplied lOX PCR buffer (100mM Tris-HCl (pH 9.0), 500 mM 
KCI, 1% Triton X-100, and with or without 15mM MgCh) and 0.1 ~L (5 units/~L) 
EconoTaq DNA polymerase (Lucigen). When using Pfu polymerase, 0.2 ~L (2.5 
unitl~L) enzyme was used with 2 ~L of lOX reaction buffer (200 mM Tris-HCI (pH 8.8 
at 25cC), 100 mM (NH4hS04, 100 mM KCl, 1% (v/v) Triton X-lOO, 1 mg/ml bovine 
serum albumin (BSA)). The reaction volume was completed with dH20. 
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The reaction program was started with 3 minutes at 94°e to dissociate the DNA 
template. Annealing was applied for 15 seconds at 5°e lower than the primers' melting 
temperature (Tm), followed by an extension time of 1 minute per 1 kbp or 2 minutes per 
1 kbp at noe with Taq or Pfu DNA polymerases, respectively, then a denaturation step 
for 15 seconds at 94°e. Thirty to thirty-five cycles (annealing-extension-denaturation) 
were used, with holding the reaction for 5 minutes at noe and a final incubation at 4°C. 
Table 2.1: Names, sequences and amplicon sizes of the different PCR primers. Tm can be 
obtained by for each primer by using Sigma Genosys's online DNA calculator (http://www. 
sigma-genosys.com!calcIDNACalc.asp). Parentheses indicate nucleotides added as linkers. 
Name Sequence Amplicon 
size (bp) 
DBP-F 5' ACCATGGAGGACGTGTCG 3' 489 
DBP-R 5' AGCCTCCATGCCCTTCTC 3' 
EIA-13S-F 5' CTGGCTGATAATCTTCCACCTC 3' 479 ElA-13S-R 5' (CACAGG)ACTGTAGACAAACATGC 3' 
ElB-55k-F 5' GGAGGATAGGGTGGCCTTTA 3' 867 ElB-55k-R 5' (GCGGCTG)CTCAATCTGTATC 3' 
E2RB-F 5' CGGCTATTACCACCACACCT 3' 558 
E2RB-R 5' AGTGGACCAGGTGTTTCAGG 3' 
GA-F 5' (GGGCCC)TGTTGCCTTTACTTC 3' 969 GA-R 5' (GACGTC)CCTCCCACACCTCC 3' 
GFP-F 5' ATCCTGATCGAGCTGAATGG 3' 484 
GFP-R 5' TGCCATCCTCGATGTTGTG 3' 
MT-Fl 5' ATAAGAGCCAAGTTCCAGCGTCC 3' 493 
MT-Rl 5' AATACCTGTGGCTTGCGATACCG 3' 
pCMV~-F 5' TCGCTACCATTACCAGTTGGTC 3' 677 pCMV~-R 5' GAGTTAGCTCACTCA-TTAGGCACC 3' 
pE2F-F 5' TTGTACTGAGAGTGCACCATACATG 3' 743 
pE2F-R 5' AACTGTCCTAACCTTGGATTACATCAAG 3' 
pTP-F 5' ATGGCCAACTGCACTTACACC 3' 565 pTP-R 5' ACCTGAGCGAGTCCGCATC 3' 
TPLl,2-F 5' GTGACCGGGTGTTCC 3' 183 TPLl,2-R 5' (GATACCATGG)TACCGTTCGGAGGCC 3' 
VPol-F 5' TCTTGCAAGCCATCGACG 3' 701 
VPol-R 5' TTCCCAGCGGTCCCATC 3' 
VPro-F 5' AGCCATTGTCAAAGATCTTGGTTG 3' 562 
VPro-R 5' AGTGGCGCTCCTAATCTGC 3' 
TPLatel-F 5' CGAGGGCCAGCTGTTGG 3' 160,219 & 
GFPlate-R 5' TGCCGTAGGTGGCATCG 3' 332 
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2.3.14- Agarose gel electrophoresis 
Agarose gel electrophoresis was carried out according to Sambrook et al. (1989). 
Alphalmager 2200 (Alpha Innotech) was used to capture gel pictures under ultraviolet 
(UV) light exposure. 
2.3.15- Quantitative peR 
Quantitative PCR (qPCR) was performed on a known concentration of template 
DNA (4 to 10 ng) or complementary DNA (cDNA) (volume equivalent to 20-100 ng of 
initial RNA used in a reverse transcription reaction), using the Bio-Rad iCycler thermal 
cycler. The reaction mixture contained 10 ilL of 2X SYBR GREEN master mix (Bio-
Rad) , and 1.2 ilL of each primer (5 mM stock). The total volume of the reaction was 
completed with dH20 to 20 ilL. A 15 minutes heating at 95°C was used to activate the 
hotstart enzyme. Forty amplification cycles were performed as follow: 15 seconds at 
95°C, 30 second at 59°C and 1 minute at noc. The reaction was kept at 57°C for 1 
minute before starting a melting curve analysis by a 0.5°C increment every 10 sec over 
80 rounds. A standard curve of known plasmid concentration (10 fg to 1 ng) was used to 
determine the initial concentration of plasmid in each sample. 
2.4- RNA MANIPULATION 
2.4.1- Total RNA isolation 
Total RNA was extracted using the Total RNA Purification Kit (Norgen Biotek 
Corp.), according to the manufacturer's instructions. 
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2.4.2- Cytoplasmic and nuclear RNA isolation 
Both cytoplasmic and nuclear RNA were isolated using Cytoplasmic & Nuclear 
RNA Purification Kit (Norgen Biotek Corp.), according to the manufacturer's 
instructions. 
2.4.5- DNase treatment of RNA 
The digestion of residual DNA in the isolated RNA samples was performed by 
using TURBO DNase (Ambion). Each 50 ilL of sample was digested in a 100 ilL 
reaction mixture containing the provided buffer and four units of TURBO DNase, with 
incubation at 37°C for 30 minutes. 
2.4.3- RNA cleaning 
All cleaned RNA samples were carried out by using the RNA CleanUp and 
Concentration Kit (Norgen Biotek Corp.), according to the manufacturer's instructions. 
2.4.4- RNA quantification 
RNA was quantified using a spectrophotometer after dilution with RNase-free 
water. Then absorbances were measured at wavelengths 260 nm (A26o) and 280 nm 
(A2so), RNA concentration was then calculated according to the following formula 
(Sambrook et ai., 1989): 
(A26o) x (dilution factor) x (40 ng/ ilL) 
1000 
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2.4.6- Formaldehyde agarose gel electrophoresis 
RNA integrity was determined by using formaldehyde agarose gel electrophoresis, 
prepared according to Sambrook et al. (1989). AlphaImager 2200 (Alpha Innotech) was 
used to capture gel pictures under UV light exposure. 
2.4.7- Reverse transcription 
Two to five hundred nanograms of total RNA was used in reverse transcription 
(RT) reactions. RNA was mixed with 0.5 IlL of 100 mM 01igo(dT)18 primer (Sigma), and 
completed to a final volume of 5 IlL using RNase/DNase-free water (Ambion). This 
mixture was heated up for 5 minutes at 70°C, then chilled to 4°C. During the cooling 
step, 15 IlL of the RT reaction solution is added to the mixture. The added RT reaction 
solution contains 4 IlL of 5X First Strand Buffer (250 mM Tris-HCl pH 8.3, 375 mM 
KCl and 15 mM MgCh), 2 IlL of 0.1 M Dithiothreitol (DTT), 1 IlL of 10 mM dNTPs, 0.1 
IlL Superscript III reverse transcriptase (Invitrogen) and 7.9 IlL RNase/DNase-free water 
(Ambion). The reaction was continued by an incubation step at 25°C for 5 minutes, 
followed with 90 minutes incubation at 42°C and 15 minutes incubation at 70°C before 
finally holding the reaction at 4°C. 
2.5- GFP FLUORESCENCE INTENSITY QUANTIFICATION 
The fluorescence intensity of green fluorescence protein (GFP) was quantified 
directly from mammalian cells by measuring the relative fluorescence units (RFU) using 
the BioTek Synergy HT Multi-Mode Microplate Reader. Transfected cells were washed 
twice with PBS, lifted from the plate and counted. Fifty thousand cells per well were then 
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transferred to a black rounded-bottom 96-well plate (Costar) in a total volume of 200 ~L 
of PBS. The RFU was then measured at an excitation wavelength of 485 nm and an 
emission wavelength of 528 nm, using non-transfected cells as a blank. 
2.6- DATA GRAPHING AND ANALYSIS 
The obtained data was graphed by using OriginPro version 8.0724 (Origin Lab, 
Northampton, MA, USA). The same software was used for statistical analysis of the data. 
The significance of all values were attested at P<0.05 using the two sample t-Test for 
comparing the means of two samples and the one or two way ANOVA using Tukey's 
test when comparing the means of more than two samples at the same time. 
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3.1- EFFECT OF DNA CONTAMINANTS ON TRANSFECTION EFFICIENCY AND 
MUTATION FREQUENCY 
Contamination is a major problem that is encountered when using different 
methods of DNA preparation. The purity of a DNA preparation is important and often an 
overlooked parameter when studying transfection efficiency and DNA stability. Since 
DNA preparation involves many different steps, the risk of having DNA contamination is 
high. These contaminants include ethidium bromide (EtBr), cesium chloride (CsCl), 
endotoxin and ethanol (EtOR). In this section, the effect of these contaminants on 
transfection efficiency, gene expression and mutation frequency in mammalian cells was 
investigated. Experiments were carried out in Chinese hamster ovary (CRO) cells using 
calcium phosphate transfection of DNA, after spiking with varying concentrations of 
contaminants. 
3.1.1- Ethidium bromide 
Different concentrations of EtBr (0, 2.5, 25 and 250 nM) were used to spike the 
plasmid pCMV~. After spiking, plasmid DNA was incubated for 10 minutes at room 
temperature and then transfected into CRO cells using calcium phosphate in 6-well 
plates. Samples were done in two groups as one was used for staining and the second for 
DNA isolation. In each group, triplicate wells were used for each concentration. Twenty-
one hours post-transfection, cells were stained by X-gal and the numbers of cells which 
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developed the blue color were counted under a light microscope. Records were 
calculated as a percentage from the control value (Figure 3.l-A). 
Quantitative polymerase chain reaction (qPCR) was performed to determine the 
exact transfection efficiency by using equal amounts (10 ng) from the isolated DNA. A 
standard curve of known plasmid concentration was used to determine the initial plasmid 
concentration. Duplicate measurements were carried out for each of the triplicate 
samples. Since the amount of DNA per CHO cell is 3.1 pg (Gregory, 2005), and 10 ng of 
DNA was used per reaction, it was possible to calculate the average plasmid copy 
number per cell (Figure 3.l-B). 
All the results were analyzed by a one-way ANOVA using Tukey's test at a 
significance level of 0.05. Significant reduction in LacZ expressing cells was obtained 
with EtBr concentrations of 25 and 250 nM (Figure 3.l-A). However no significant 
differences were obtained with the DNA delivery at any used concentration (Figure 3.1-
B). 
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Figure 3.1: Effect of EtBr on gene expression and delivery. (A) Number of cells expressing 
LacZ and (B) Plasmid copy number per cell. 
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3.1.2- Cesium chloride 
After spiking the plasmid pCMV~ with different concentrations of CsCl (0, 0.56, 
5.6 and 56 11M), DNA was transfected into CRO cells as outlined above for EtBr. 
Significant reduction in the number of LacZ expressing cells was found with the higher 
two concentrations of 5.6 11M and 56 11M (Figure 3.2-A). On the other hand, a significant 
decrease in plasmid copy number per cell was observed in all of the higher CsCl 
concentrations (Figure 3.2-B). 
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Figure 3.2: Effect of CsCI on gene expression and delivery. (A) Number of cells expressing 
LacZ and (B) Plasmid copy number per cell. 
3.1.3- Ethidium bromidelCesium cloride 
Spiking was carried out by using a combination of EtBr and CsCl (010, 2.2/0.51, 
2215.1 and 220nM/51 11M). The same transfection and collection procedures were 
followed according to part 3.1.1. Significant reduction in the number of LacZ expressing 
cells (Figure 3.3-A) was found in the highest used concentrations. The reduction in 
plasmid copy number per cell (Figure 3.3-B) was significant with all the used 
concentrations. 
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Figure 3.3: Effect ofEtBr/CsCI on gene expression and delivery. (A) Number of cells expressing 
LacZ and (B) Plasmid copy number per cell. 
3.1.4- Endotoxin 
Spiking was carried out by using a combination of endotoxin (0.32, 4, 40 and 400 
EU/llg DNA). Same transfection and collection procedures performed previously were 
followed. Significant reduction in the number of LacZ expressing cells (Figure 3.4-A) as 
well as the plasmid copy number per cell (Figure 3.4-B) was found in all the used 
concentrations, with a steady state between the middle two concentrations. 
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Figure 3.4: Effect of endotoxin on gene expression and delivery. (A) Number of cells expressing 
LacZ and (B) Plasmid copy number per cell. 
70 
,%su(ts 
3.1.5- Ethanol 
EtOH spiking of pCMV~ was carried out by using different concentrations (0, 0.1, 
0.5 and 1%). The same transfection and collection procedures performed earlier were 
followed. Significant reduction in the number of LacZ expressing cells (Figure 3.5-A) 
was observed only in the 0.5% concentration. On the other hand, no significant 
differences were obtained with the DNA delivery at any used concentration (Figure 3.5-
B). 
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Figure 3.5: Effect of EtOH on gene expression and delivery. (A) Number of cells expressing 
LacZ and (B) Plasmid copy number per cell. 
3.1.6- Reversibility of the spiking effect 
To study the reversibility of contaminant interaction with DNA, a spiking followed 
by DNA cleaning and transfection was carried out. The highest concentration of each 
contaminant was used to spike the same amount of DNA. Following the incubation time 
at room temperature, spiked DNA as well as the control DNA was cleaned. DNA was 
then quantified to transfect cells with consistent amounts of DNA. Twenty-one hours 
post-transfection, the LacZ activity assay and DNA isolation were performed (triplicate 
samples for each). 
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Blue cells expressing LacZ were counted under a light microscope and the 
percentage of cells expressing the gene was calculated from the control value that was set 
at 100% (Figure 3.6). Three of the conditions (EtBr, CsCl and endotoxin) had values 
over 70%. The two other conditions (EtBr/CsCl and EtOH) had a lower value of 
expressing cells. The effect of cleaning was compared to direct spiking (no cleaning), 
with respect to the number of cells expressing LacZ (Figure 3.6). The data was analysed 
statistically by a Student's t-test at a significance level of O.OS. Significant improvement 
(at P<O.OS) in the expression of LacZ was noted in three of the cleaned conditions (EtBr, 
CsCl and endotoxin). The percentage of cells expressing the LacZ gene increased from 
18.9±S.8% to 73.9±6.1 % with EtBr and 42.3±1.7% to 70.6±6.7% with CsCl (Figure 3.6). 
The improvement was dramatic with endotoxin, increasing from 9.4±2.4% to 98.S±4.1 %. 
Insignificant improvement was obtained with EtBr/CsCl and EtOH . 
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Figure 3.6: Effect of contaminants on the number of cells expressing LacZ. Numbers were 
calculated as a percentage from the control value. The used contaminant concentrations were: 
250 nM (EtBr), 56 flM (CsCl), 220 nM/51 mM (EtBr/CsCl), 400 EU/flg DNA (endotoxin) and 
1% (EtOH). 
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The percentage of transfection efficiency of cleaned and uncleaned conditions, 
relative to their controls, is shown in Figure 3.7. No significant change in transfection 
efficiency was obtained in both EtBr and EtOH. On the other hand, significant 
improvement in transfection efficiency of the cleaned CsCI, EtBr/CsCI and endotoxin 
was achieved. Transfection efficiency improved from the uncleaned to the cleaned of 
these three conditions by 5,67 and 7.7 folds, respectively. 
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Figure 3.7: Transfection efficiencies of Spiked and cleaned DNA. The used contaminant 
concentrations were: 250 nM (EtBr), 56 J-LM (CsCl), 220 nM/51 mM (EtBr/CsCl), 400 EUlJ-Lg 
DNA (endotoxin) and 1 % (EtOH). 
3.1.7- Effect of contaminants on mutation frequency 
In order to evaluate the effect of these contaminants on mutation frequency, 
pCMVB was spiked with various contaminant concentrations. To screen for the mutation 
rate after spiking and transfection into mammalian cells, an ultra sensitive mutation 
detection method was developed (Figure 3.8) based on the use of restriction enzyme 
73 
tJ<§suCts 
digestion followed by polymerase chain reaction (PCR) amplification with two primers 
flanking the restriction site. Briefly, any mutation within the recognition sequence of this 
enzyme would prevent the plasmid digestion and that in turn will allow the PCR 
amplification to take place. In contrast, the lack of mutations would allow the proper 
recognition and subsequently digestion of the plasmid (Figure 3.8). 
peR 
primer 
--+ 
DNA ========= 
No mutation 
Complete digestion 
No amplification 
Mutations 
Incomplete digestion 
+ 
Ampli iication proportional I 
to undigested molecules I 
Figure 3.8: Strategy of ultrasensitive mutation detection. Restriction endonuclease digestion is 
followed by peR amplification using primers flanking the digestion sites. 
In this study, 40 ng of DNA isolated from CHO cells was digested with 10 units of 
HindIII in an overnight reaction (20 J.lL) at 37°C and then the enzyme was heat 
inactivated at 70°C for 20 minutes. Five microlitres (lOng DNA) from this reaction and 
lOng from the undigested template were used for the PCR reactions. This allowed the 
recognition of the PCR amplification profile before and after HindIII digestion. 
Amplification was obtained with all the undigested conditions. However, amplification 
from the digested templates was positive only with the highest concentrations of EtBr 
(Figure 3.9). No amplification was noted with any of the other conditions (See the 
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appendix). The same peR reactions were performed on pre-transfected cleaned DNA 
that was spiked with the separate highest contaminants concentrations. No amplification 
occurred in the digested templates, including the cleaned DNA that was spiked with EtBr 
(See the appendix). 
Undigested 
Digested 
700bp 
600bp 
L o 2.5 
L +ve digestion -ve digestion 
25 250nM L 
-ve +ve L 
700bp 
600bp 
700bp 
600bp 
700bp 
600bp 
Figure 3.9: PCR amplification before and after HindIII digestion of DNA isolated from cells 
transfected with pCMV~ spiked with EtBr. The amplicon size of 677 bp and EtBr spiking 
concentrations are shown on the Figure. HindIlI digestion of 0.4 ng of the plasmid (+ve 
digestion) and same plasmid amount with no HindIII added (-ve digestion). (-ve) and (+ve) are 
the direct negative and positive controls, respectively. The DNA ladder (L) used is Norgen's 
PCRSizer. 
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HindUI digested and undigested EtBr-spiked DNA (isolated from CRO cells after 
transfection) was used in a qPCR reaction to quantify the number of mutated AAGCTT 
recognition sequence. Ten nanograms of DNA was used per reaction (either digested or 
undigested DNA). The percentage of mutations in the HindUI site was determined from a 
standard curve of known initial concentration of plasmid DNA using the following 
equation: 
% of molecules which lost HindUI sites= (Plasmid copy number of digested 
sample/Plasmid copy number of undigested DNA sample) x 100 
Figure 3.10 shows the relation between the percentage of molecules with lost 
HindUI sites and EtBr spiking concentration. No significant changes were obtained 
between the lower EtBr concentrations (2.5 and 25 nM) and the control sample without 
spiking. The percentage of molecules with lost HindIII sites with the 0, 2.5 and 25 nM 
concentrations were 0.037, 1.37 and 1.56%, respectively. The number of lost sites 
increased significantly (at P<0.05) over all the EtBr concentrations when using a spiking 
concentration of250 nM, with 9.8% lost sites. 
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Figure 3.10: Percentage ofpCMV~ molecules with lost HindIII sites, Values were determined 
through qPCR of EtBr-spiked DNA (concentrations: 0, 2,5, 25 & 250 nM), before and after 
HindIII digestion, 
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3.2- EFFECT OF ADENOVIRAL TRIPARTITE LEADER SEQUENCE AND El ON 
GENE EXPRESSION 
Adenoviruses have different elements that may affect gene expreSSIOn. These 
elements include the activity of the major late promoter (MLP) and the presence of 
complete or incomplete tripartite leader sequence (TPL). The El region and cell type are 
also other elements that affect the MLP as well as the TPL. Experiments in this section 
were done by in vitro transfection and transient gene expression and all of the plasmids 
used were engineered for this study. 
3.2.1- Plasmid construction 
The expression vector pEl is a shuttle plasmid that was engineered to contain the 
expression cassette in addition to the adenovirus serotype 5 (Ad5) EI region and both the 
left and right inverted terminal repeats (ITRs). The expression cassette contains the 
adenovirus MLP and the TPL with green florescence protein (GFP) as a reporter gene 
and simian virus 40 poly(A) signal (SV40 poly(A)) and is based on pUCI9 backbone 
(see the appendix for a detailed engineering strategy). In addition, another four plasmids 
(pMGA, pMT,GA, pMT,,2GA and pMTGA) were constructed with EI deletion and 
sequential addition of TPL exons. These plasmids were engineered through an extensive 
series of cloning steps utilizing various cloning strategies and techniques (see the 
appendix for a detailed engineering strategy). The final engineered plasmids needed for 
this study are shown in Figure 3.11. 
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Figure 3.11: Schematic diagrams of the constructed p\asmids and their expression cassettes. 
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3.2.2- Transcription of pEl genes 
To confirm that the various cloned genes and the two promoters are biologically 
active, it was necessary to examine the transcription of these genes in CRO cells. Briefly, 
plasmid pEl was transfected into CRO cells using the calcium phosphate method and 
cells were harvested 24 hours post-transfection. Total RNA was isolated and treated with 
DNase to digest any plasmid DNA background. The transcription of three pEl genes was 
evaluated by RT-PCR using specific primers. These genes include: GFP driven by the 
MLP and the ElA and ElB transcripts driven by the El promoter. Primers used to detect 
GFP mRNA were GFP-F and GFP-R, while those used for ElA 13S and ElB 55K 
mRNAs detection were ElA-13S-F, ElA-13S-R, ElB-55k-F and ElB-55k-R, 
respectively. The agarose gel of the amplification products shows -positive transcription 
of the three genes (Figure 3.12). The gel indicates that both the MLP and the El 
promoters are active and the genes under their control are being transcribed successfully. 
L 2 3 4 5 6 7 8 9 L 
GFP EIA 13S ElB 55k 
Figure 3.12: Transcription of pEl genes 24 hours post-transfection in CRO cells. RT -PCR on 
mRNAs of GFP, EIA 13S and ElB 55k are shown in lanes 1, 4 and 7, with amplification 
products of 484 bp, 479 bp and 867 bp, respectively. RT-PCR negative controls (water) of the 
three genes are shown in lanes 2, 5 and 8 with their PCR positive controls in lanes 3, 6 and 9, 
respectively. The bp size of each ladder band is shown on the left side (Norgen's PCRSizer). 
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3.2.3- Effect of AdS TPL exons on GFP gene expression 
The effect of TPL exons sequences on GFP gene expression was evaluated using 
three parameters: plasmid stability, transcription efficiency and transport rate. Equal 
amounts from each of the four plasmids (pMGA, pMT,GA, pMT,,2GA and pMTGA) 
were transfected into CRO cells using the calcium phosphate method. Transfection was 
done in triplicate wells in 6-well plates and the medium was replaced 6 hours post-
transfection. Transfected cells in each of the triplicate wells were divided into two 
isolation procedures. The first was used to isolate cytoplasmic and nuclear RNA and the 
second was used to isolate DNA and total RNA. Samples were collected after 0, 12 and 
24 hours post-transfection and processed for further analysis. 
3.2.3.1- Plasm ids stability 
Quantitative PCR was performed on equal amounts of the isolated DNA using the 
GFP specific primers. A standard curve of known plasmid concentration was used to 
determine the copy number of each plasmid per cell, at each collection point. Maximum 
plasmid copy number was reached at 12 hours post-transfection. This starts to decline 
thereafter with all plasmids in a very similar decay rate. In spite of the fast drop in 
plasmid copy number at 24 hours, the plasmid copies are still significantly (at P<0.05) 
more than that of the starting copy number at 0 hour (Figure 3.13). Plasmid DNA copy 
numbers would be used to normalize the mRNA results and obtain the transcription 
efficiency from each cassette. 
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Figure 3.13: Copy numbers of plasm ids containing incomplete or complete TPL over 24 hours 
post-transfection in CHO cells. Copy numbers were obtained by qPCR using a standard curve of 
known plasmid DNA concentration. 
3.2.3.2- GFP mRNA transcription 
All isolated RNAs were treated with DNase to digest any residual DNA 
background and were then cleaned to remove the DNase. A specific PCR for the GFP 
fragment was used to check the success of the digestion step. The different cleaned RNA 
samples (total, cytoplasmic and nuclear) in addition to the isolated DNA were quantified 
to determine their concentration. Equal amounts of total RNA were used as templates of 
the RT reaction followed by qPCR to measure copy numbers of GFP mRNA using the 
GFP specific primers and a standard curve of known plasmid concentration (Figure 
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3.14). The data obtained was statistically analysed by the two-way ANOVA using 
Tukey's test. The mRNA copy numbers were increasing significantly by 24 hours post-
transfection, not by 12 hours, with all of the different cassettes. By 24 hours, higher OFP 
mRNA copy numbers per cell were obtained from cassettes with no TPL exons or with 
the complete TPL (three exons). The cassette with the first TPL exon showed non-
significant increase in mRNA levels, however, the cassette with the first and second 
exons showed significant decrease in OFP mRNA content when compared to the control 
cassette that does not contain any TPL exons. 
Figure 3.14: GFP mRNA transcripts from cassettes with complete and incomplete TPL exons, 
over 24 hours post-transfection in CHO cells. Copy numbers were obtained by qPCR using a 
standard curve of known plasmid DNA concentration. 
3.2.3.3- GFP Transcription efficiency 
Transcription efficiency was measured from the data obtained for plasmid copy 
number per cell and OFP mRNA copy number per cell. Values of transcription efficiency 
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were calculated by dividing the copy number of mRNA by that of their plasmid copies 
per cell, and are illustrated in Figure 3.15. No significant changes were found in 
transcription efficiency from all the different plasm ids at 12 hours post-transfection, 
however, at 24 hours the efficiency increased significantly (at P<O.05). The highest 
efficiency was obtained in the absence of TPL exons and the lowest was found when the 
first and second exons were incorporated. Similar values resulted from using only the 
first TPL exon or the complete three exons. The differences between the three different 
cassettes that contain TPL exons were insignificant. 
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Figure 3.15: Transcription efficiency of GFP mRNA over 24 hours post-transfection in CHO 
cells, from cassettes with complete and incomplete TPL exons. Efficiency was defined as GFP 
mRNA copy numbers per plasmid per cell. 
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3.2.3.4- GFP mRNA transport rate 
Both cytoplasmic and nuclear RNA were isolated from the same sample, and they 
were treated with DNase and then cleaned. RT-qPCR was used in the same way as 
previously described with total RNA. GFP mRNA copy numbers were quantified by the 
RT-qPCR using a standard curve and was then calculated per cell. The significant 
increment (at P<O.05) in mRNA copy numbers in both cytoplasmic (Figure 3.l6) and 
nuclear (Figure 3.17) samples was found at 24 hours post-transfection. 
In cytoplasmic RNA samples, higher mRNA copy numbers resulted with the lack 
of TPL exons (pMGA) or the presence of the entire TPL (pMTGA) and minor 
increments were obtained with the other two plasmids. However, statistical analysis of 
the data (at P<O.05) showed significant changes only between pMGA and pMT',2GA. 
The trend of GFP mRNA over time in nuclear RNA samples can be placed in a 
descending order, from higher to lower increment levels, as follows: pMGA, pMTGA, 
pMT,GA and pMT' ,2GA. Similar to cytoplasmic mRNA, statistical significance (at 
P<O.05) was found only between pMGA and pMT, ,2GA. 
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Figure 3.16: Cytoplasmic GFP mRNA transcribed from cassettes with complete and incomplete 
TPL exons, over 24 hours post-transfection in CHO cells. Copy numbers were obtained by qPCR 
using a standard curve of known plasmid DNA concentration. 
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Figure 3.17: Nuclear GFP mRNA transcribed from cassettes with complete and incomplete TPL 
exons, over 24 hours post-transfection in CHO cells. Copy numbers were obtained by qPCR 
using a standard curve of known plasmid DNA concentration. 
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The rate of GFP mRNA transport from the nucleus to the cytoplasm was calculated 
from the data obtained from cytoplasmic and nuclear GFP mRNA quantification. The 
percentage of transport rate at each time point was calculated according to the following 
equation: 
where T is the transport rate, C and N stands for cytoplasmic and nuclear RNAs at time t. 
mRNA was measured in our experiment as copy number per cell. The data is illustrated 
in Figure 3.18 and statistical analysis was performed by the two-way ANOVA using 
Tukey's test. No significant change (at P<O.05) was noted in the transport rate between 
12 hours and 24 hours post-transfection, with all the used plasmids. Significantly lower 
transport rate was observed with mRNA transcribed from pMT1GA (only the first TPL 
exon), when compared to the other three plasmids. 
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Figure 3.18: GFP mRNA percentage transport rate after transcription from cassettes with 
complete and incomplete TPL exons, over 24 hours post-transfection in CHO cells. Percentage 
transport rate was calculated from data obtained after estimating mRNA copy numbers in the 
cytoplasm and nucleus by RT-qPCR. 
3.2.3.5- Integrity of the GFP mRNA transcripts 
RT-PCR was used to ensure the presence of the incomplete and complete TPL in 
the 5' end, upstream to the GFP mRNA. Specific primers (TPLate I-F & GFPlate-R) were 
designed in both the first TPL exon as well as the GFP sequence. The amplicon size of 
these primers varies according to the incorporated TPL exons (Figure 3.19). Reverse 
transcription was performed on DNase treated and cleaned RNA samples isolated 24 
hours post-transfection. Then, the RT products together with negative and positive RT 
controls were used in PCRs performed using Taq polymerase and the amplification 
products were visualized by agarose gel electrophoresis (Figure 3.20). 
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Figure 3.19: Schematic diagrams of the GFP mRNA transcripts with the different TPL 
constructs. The red arrow refers to the position of the PCR primers and the amplicon size from 
each transcript is shown. 
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Figure 3.20: RT-PCR amplification of the incomplete and complete TPL attached to GFP 
mRNA. The different samples were collected at 24 hours post-transfection in CHO cells. The 
used conditions for each plasmid are: RNA with RT (+RT), RNA with no RT (-RT) and the 
template plasmid DNA (+ve). CHO DNA (C) as well as water (W) was used as negative controls. 
Plasm ids names and amplicon size are shown on the Figure. Lanes L are Norgen's PCRSizer 
DNA ladder. The bp size of each ladder band is shown on the left side of the picture. 
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3.2.4- Effect of the adenoviral El on plasmid stability and MLP activity in CHO 
cells 
The two plasmids, pE 1 and pMTGA have exactly the same GFP expression cassette 
in identical plasmid, except for the Ad5 El region that is missing in pMTGA. This 
allows us to look at the effect of the El region on plasmid stability as well as the 
expression from the MLP. The two plasmids were transfected into CRO cells, triplicate 
wells for each plasmid, using Lipofectamine 2000. Following transfection, cells were 
collected from the transfected wells over 14 days (0, 1, 2, 3, 5, 8, 11 & 14 days) post-
transfection. CRO cells transfected with pUC19 were included as a negative control. 
Samples were processed to isolate DNA and RNA, both from same sample, and were 
then used afterwards in the different analyses. DNA was quantified and used to 
investigate plasmid stability, transcription and translation over the experimental time. 
3.2.4.1- Plasmid stability 
Equal amOlmts of DNA were used in the qPCR reaction with the GFP specific 
primers. Plasmids copy numbers were determined from a standard curve of a known 
plasmid concentration and then converted to copy number per CRO cell and illustrated in 
Figure 3.21. A two-way ANOVA using Tukey's test was used to analyze the data. 
Plasmid copy number reaches its highest concentration one day post-transfection and 
starts to decline after this to reach insignificant values (at P<0.05) from the starting copy 
numbers in day O. The plasmid pMTGA shows significantly higher copy number (at 
P<0.05) after one day post-transfection than pEl. 
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Figure 3.21: Copy numbers of pMTGA and pEl over 14 days post-transfection in CHO cells. 
Copy numbers were obtained by qPCR using a standard curve of known plasmid DNA 
concentration. 
3.2.4.2- GFP transcription efficiency 
MLP activity in the presence of E 1 was investigated by looking at GFP mRNA 
transcription from both plasm ids over time. RNA samples were treated with DNase and 
cleaned afterwards. The samples were quantified and run in an RT reaction to generate 
the first strand complementary DNA (cDNA) that was later used as a template for qPCR 
with specific GFP primers. Figure 3.22 shows the GFP mRNA copy number in each 
sample as quantified using a standard curve. The results were analysed statistically by the 
two-way ANOYA using Tukey's test. The mRNA transcription was found to be 
significantly increasing (at P<O.05) on the second and third days post-transfection, but 
started to decline until the baseline was almost reached by day five. pE 1 showed 
significant higher levels of GFP mRNA per cell within the period between day one and 
day three post-transfection. 
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Figure 3.22: GFP mRNA transcripts from pMTGA and pEl over 14 days post-transfection in 
CHO cells. Copy numbers were obtained by qPCR using a standard curve of known plasmid 
concentration. 
The transcription efficiency was calculated as the copy number of GFP mRNA 
produced from each plasmid per cell (Figure 3.23). The efficiency from the pEl plasmid 
was higher than pMTGA after day one and until day eight post-transfection. The results 
were analysed statistically by the two-way ANOYA using Tukey's test (at P<O.05) and 
the difference between the efficiencies from the two plasmids was significant at the peak 
period. However, from day eight on, the efficiencies were close to the baseline. 
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Figure 3.23: Transcription efficiency of GFP mRNA over 14 days post-transfection of pMTGA 
and pE 1 in CHO cells. Efficiency was defined as GFP mRNA copy numbers per plasmid per cell. 
Copy numbers per cell of plasmid DNA and GFP mRNA were estimated by qPCR using a 
standard curve of a known plasmid concentration. 
3.2.4.3- GFP translation 
The GFP was quantified from its fluorescence intensity by measuring the relative 
fluorescence units (RFU) in 50,000 cell. The data obtained was graphed and analyzed 
statistically at a significance level of less than 0.05 (Figure 3.24). The results show a 
significant increase in protein expression from the pE 1 plasmid over pMTGA after the 
second day and up until the eighth day post-transfection. The values reached almost the 
baseline on day 11 post-transfection. 
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Figure 3.24: GFP fluorescence intensity over 14 days post-transfection of pMTGA and pEl in 
CHO cells. Fluorescence intensity was measured by the relative fluorescence units (RFU) of 
equal cell counts. 
3.2.5- Plasmid pEl stability, transcription and translation in CHO and HEK 293 
cells 
To evaluate MLP activity in the presence of pre-existing Ad5 E 1 gene products, 
HEK 293 and CHO cells were transfected with pE I using Lipofectamine 2000 and 
various parameters were evaluated including plasmid stability, OFP transcription and 
translation. Negative controls for each cell line transfected with pUC19 were included. 
DNA and RNA were isolated over time, both from the same sample and used for 
downstream analysis. Collection times were as follow: 0, 1, 2, 3, 5, 8, 12 and 14 days 
post-transfection. 
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3.2.5.1- Plasmid stability 
DNA was quantified and equal amounts were used in a qPCR reaction using GFP 
specific primers. A standard curve of known pE 1 concentration was used to determine 
the plasmid copy number per cell for each collection time, since the amount of genomic 
DNA per HEK 293 cells and CHO cell is 3.5 pg and 3.1 pg, respectively (Gregory, 
2005). The data obtained is illustrated in Figure 3.25 . A two-way ANOVA using Tukey's 
test was used in statistical analysis, at a significance level of 0.05 . Both cell lines showed 
significant high levels of plasmid copy numbers only on day one post-transfection. 
Plasmid copies started to drop after this to reach insignificant levels compared to the 
baseline. When looking at the differences between both cell lines, CHO cells showed 
significant higher ability (at P<0.05) in uptaking plasmid DNA than HEK 293. This is 
observed in the first two days post-transfection. However, the trend of plasmid stability 
seems to be identical in both cell lines. 
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Figure 3.25: Copy numbers of pEl over 14 days post-transfection in HEK 293 and CHO cells. 
Copy numbers were obtained by qPCR using a standard curve of known plasmid concentration. 
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3.2.5.2- GFP transcription efficiency 
DNA residues in the isolated RNA were digested by DNase treatment followed by 
RNA cleaning. After quantification, equal amounts of RNA were used in an RT reaction 
to synthesise the first strand cDNAs. Following this, equal volumes of the RT product 
were used in a qPCR reaction using the GFP specific primers. A standard curve of 
known pEl concentration was used to determine the GFP mRNA copy number. The 
amount of total mRNA per REK 293 cell and CRO cell is 8.88 pg and 8.17 pg, 
respectively (determined by total RNA isolation and spectrophotometric quantification). 
These numbers were used to determine the copy number of GFP mRNA per cell (Figure 
3.26). A significant (at P<0.05) increase in GFP mRNA was obtained on the second and 
third days post-transfection. REK 293 cells showed significantly more GFP mRNA 
transcripts per cell than CRO cells, especially on the third day post-transfection. Both 
cell lines show no significant differences from each other or the baseline over days eight 
to 14 post-transfection. 
Transcription efficiency was calculated from the plasmid copy number and GFP 
mRNA copy number per cell. Figure 3.27 shows the transcription efficiencies in both cell 
lines over the 14 day time period. The statistical analysis of the data at the significance 
level of 0.05 showed overall significant higher transcription efficiency in REK 293 cells 
over CRO cells. 
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Figure 3.26: GFP mRNA transcripts from pEl over 14 days post-transfection in HEK 293 and 
CHO cells. Copy numbers were obtained by qPCR using a standard curve of known plasmid 
DNA concentration. 
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Figure 3.27: Transcription efficiency of GFP mRNA over 14 days post-transfection of pE 1 into 
HEK 293 and CHO cells. Efficiency was defined as GFP mRNA copy numbers per plasmid per 
cell. Copy numbers per cell of plasmid DNA and GFP mRNA were estimated by qPCR using a 
standard curve of a known plasmid concentration. 
97 
tJl.§sufts 
3.2.5.3- GFP translation 
The expressed GFP in both cell lines was measured by its fluorescence intensity 
and was significantly (at P<O.05) increased in both cell lines from day one to day eight 
post-transfection. The GFP fluorescence intensity detected in HEK 293 cells over this 
period of time was significantly higher than that obtained from CHO cells. Fluorescence 
intensity remained close to the baseline after day eight post-transfection in both cell lines 
(Figure 3.28). 
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Figure 3.28: OFP fluorescence intensity over 14 days post-transfection of pE 1 in HEK 293 and 
CHO cells. Fluorescence intensity was measured by the relative fluorescence units (RFU) of 
equal cell counts. 
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3.3- CONSTRUCTION OF A CELL LINE EXPRESSING THE ADS E2 AND 
PROTEASE GENES 
3.3.1- pE2 construction 
Engineering a plasmid containing the AdS E2 and viral protease genes is essential 
for the establishment of a cell line that expresses these genes, constitutively or upon 
induction by the AdS El genes. For this purpose, the pE2 plasmid was engineered to 
contain all the needed sequences for the cell line construction and selection. We used 
pUC 19neo as a backbone plasmid which contains the neomycin resistance cassette for 
selection in mammalian cells. The construction ofpE2 (Figure 3.29) involved the cloning 
of E2 (E2A and E2B), the E2 promoter and viral protease. E2A encodes for the single 
stranded DNA binding protein (ssDBP), whereas E2B encodes for viral polymerase and 
precursor terminal protein (pTP) and all are driven by the E2 promoters. Expression of 
the viral protease is driven by the MLP which is located on the complementary strand of 
the E2B region. All of the viral fragments of this construction were obtained from the 
plasmid pBHGfrtdell,3FLP, which contains the adenoviral backbone with deleted El 
and E3 regions (see the appendix for a detailed engineering strategy). 
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Figure 3.29: Schematic diagrams of pE2. 
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3.3.2- Evaluation of pE2 gene transcription in HEK 293 cells and CHO cells 
The basic expression levels from the pE2 plasmid were performed by calcium 
phosphate transfection of the cesium chloride banded preparation of the plasmid into 
both HEK 293 and CHO cells. Samples were collected and handled as previously 
described with .pEl transfection. RT-PCR was used to detect the transcription of the 
different pE2 genes in the two cell lines. Four genes were tested including three in the E2 
region in addition to the viral protease. E2 promoters drive the transcription of the three 
E2 genes, which are the ssDBP, viral polymerase and pTP. The expression of the viral 
protease is driven by the MLP located on the complementary strand of the E2B region. 
The specific primers used were DBP-F and DBP-R for ssDBP, VPol-F and VPol-R for 
viral polymerase, pTP-F and pTP-R for the pTP and VPro-F and VPro-R for the viral 
polymerase. The gel picture of the PCR product shows positive amplification of all genes 
in HEK 293 cells (Figure 3.30). On the other hand, viral protease was the only 
transcribed gene in CHO cells (Figure 3.31). 
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Figure 3.30: Transcription ofpE2 genes 24 hours post-transfection in REK 293 cells. RT-PCR 
on mRNAs of ssDBP, viral polymerase, pTP and viral protease are shown in lanes 1,4, 7 and 10, 
with amplification products of 489 bp, 701 bp, 565 bp and 562 bp, respectively. RT-PCR 
negative controls (water) of the four genes are shown in lanes 2, 5, 8 and 11 with their PCR 
positive controls in lanes 3, 6, 9 and 12, respectively. The bp size of each ladder band (Norgen's 
PCRSizer) is shown on the left side. 
L 2 3 4 5 6 7 8 9 10 11 12 L 
ssDBP viral polymerase pTP Viral protease 
Figure 3.31: Transcription of pE2 genes 24 hours post-transfection in CRG cells. RT -PCR on 
mRNAs of ssDBP, viral polymerase, pTP and viral protease are shown in lanes 1,4, 7 and 10. 
RT-PCR negative controls (water) of the four genes are shown in same order in lanes 2, 5, 8 and 
11 with their PCR positive controls in lanes 3, 6, 9 and 12, with amplification products of 489 bp, 
701 bp, 565 bp and 562 bp, respectively. The bp size of each ladder band (Norgen's PCRSizer) is 
shown on the left side. 
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3.3.3- Co-transfection and evaluation of pEl and pE2 stability and expression in 
CHO cells 
pEl and pE2 plasmids were co-transfected into CHO cells using Lipofectamine 
2000, to guarantee high levels of co-transfection. Different molar ratios were used from 
each plasmid to verify their effect on gene expression over 15 days. The used pE 1 :pE2 
molar ratios were: 0:0, 1:0, 0:1, 1:1, 1:3, 1:6, 1:9, 3:1, 6:1 and 9:1. Samples were 
collected at days 0, 1, 3, 5, 8, 12 and 15 post-transfection. RNA, DNA and protein were 
all isolated from the same samples and used for analysis of plasmid stability and gene 
expressIon. 
3.3.3.1- Plasmid stability 
Stability of both pEl and pE2 were investigated over time using the isolated DNA 
of the different samples. After the spectrophotometric quantification of DNA, the GFP 
primers and the pTP primers were used in a PCR reaction with the same starting amount 
of DNA template. The agarose gel electrophoresis of the GFP PCR product (Figure 3.32) 
showed positive amplification in almost all of days I and 3. No observed changes in pEl 
stability were obtained with the different molar ratios of either pEl or pE2. A similar 
profile was resulted from pTP PCR (Figure 3.33). Neither of the plasmids was affected 
by the presence of the other plasmid or by the different molar ratios. 
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L 0 3 5 8 12 15 0 3 5 8 12 15 L 
1:6 1:9 
Figure 3.32: pEl stability in CRO cells, over 15 days, after co-transfection with different molar 
ratios of pEl and pE2. Post-transfection sample collection times are shown on the top of the 
Figure. The molar ratio of pEl :pE2 is written underneath its collection set, after perfOlming PCR 
amplification with a pl:'oduct size of 484 bp. Lanes L are Norgen's PCRSizer DNA ladder. 
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1:6 1:9 
Figure 3.33: pE2 stability in CRO cells, over 15 days, after co-transfection with different molar 
ratios of pEl and pE2. Post-transfection sample collection times are shown on the top of the 
Figure. The molar ratio of pEl :pE2 is written underneath its collection set, after performing PCR 
amplification with a product size of 565 bp. Lanes L are Norgen's PCRSizer DNA ladder. 
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3.3.3.2- Transcription levels 
Transcription of GFP mRNA (pEl) and both pTP and viral protease (pE2) were 
investigated by RT-PCR. First, isolated RNA was treated with DNase to digest any 
plasmid DNA contamination. RNA was then cleaned and quantified. Equal amounts of 
RNA were used in an RT reaction to synthesize the first strand cDNA of the different 
mRNAs. Equal volumes were used from the RT product to perform a PCR reaction using 
specific primers for GFP, pTP and viral protease (VPro). Agarose gel electrophoresis was 
used to identify the PCR products of the different reactions. Positive amplification from 
GFP mRNA was obtained only in day 1 and days 1-3 of co-transfected pE1:pE2 molar 
ratios of6:1 and 9:1, respectively (Figure 3.34). No amplification was obtained with any 
of the different co-transfection ratios after performing RT-PCR on pTP mRNA (data not 
shown). However, positive amplification from viral protease mRNA was obtained only 
in day 1 of co-transfected pEl :pE2 molar ratios ofl:6 and 1:9 (Figure 3.35). 
Days Days 
o 3 5 8 12 15 L L o 1 3 5 8· 12 15 
6:1 9:1 
Figure 3.34: GFP mRNA transcription in CRO cells over 15 days, after co-transfection with pEl 
and pE2. Post-transfection sample collection times are shown on the top of the Figure. The molar 
ratio ofpEl:pE2 is written underneath its collection set, after perfOlming RT-PCR amplification 
with a product size of 484 bp. Lanes L are Norgen's PCRSizer DNA ladder. 
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Figure 3.35: Viral protease mRNA transcription in CHO cells over 15 days, after co-transfection 
with pE 1 and pE2. Post-transfection sample collection times are shown on the top of the Figure. 
The molar ratio of pEl:pE2 is written underneath its collection set, after performing RT-PCR 
amplification with a product size of 562 bp. Lanes L are Norgen's PCRSizer DNA ladder. 
3.3.4- Transfection and selection of eHO cell line 
The construction of CRO-E2 cell line is based on the transfection of CRO cells 
with the pE2 plasmid followed by the specific selection of positively transfected cells 
using 0418. Cells that have the pE2 plasmid will resist the 0418 selection due to the 
presence of the neomycin resistant cassette. The selection will force the cells to retain the 
plasmid as well as force its integration into the genomic DNA. The integration of this 
circular plasmid is completely random with regards to both the site of plasmid 
linearization as well as genomic integration site. Therefore, the restriction enzyme NdeI 
was used to linearize the plasmid with heat inactivation after the complete digestion, 
prior to plasmid transfection into CRO cells. Only one restriction site of NdeI is present 
in the pE2 plasmid and it does not interfere with any of the regulatory or coding 
sequences of the different cassettes (Figure 3.36). 
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Figure 3.36: Map of NdeI linearized pE2. 
After calcium phosphate transfection and 0418 selection, cells were kept under the 
selection pressure for 14 days till the small resistant foci started to form. After that, 96 
foci were picked under a light microscope and grown in separate wells in four of 24-well 
plates. The picked foci were kept for an additional three days under the selection pressure 
of 0418. Fifty-six of the picked foci continued to grow afterwards and were split with 
replating half of each well and harvesting the other half for DNA isolation. 
PCR amplification of the right border of the linear plasmid was used to screen for 
the presence of the full size linear pE2, since the left borders already contain the 
neomycin resistant cassette. Two specific primers were used in the amplification 
reaction, named E2RB-F and E2RB-R. Amplification was obtained only in five foci and 
they were designated CHO-E2-1 to CHO-E2-5 (Figure 3.37). These five foci were 
transferred into larger plate and kept under 0418 selection for an additional 40 days. 
L 2 3 4 5 6 7 
Figure 3.37: Amplification of linear pE2 right borders from foci CHO-E2-1 to CHO-E2-5. DNA 
isolated from the different foci was used in a PCR reaction of an amplicon size of 558 bp. Lanes 
1-5 shows the amplification from the five foci, respectively. Lane 6 is the positive control, lane 7 
is CHO DNA and lane L is Norgen's MidRanger DNA ladder. 
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3.3.5- Detection of the different pE2 genes in the constructed CHO-E2 cell lines 
The four main genes of pE2 were detected in the newly constructed cell lines that 
were kept under the selection pressure for two months. Primers that have been used to 
test the basic transcription levels of the different pE2 genes were used to screen for the 
presence of these genes in the foci. All of the foci showed positive amplification of 
ssDBP, viral polymerase, pTP and the viral protease (Figures 3.38-3.41). Two negative 
controls were used, the first is DNA isolated from eRO cells and the second is water. 
The used positive control was the pE2 plasmid. 
bp 
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Figure 3.38: PCR amplification of ssDBP fragment from cell lines CHO-E2-1 to CHO-E2-5. 
DNA isolated from the different cell lines was used in a PCR reaction of an amplicon size of 489 
bp. Lanes 1-5 shows the amplification from the five cell lines, respectively. Lane 6 is CHO DNA, 
lane 7 is the negative control (water), lane 8 is the positive control and lanes L are Norgen's 
FullRanger DNA ladder. 
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Figure 3.39: PCR amplification of viral DNA polymerase fragment from cell lines CHO-E2-1 to 
CHO-E2-5. DNA isolated from the different cell lines was used in a PCR reaction of an amplicon 
size of701 bp. Lanes 1-5 shows the amplification from the five cell lines, respectively. Lane 6 is 
CHO DNA, lane 7 is the negative control (water), lane 8 is the positive control and lanes L are 
Norgen's PCRSizer DNA ladder. 
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Figure 3.40: PCR amplification ofpTP fragment from cell lines CHO-E2-1 to CHO-E2-5. DNA 
isolated from the different cell lines was used in a PCR reaction of an amp Ii con size of 565 bp. 
Lanes 1-5 shows the amplification from the five cell lines, respectively. Lane 6 is CHO DNA, 
lane 7 is the negative control (water), lane 8 is the positive control and lanes L are Norgen's 
FullRanger DNA ladder. 
109 
IJ?gsufts 
bp 
2000 
1500 
1000 
600 
500 
L 2 3 4 5 6 7 8 L 
Figure 3.41: PCR amplification of viral protease fragment from cell lines CHO-E2-1 to CHO-
E2-5. DNA isolated from the different cell lines was used in a peR reaction of an amplicon size 
of 562 bp. Lanes 1-5 shows the amplification from the five cell lines, respectively. Lane 6 is 
CHO DNA, lane 7 is the negative control (water), lane 8 is the positive control and lanes L are 
Norgen's FullRanger DNA ladder. 
3.3.6- Detection of the ligated pE2 terminal ends in the new cell lines 
Linearized pE2 was used for cell line construction. However to test the probability 
of plasmid ligation after transfection, we used specific PCR primers (pE2F primer set) 
that lie at both terminal ends of the NdeI-linearized plasmid. Positive PCR amplification 
would be obtained only if the linearized plasmid ends were ligated to each other. PCR 
was performed on DNA isolated from the five cell lines. Negative controls included 
DNA isolated from CHO cells and water. In addition, PCR was performed on 100 ng of 
the transfection stock of NdeI-linearized pE2. Positive amplification was obtained with 
CHO-E2-2, CHO-E2-4 and CHO-E2-5 cell lines and no amplification was obtained with 
CHO-E2-1, CHO-E2-3, negative controls or the NdeI-linearized pE2 transfection stock. 
The agarose gel picture of the PCR result is shown in Figure 3.42. 
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Figure 3.42: peR amplification of the ligated terminal ends of pE2 in the five cell lines. DNA 
isolated from the different cell lines was used in a peR reaction of an amplicon size of 743 bp. 
Lanes 1-5 shows the amplification from the five cell lines, respectively. Lane 6 is eRO DNA and 
lane 7 is the negative control (water). Lane 8 is the product of peR performed on 100 ng of the 
transfection stock of NdeI-linearized pE2. Lanes L are Norgen's FullRanger DNA ladder. 
3.3.7- pEl expression and stability in CHO-E2 cell lines 
Having established CHO cell lines containing the AdS E2 and protease genes, it 
was anticipated that the transfection of these cell lines with a plasmid carrying the AdS 
E 1 would lead to the induction of the integrated genes and would in turn increase gene 
expression. Therefore, pEl was transfected into the five CHO-E2 cell lines in addition to 
CHO cells performed by Lipofectamine 2000 in a 6-well plate. One day post-
transfection, monolayer cells were washed with PBS and visualized under the confocal 
microscope directly from the 6-well plate, without lifting the cells. Images of the 
transfected cells were acquired by monitoring GFP expression with a 4X objective lens. 
All the different cell lines showed almost the same fluorescence intensity (Figure 3.43). 
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Figure 3.43: Confocal microscope pictures of GFP expression in monolayers of the different 
CHO-E2 cell lines. Images were processes 24 hours post-transfection of pEl using 
Lipofectamine 2000. CHO-E2-1 (A), CHO-E2-2 (B), CHO-E2-3 (C), CHO-E2-4 (D), CHO-E2-5 
(E) and CHO (F). Fluorescence was visualized by Nikon's confocal microscopy and images were 
acquired with a 4X obje~tive lens. 
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3.3.7.1- pEl stability in the different cell lines 
Next, it was anticipated that the transfected plasmid will replicate inside the 
established cell lines. Therefore, the stability of pEl in the different CRO cell lines, in 
addition to CRO cells, was monitored over time using PCR amplification perfonned on 
DNA isolated from cells transfected with pEl. Transfection was performed by the 
calcium phosphate method and samples were collected at times 0, 2, 6, 12,24,48 and 72 
hours post-transfection. RNA was isolated along with DNA, both from the same sample. 
The GFP primer set were used in the PCR amplification, with an amplicon size of 484 
bp. Agarose gel electrophoresis was used to run the PCR products. The amplification 
results revealed plasmid stability in all the different cell lines over the first 24 hours. 
Plasmid starts to be lost from the cells at 48 and 72 hours post-transfection. CRO-E2-3 
and CRO cells retained more plasmids at 48 and 72 hours post-transfection than the other 
CRO-E2 cell lines (Figure 3.44). 
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Figure 3.44: pEl stability in CHO-E2 cell lines and CHO cells, over 72 hours post-transfection. 
Post-transfection sample collection times are shown on the top of the Figure. The name of each 
cell line is written underneath its collection set, after performing GFP PCR amplification with a 
product size of 484 bp. Lanes L are Norgen's PCRSizer DNA ladder. 
3.3. 7.2~ Transcription from the different genes of pEl and pE2 in CHO~E2 cell lines 
Lastly, it was anticipated that the transcription of the various genes encoded in pEl 
and pE2 may be affected in the established cell lines. Therefore, RNA samples from the 
different pEl transfected cell lines were isolated along with the DNA, over 72 hours, as 
in the previous step. Samples were subjected to DNase treatment to digest any DNA 
background. RNA was cleaned afterwards to completely remove residual DNase. The 
success of the DNA digestion was checked by running peR reactions on the treated 
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RNA and using the GFP specific primer set. Negative amplification was obtained with 
all the samples indicating the success of the background digestion. RT was performed on 
the same amount of treated RNA samples to create the first strand cDNA of the different 
mRNA templates. Subsequently, PCR was performed on the same volume ofRT product 
to amplify the first strand cDNA, using specific primers of the target mRNA. Different 
mRNAs were checked for their transcription including both pEl genes (GFP, ElA and 
ElB: Figures 3.45 - 3.47) and pE2 genes (ssDBP, viral polymerase, pTP and viral 
protease). The RT-PCR on the E2 genes mRNA resulted in negative amplification with 
all the CHO-E2 cell lines (data not shown). However, minor amplification was obtained 
from viral protease mRNA, 48 hours post-transfection, only with three cell lines: CHO-
E2-l, CHO-E2-3 and CHO-E2-5 (Figure 3.48). 
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Figure 3.45: GFP mRNA transcription in CHO-E2 cell lines and CHO cells, over 72 hours post-
transfection with pEl. Post-transfection sample collection times are shown on the top of the 
Figure. The name of each cell line is written underneath its collection set, after performing PCR 
amplification with a product size of 484 bp. C is non-transfected cells, -ve and +ve are the 
negative and positive controls, respectively and lanes L are Norgen's PCRSizer DNA ladder. 
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Figure 3.46: ElA-13S mRNA transcription in CHO-E2 cell lines and CHO cells, over 72 hours 
post-transfection with pEl. Post-transfection sample collection times are shown on the top of the 
Figure. The name of each cell line is written underneath its collection set, after performing RT-
PCR amplification with a product size of 479 bp. C is non-transfected cells, -ve & +ve are the 
negative and positive controls, respectively and lanes L are Norgen's PCRSizer DNA ladder. 
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Figure 3.47: ElB 55k mRNA transcription in CHO-E2 cell lines and CHO cells, over 72 hours 
post-transfection with pEl. Post-transfection sample collection times are shown on the top of the 
Figure. The name of each cell line is written underneath its collection set, after perfonning RT-
PCR amplification with a product size of 867 bp. C is non-transfected cells, -ve & +ve are the 
negative and positive controls, respectively and lanes L are Norgen's PCRSizer DNA ladder. 
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Figure 3.48: Viral protease mRNA transcription in the different CHO-E2 cell lines and CHO 
cells, over 72 hours post-transfection with pEl. Post-transfection sample collection times are 
shown on the top of the Figure. The name of each cell line is written underneath its collection set, 
after performing RT-PCR amplification with a product size of 562 bp. C is non-transfected cells, 
- ve & +ve are the negative and positive controls, respectively and lanes L are Norgen's 
PCRSizer DNA ladder. 
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3.4- INDUCTION OF GENE EXPRESSION BY ADENOVIRUS SUPER-INFECTION 
This section focuses primarily on the effect of adenovirus super-infection on gene 
expression under the control of the AdS MLP with incomplete or complete TPL and in 
the presence of AdS lTRs and El region. It was anticipated that super-infection of cells 
(CHO or HEK 293) harbouring plasmids would lead to measurable effect on plasmid 
copy number, transcription and translation. 
3.4.1- Stability and transcription from pMTGA in HEK 293 and CHO cells super-
infected with adenovirus 
Two groups of triplicate wells for each cell line were transfected with pMTGA 
using Lipofectamine 2000. The growth medium was replaced 6 hours post-transfection to 
remove the transfection reagent and allow the cells to recover. At 12 hours post-
transfection, one of the two groups of each cell line was super-infected with adenovirus 
at a multiplicity of infection (MOl) of 10 plaque forming units (PFU) per cell. Samples 
were collected from the transfected and super-infected groups at: 0, 0.5, 1.5, 2.5, 3.5 and 
4.5 days post-transfection. Two negative controls were included for each cell line; the 
first is transfected with pUC 19 and used as a control for transfected cells, while the 
second is pUC19 transfected and super-infected with the wild type virus. An additional 
group of viral infection into both cell lines was included as a negative control. DNA and 
RNA were isolated, both from same sample, and used for downstream analysis. 
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3.4.1.1- Plasmid stability 
DNA samples were quantified and equal amounts were used in a qPCR with 
specific primers for OFP. The copy number of the plasmid DNA was obtained using a 
standard curve of known plasmid concentration. Figures 3.49 and 3.50 show the plasmid 
copy number per cell in HEK 293 and CHO cells respectively, over the collection period. 
Data was statistically analyzed by the two way ANOVA using Tukey's test. Both cell 
lines showed significantly (at P<0.05) higher plasmid copies after 12 hours and 1.5 days 
post-transfection (zero and one day after super-infection). No significant changes were 
observed in the trends of plasmid stability with the transfection and super-infection 
conditions. The lysis of HEK 293 cells was observed after 2.5 days post-transfection. In 
contrast, CHO cells did not lyse upon super-infection, although they showed a large 
amount of detached cells after 3.5 days post-transfection. 
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Figure 3.49: Copy numbers of pMTGA over 4.5 days post-transfection in HEK 293 cells with 
transfection and super-infection conditions. Copy numbers were obtained by qPCR using a 
standard curve of known plasmid DNA concentration. 
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Figure 3.50: Copy numbers of pMTGA over 4.5 days post-transfection in CHO cells, with 
transfection and super-infection conditions. Copy numbers were obtained by qPCR using a 
standard curve of known plasmid DNA concentration. 
3.4.1.2- GFP transcription efficiency 
DNase was used to digest any residual DNA in the RNA samples, followed by 
cleaning and quantification. Equal amounts of RNA were used in an RT reaction to 
synthesize the first strand cDNA of the different mRNAs. After this, a qPCR was 
performed on equal volumes of the RT product using the OFP specific primer set. OFP 
mRNA copy numbers were quantified using a standard curve and then were calculated 
per cell. The data obtained from the different samples collected over time from both 
HEK 293 and CHO cells are shown in Figures 3.51 and 3.52, respectively. Statistical 
analysis of the data at a significance level of 0.05 showed no significant increase in OFP 
mRNA from the super-infected HEK 293 cells over the transfected ones. Only at 2.5 
days post-transfection was a change noted as cell lysis started to occur. However, in 
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CHO cells, the increment in GFP mRNA was significant after the super-infection, 
particularly on 1.5 days post-transfection. 
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Figure 3.51: GFP mRNA transcripts from pMTGA over 4.5 days post-transfection in HEK 293 
cells with transfection and super-infection conditions. Copy numbers were obtained by qPCR 
using a standard curve of known plasmid DNA concentration. 
Figure 3.52: GFP mRNA transcripts from pMTGA over 4.5 days post-transfection in CHO cells, 
with transfection and super-infection conditions. Copy numbers were obtained by qPCR using a 
standard curve of known plasmid DNA concentration. 
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Transcription efficiency was calculated from the obtained copy numbers of both 
plasmid DNA and OFP mRNA. Figures 3.S3 and 3.54 illustrate the transcription 
efficiency over time in both HEK 293 and CHO cells. The statistical analysis of the data 
(at P<O.OS) demonstrated insignificant increase of OFP transcription efficiency upon 
super-infection of HEK 293 cells, with elevated efficiency 2.S days post-transfection. On 
the other hand, super-infection of CHO cells showed significant (at P<O.OS) increase in 
OFP transcription efficiency over time relative to non-infected. The fold increase in 
transfection efficiency of the super-infected samples over the corresponding transfected 
ones is shown in Figure 3.SS. CHO cells have a higher relative increase in transfection 
efficiency with time over HEK 293 cells. Up to an eight fold increase was obtained from 
super-infected CHO cells at 4.S days post-transfection. 
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Figure 3.53: Transcription efficiency ofGFP mRNA over 4.5 days post-transfection in HEK 293 
cells, with transfection and super-infection conditions. Efficiency was defined as GFP mRNA 
copy number per plasmid per cell and. Copy numbers per cell of plasmid DNA and GFP mRNA 
were estimated by qPCR using a standard curve of a known plasmid concentration. 
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Figure 3.54: Transcription efficiency of GFP mRNA over 4.5 days post-transfection in CHO 
cells, with transfection and super-infection conditions. Efficiency was defined as GFP mRNA 
copy number per plasmid per cell. Copy numbers per cell of plasmid DNA and GFP mRNA were 
estimated by qPCR using a standard curve of a known plasmid concentration. 
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Figure 3.55: Fold increase in transcription efficiency in HEK 293 and CHO cells, after super-
infection with adenovirus. HEK 293 cells underwent lysis after 2.5 days post-transfection. 
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3.4.2- Gene expression from different plasmids in CHO cells super-infected with 
adenovirus at MOl of 10 PFU/cell 
The following five plasmids were used in this experiment: pMGA, pMT1GA, 
pMT1 ,2GA, pMTGA and pEl. All of these plasmids contain the MLP and GFP in their 
expression cassette with partial or complete TPL. pMGA has no TPL however pEl 
contains the complete TPL in addition to the adenovirus ITRs-EI fragment. The maps of 
the different GFP expression cassettes are shown in Figure 3.11. 
Plasmids were transfected into CRO cells using Lipofectamine 2000 in two 
triplicate groups for each plasmid. The medium was changed 6 hours post-transfection. 
Twelve hours after transfection, Super-infection was carried out on one group of each 
plasmid. In addition to the zero and 12 hours collection times, samples were collected at 
l.S and 3.S days and then every 3 days thereafter. Two negative controls were included; 
the first is the CRO cells transfected with pUCI9 and used as a control for the transfected 
cells, while the second is pUCI9 transfected and super-infected with the wild type virus. 
DNA and RNA were isolated from the same collected samples. 
3.4.2.1- Plasmid stability 
After quantifying the isolated DNA, it was used in a qPCR reaction to determine 
the copy number of each plasmid. A GFP primers set was used with all the plasmids 
since they all contain the GFP gene. A standard curve was used as previously mentioned, 
and the copy numbers per cell for transfection and super-infection conditions of each 
plasmid were calculated and illustrated in Figure 3.S6 . The obtained data was statistically 
analyzed by the two way ANOVA using Tukey's test at a significance level of O.OS. All 
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of the plasmids, with the exception of pEl, share the same stability trend over time in 
eRO cells with both transfection and super-infection. The maximum plasmid copy 
numbers in the cell were at 12 hours post-transfection, followed with a significant (at 
P<O.05) decrease in the copy number over the next two collection points (1.5 and 3.5 
days, post-transfection) to reach very close to the baseline on day 3.5 . Super-infection of 
the pEl showed different stability, with significantly (at P<O.05) increased copy number 
on day 1.5 post-transfection. A dramatic drop in pEl copy number was observed on day 
3.5 post-transfection. 
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Figure 3.56: Copy numbers of the different p\asmids over 3.5 days post-transfection in CHO 
cells, with transfection and super-infection (at MOl of 10 PFU/cell) conditions. Copy numbers 
were obtained by qPCR using a standard curve of known plasmid DNA concentration. 
128 
'Rgsu[ts 
3.4.2.2- GFP transcription efficiency 
As done in the previous experiments, RNA was treated with DNase, cleaned then 
quantified and used in an RT reaction followed by qPCR using the GFP specific primers. 
The GFP mRNA copy numbers, transcribed from the different plasmids in both 
transfection and super-infection conditions, were then quantified using a standard curve. 
RNA was then calculated per cell and illustrated for each plasmid in both the transfection 
and super-infection conditions (Figure 3.57). Statistical analysis was done as described 
with the DNA data. The mRNA of all the transfection conditions showed almost same 
trend, with a significant (at P<O.05) peak on day 1.5 post-transfection followed by a 
decline in levels. The effect of super-infection on mRNA levels varies with the different 
plasmids. An insignificant (at P<O.05) increase in mRNA levels was observed upon 
super-infection ofpMGA, pMT1GA and pEl. In contrast, significant increase was noted 
with pMT1,2GA and pMTGA. 
The transcription efficiency was calculated as the copy number of GFP transcripts 
per plasmid per CHO cell. Efficiencies from the transfection and super-infection 
conditions of each plasmid are shown in Figure 3.58. Statistical analysis of the data 
obtained was performed as previously mentioned. Increased transcription efficiency 
levels were observed in the super-infected conditions ofpMGA and pMTIGA compared 
to their transfection conditions on day 1.5 post-transfection. Efficiencies from both 
plasmids declined on day 3.5 post-transfection of the super-infection conditions while the 
transfection conditions continued to increase. However, the overall difference was not 
significant when analyzed at P<O.05. The plasmid pEl showed no significant increase in 
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transcription efficiency over time when comparing the transfected to the super-infected 
conditions. In addition, the transcription efficiency of the super-infection condition of 
pMT [,2GA was insignificantly increasing over time when compared to the efficiencies of 
the transfection conditions. Only pMTGA showed a significant (at P<0.05) increase in 
transcription efficiency over time within the super-infection condition than that of 
transfection. 
130 
~sufts 
400 pMGA (no TPL) 400 pMT,GA (TPL exon 1) 
350 350 
300 
-.- Transfection 300 
= 
'8 8 -.- Super-infection 1 250 ] 250 
E E 
~ 200 ~ 200 
,., ,., 
Q. Q. 
8 150 8 150 
« :l z 
0: 100 E 
0: 100 E 
50 50 I 
0 0 
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 
Days Days 
400 pMT,~GA (TPL exon 1 & 2) 400 pMTGA (complete TPL) 
350 350 
300 300 
'8 '8 i 250 1 250 
.0 
E E 
~ 200 ~ 200 
Ei: Ei: 8 150 8 150 
:l :l 
'li 100 0: 100 ~ E I 50 50 ;JE T 0 .. 
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 
Days Days 
400 pel 
350 
300 
1250 
.<> 
E E 200 
i!: 
3 150 
« 
z 
~ 100 
50 
0.0 0.5 '.0 1.5 2.0 2.5 3.0 3.5 4.0 
Days 
Figure 3.57: GFP mRNA transcripts from the different plasm ids over 3.5 days post-transfection 
in CHO cells, with transfection and super-infection (at MOl of 10 PFU/cell) conditions. Copy 
numbers were obtained by qPCR using a standard curve of known plasmid DNA concentration. 
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Figure 3.58: Transcription efficiency of GFP mRNA over 3.5 days post-transfection in CHO 
cells, with transfection and super-infection (at Mal of 10 PFU/cell) conditions. Efficiency was 
defined as GFP mRNA copy number per plasmid per cell. Copy numbers per cell of plasmid 
DNA and GFP mRNA were estimated by qPCR using a standard curve of a known plasmid 
concentration. 
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3.4.2.3- GFP translation 
Fluorescence intensity was used to measure GFP level in equal cell counts from the 
different samples. CHO cells were used as a blank and the two negative controls 
(pUCI9-transfected and pUCI9-transfected/super-infected CHO cell) were included. The 
fluorescence intensity from the transfection and the super-infection conditions of each 
plasmid are shown in Figure 3.59. Statistical analysis of the data obtained was performed 
as previously mentioned. All of the plasmids showed significant (at P<O.05) increase in 
GFP fluorescence intensity after 12 hours post-transfection, in both the transfection and 
the super-infection conditions. On the other hand, all of the plasmids used showed 
similar or insignificant change in their GFP expression on day 3.5 of both conditions. At 
this time point, there were still significantly elevated GFP levels. However, on day l.5, 
the differences between the two conditions were clearly observed. Only pMGA showed 
significantly higher GFP in the transfected condition over the super-infected one. The 
opposite was seen with pMT\,2GA; it had significantly elevated GFP on day l.5 of the 
super-infected over the transfected conditions. The remaining plasmids showed minor, 
non-significant differences between their expressed GFP in the two conditions. 
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Figure 3.59: GFP fluorescence intensity over 3.5 days post-transfection in CHO cells, with 
transfection and super-infection (at MOl of 10 PFU/cell) conditions. Fluorescence intensity was 
measured by the relative fluorescence units (RFU) of equal cell counts. 
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Although the experimental aim was to investigate gene expression over longer 
periods of time, this was not possible due to cell detachment. Detachment started after 
day 3.5 and about 95% of the cells detached after 5.5 days of the super-infection. The 
cell mono layers of all of the transfected conditions remained attached with few cells 
detaching. The question that arose was if these detached cells were viable or dead. 
Therefore, detached cells on day 3.5 were collected from the pEl super-infected 
samples and cell vitality was determined using trypan blue. The dye penetrates and stains 
dead cells but not viable cells. Most of the detached cells were still alive (S1.3±41. 7%) 
and small number of cells were dead (1S.S±5.3%). 
The plasmid copy number and OFP mRNA transcripts per cell were measured in 
detached cells, using qPCR and RT-qPCR, respectively. In addition, transcription 
efficiency was also calculated. Figure 3.60 shows the number of plasm ids copies, mRNA 
transcripts and transcription efficiency in both attached and detached cells of the pEl 
super-infected condition. A two sample t-test (at P<0.05) showed significant increase in 
plasmid copies and transcription efficiency in detached cells. 
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Figure 3.60: Plasmid copies, transcripts copies and transcription efficiency in attached and 
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3.4.3- Effect of adenovirus super-infection on gene expression in CHO cells at 
different MOIs 
In the previous super-infection experiments, an MOl of 10 PFU/cell was used. The 
high MOl may be the reason for the cell detachment after 3.5 days post-transfection in 
the super-infected conditions of the last experiment. Therefore, lower MOls were used to 
super-infect CRO cells that have been transfected with pEl and examined gene 
expression as well as cell adhesion. Four groups of triplicate wells of CRO cells were 
first transfected with pEl, using Lipofectamine 2000. The transfection medium was 
changed 6 hours after transfection and cells were allowed to recover from the 
transfection for another 6 hours. Then, three groups were super-infected with the wild 
type virus d1309 at MOls of 0, 1, 5 and 10 PFU/cell. Samples were collected over time 
(0, 0.5, 1.5, 4.5, 9.5 and 14.5 days post-transfection) and DNA and RNA were isolated 
from the same samples, and used for gene expression analysis. Two negative controls 
were included; the first is CRO cells transfected with pUC19 and used as a control for 
transfected cells, while the second is pUC19 transfected and super-infected with the wild 
type virus. Statistical analysis of all the data obtained was performed by two way 
ANOVA using Tukey's test, at a significance level of <0.05. 
The cells remained attached in monolayers with MOls of 0 and 1 PFU/cell, while 
cell detachment was observed with MOls of 5 and 10 PFU/cell. The confluencey of 
detached cells, on day 5 post-transfection, was estimated to be 40-50% with MOl 5 
PFU/cell and 80-90% with MOllO PFU/cell using a light microscope. Cell detachment 
seems to be proportional to the MOL 
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3.4.3.1- Plasmid stability 
Equal amounts of DNA were used in a qPCR reaction, using the specific OFP 
primers set, to determine the plasmid copy number per cell, within the different collected 
samples (Figure 3.61). A significant (at P<O.OS) increase in plasmid copy number was 
observed at 12 hours post-transfection, then it decreases significantly on day I .S post-
transfection but is still significantly higher than the baseline. Insignificant increase from 
the baseline was reached on day 4.S and afterwards. The same trend was observed for 
plasmid stability with all of the MOls. 
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Figure 3.61: Copy numbers of pE lover 14.5 days post-transfection in CHO cells, with super-
infection using different MOls. Copy numbers were obtained by qPCR using a standard curve of 
known plasmid DNA concentration. 
138 
!J?ssu{ts 
3.4.3.2- GFP transcription efficiency 
RNA samples were treated with DNase, cleaned and then equal amounts were used 
in an RT reaction. Equal volumes of the RT product were used in a qPCR reaction (using 
the GFP primers set) to quantify GFP mRNA copy numbers. Figure 3.62 shows the GFP 
mRNA transcripts per cell. Statistical analysis of the data revealed significant (at P<O.OS) 
elevation in GFP mRNA transcripts on day 1.S post-transfection. An insignificant 
increase from the baseline was observed after this time point. The same mRNA 
transcription trend was observed with all of the Mors used. 
The obtained plasmid and GFP mRNA copy numbers for each sample were used to 
calculate the transcription efficiency over time (Figure 3.63). A significant (at P<O.OS) 
increase in transcription efficiency was obtained from day 4.S post-transfection with all 
of the used MOrs except with an Mor of 10 PFU/cel1. The MOrs of 1 and S PFU/cell 
were significantly higher than the Mor of 10 PFU/cell, with a lower effect on cell 
attachment, particularly when using Mor of 10 PFU/cel1. 
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3.4.3.3- GFP translation 
The GFP intensity was determined in equal cell counts from each sample by 
measuring the RFU (Figure 3.64). A significant (at P<O.05) increase in fluorescence 
intensity was obtained over days 1.5 to 5.5 post-transfection with all of the MOls used 
and reached the baseline on day 9.S and thereafter. Super-infection at an MOl of 1 PFU 
has significantly higher expressed GFP than MOls of 0 and 10 PFU and insignificantly 
higher than the expression with an MOl of 5 PFU. 
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Figure 3.64: GFP fluorescence intensity over 14.5 days post-transfection in CHO cells, with 
super-infection using different MOls. Fluorescence intensity was measured by the relative 
fluorescence units (RFU) of equal cell counts. 
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3.4.4- Gene expression from different plasmids in CHO cells super-infected with 
adenovirus at MOl of 1 PFU/cell 
Expression from the different plasmid constructs was investigated with wild type 
super-infection at MOil PFU/cell. The lower MOl allows the side effects encountered at 
MOllO PFU/cell to be overcome, which is the massive cellular detachment from the 
monolayer. The same experimental conditions for transfection (as in part 3.4.2) were 
performed, with the exception of the super-infection step that was done at an MOl of 1 
PFU/ceIL Triplicate samples were collected on 0, O.S, 1.S, 3.S, 7.S, l1.S and lS.S days 
post-transfection, in which the super-infection was performed at 12 hours post-
transfection. Two negative controls were included; the first is CRO cells transfected with 
pUC19 and used as a control for transfected cells, while the second is pUC19 transfected 
and super-infected with the wild type virus. DNA and RNA were isolated from the same 
collected samples. 
3.4.4.1- Plasmid stability 
The isolated DNA was quantified spectrophotometrically and equal amounts were 
used in a qPCR reaction to determine the copy number of each plasmid, using the GFP 
primer set. Plasmid copy number per cell was quantified in the transfected and super-
infected conditions, using a standard curve and the results are illustrated in Figure 3.6S. 
The statistical analysis was performed on the data by the two way ANOVA using 
Tukey's test at a significance level of lees than O.OS. All of the plasmids have an 
insignificant change in their stability in CRO cells with the transfection and the super-
infection conditions. The maximum plasmid copy number was obtained at 12 hours post-
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transfection with all of the plasmids used and the two conditions. The plasmids' copy 
numbers remain significantly elevated on day 1.5 post-transfection and reach the baseline 
on day 7.5 post-transfection. 
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Figure 3.65: Copy numbers of the different plasmids over 15.5 days post-transfection in CHO 
cells, with transfection and super-infection (at MOl of I PFU/cell) conditions. Copy numbers 
were obtained by qPCR using a standard curve of known plasmid DNA concentration. 
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3.4.4.2- GFP transcription efficiency 
The DNase treated and cleaned RNA was used in an RT reaction followed by 
qPCR using the specific GFP primer set. The copy numbers of GFP mRNA transcripts 
from each plasmid in the transfection and the super-infection conditions were calculated 
per cell, using a standard curve. The obtained data for each plasmid in the two conditions 
are illustrated in Figure 3.66. The statistical analysis of the data obtained was performed 
as described earlier in the plasmid quantification. The trend for mRNA transcripts 
produced from the different plasmids over time in both the transfection and the super-
infection conditions was similar, with a significant increase in days 1.5 to 3.5. The 
transcripts' levels almost reached the baseline in day 7.5 and thereafter. Despite having 
the same trend, the increment with the super-infected conditions was significantly higher 
than that of the transfected conditions in the five plasmids, especially over the peak 
period (days 1.5 to 3.5). On the other hand, more mRNA transcripts were produced from 
pEl over any of the other plasmids in both the transfection and super-infection 
conditions. 
Transcription efficiency was calculated using the data obtained from the qPCRs 
performed on both DNA and RNA. Copy numbers of mRNA per plasmid per cell were 
estimated for each plasmid in the two conditions and illustrated in Figure 3.67. The data 
obtained was analyzed statistically by the two way ANOVA using Tukey's test at a 
significance level of 0.05. The overall trend for transcription efficiency in transfected and 
super-infected conditions of pMGA, pMT1GA, pMT1,2GA and pMTGA showed 
insignificant changes over time. However, pEl showed a significant increase in its super-
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infected conditions compared with the transfected ones. The comparison between 
transfection efficiency of the different plasmids within the same condition revealed 
superiority of pEl over all the other plasmids. The increased efficiency from pEl over 
the other plasm ids was more dramatic in the super-infected conditions than that of the 
transfected conditions. 
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Figure 3.66: OFP mRNA transcripts from the different plasm ids over 15.5 days post-transfection 
in CHO cells, with transfection and super-infection (at MOl of I PFU/cell) conditions. Copy 
numbers were obtained by qPCR using a standard curve of known plasmid DNA concentration. 
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Figure 3.67: Transcription efficiency of OFP mRNA over 15.5 days post-transfection in CHO 
cells, with transfection and super-infection (at MOl of 1 PFU/cell) conditions. Efficiency was 
defined as OFP mRNA copy number per plasmid per cell. Copy numbers per cell of plasmid 
DNA and OFP mRNA were estimated by qPCR using a standard curve of a known plasmid 
concentration. 
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3.4.4.3- GFP translation 
GFP was estimated by its fluorescence intensity and measured as the RFU in the 
equal cell counts from the different samples. CRO cells were used as a blank and the two 
negative controls (pUC 19-transfected and pUC 19-transfectedlsuper-infected CRO cell) 
were included. The RFUs of GFP expressed in each plasmid with both conditions are 
shown in Figure 3.68. Statistical analysis of the data obtained was performed as 
mentioned earlier. All of the plasmids showed significant (at P<O.OS) increase in GFP 
fluorescence intensity after 12 hours post-transfection, in both the transfection and the 
super-infection conditions, and last until day 7.S post-transfection. Only pMGA showed 
almost identical expression levels of GFP in both the transfected and the super-infected 
conditions. The rest of the plasmids showed significantly higher GFP intensity with the 
super-infection over the transfection conditions. 
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Figure 3.68: GFP fluorescence intensity over 15.5 days post-transfection in CHO cells, with 
transfection and super- infection (at MOl of 1 PFU/cell) conditions. Fluorescence intensity was 
measured by the relative fluorescence units (RFU) of equal cell counts. 
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DISCUSSION 
Exogenous gene expression is a promising research field that has a number of 
downstream applications including gene therapy, vaccination and therapeutic protein 
production. Various organisms, ranging from simple prokaryotes to complex mammalian 
cells, are exploited for heterologous protein expression. Expression systems that utilize 
mammalian cells are favoured over other systems because these cells are capable of 
expressing complex proteins of high quality which are suitable for various applications. 
However, the major drawback of exogenous gene expression in mammalian cells is their 
characteristic inefficient recombinant protein expression relative to bacterial or yeast 
systems. 
The study of viral infections, particularly the study of viral gene expression, has 
changed our views on the perceived inefficiency of mammalian cells as exogenous gene 
expression hosts. After infection, the completion of the viral life cycle results in the 
expression of many proteins in quantities that far exceed the observed expression levels 
of most non-viral transgenes. Hence, the inefficiency of mammalian recombinant gene 
expression is hypothesized to be the result of a limited understanding of the factors that 
govern gene expression in mammalian cells, rather than being a reflection on the protein-
producing ability of these cells. As previously mentioned; some viruses achieve 
extremely high levels of viral gene expression once they enter the cell and exert control 
over the various cellular regulatory processes. The key players that act on these processes 
are viral regulatory elements, which are made up of mostly proteins. 
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The present study was designed with the purpose of increasing our understanding 
of the various factors that influence exogenous gene expression in mammalian cells. 
Since viruses are the ultimate exploiters of intracellular expression of foreign genes, 
adenovirus was used as a model virus. It contains multiple elements that exert their effect 
at different regulatory levels to enhance or control the cellular expression of viral genes. 
Adenoviruses have already been used as model systems for understanding gene 
expression, as well as oncogenic transformation, DNA replication, gene delivery, gene 
therapy and other molecular biological phenomena. The accumulated knowledge on 
adenoviruses was essential for further investigations of gene expression regulation. 
We investigated exogenous gene expression at different levels; starting from the 
quality of the transgene (focusing on its delivery, stability and mutation rate) to 
evaluating adenov'iral regulatory elements, including the major late promoter (MLP), the 
tripartite leader sequence (TPL), the E1 genes (cellular regulation and promoter 
transactivation) and the inverted terminal repeats (ITRs) (replication). In addition, we 
sought to enhance trans gene expression in mammalian cells using these elements, along 
with other adenoviral components, and employing a number of different strategies. 
4.1- DNA QUALITY 
Two of the major considerations in molecular biology research that pertain to 
transgene expression are DNA purity and base pair accuracy. Contamination of DNA by 
chemical impurities and sequence mutations interferes with most downstream 
applications, including in vitro transfections and expression of trans genes, as well as in 
vivo administration of DNA for gene therapy or vaccination. Several techniques, such as 
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column-based chromatographic DNA isolation or cesium chloride gradients, have been 
developed to ensure high DNA purity and sequence accuracy. However, both of these 
methods have the potential to add even more impurities to the DNA. This is because the 
chemical reagents that are used as part of the isolation/purification procedures can 
contaminate the DNA. In this part of the study, we evaluated the effect of the major DNA 
contaminants, which are introduced to the DNA through bacterial culturing or DNA 
preparation, on trans gene delivery and expression. The contaminants evaluated include: 
ethidium bromide (EtBr), cesium chloride (CsCI) and a combination of the later two, as 
well as endotoxin and ethanol (EtOH). 
The effect of these different contaminants on the delivery of pCMVB and the 
expression of the LacZ gene (encoded by the plasmid) was evaluated using Chinese 
hamster ovary (CHO) cells. The LacZ activity assay is widely used to determine the 
transfection efficiency of most cell culture transfection methods. However, this assay is 
only an indicator, rather than a direct measurement oftransfection efficiency. To expand, 
LacZ activity is a measure of transgene (LacZ) expression efficiency, rather than the 
efficiency of transgene uptake by the cells. As such, the accuracy of this assay is subject 
to mutations within the coding sequence of the LacZ gene that may disrupt its expression 
or function but does not affect transgene uptake negatively. All of the contaminants, 
except EtOH, significantly reduced the number of cells that expressed LacZ. However, 
they did not all act to lower transfection efficiency, but some impaired trans gene 
expression without affecting the efficiency of its delivery. 
The use of qPCR allowed for a precise determination of the plasmid copy number 
per cell. This is an accurate measurement of transfection efficiency, as qPCR measures 
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the physical presence of the DNA molecule and not the expression of the genes encoded 
in the plasmid. The stability of the DNA molecule is also directly measured by this 
method, in contrast to the LacZ assay which measures an enzyme that is a downstream 
product of the transfected DNA, which differs in stability relative to the transfected DNA 
itself. The data obtained by the qPCR method indicated that spiking with CsCl, a 
combination of EtBr/CsCl or endotoxin lowered the transfection efficiency which 
accounts for the observed low expression of LacZ when spiking with these contaminants. 
However, spiking with EtBr and EtOH did not interfere with the transfection efficiency 
(the copy number of pCMVB), as measured by qPCR. Therefore, the decreased 
expression levels of LacZ, which were observed after spiking with EtBr, were not the 
result of low plasmid copy numbers. 
In addition, spiking with EtBr caused mutations in the DNA molecules which 
accounted for the lower expression of LacZ in cells that have been transfected with the 
contaminated DNA. EtBr intercalation with DNA introduces frame-shift mutations that 
inhibit transcription and subsequently, translation (Tripathi & Kumar, 1986 and Hurley, 
2002). When spiking with the highest concentration of EtBr used in this experiment (250 
nM), the number of cells expressing functional LacZ decreased by 80% relative to the 
non-spiked control. Hayashi and Harada (2007) reported that at a concentration of 1 mM 
of EtBr, 57% of base pairs will be occupied with the chemical in a single 500bp DNA 
molecule. 
These results were confirmed by the restriction enzyme-PCR mediated mutation 
detection method which was first introduced in this work (Figure 3.8). The premise of 
this mutation detection method is that the digestion of plasmid DNA (pDNA) by a 
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restriction enzyme prevents its subsequent PCR amplification (when using primers that 
flank the digestion site), unless the restriction site is masked by a mutation in its 
1/ 
sequence. It is already known that EtBr inhibits in vitro digestion with restriction 
endonuc1eases. This inhibition occurs wherever EtBr is bound to the restriction enzyme 
recognition site itself or 2-3 base pairs far from the site, with favourable binding to the 
G-C base pairs (Krugh & Reinhardt, 1975 and Hardwick et aI., 1984). However, in this 
study, spiked DNA was transfected into mammalian cells and re-isolated after 21 hours 
post-transfection. During this time, the DNA repair mechanism will introduce frame-shift 
mutations in the DNA sequence (Tripathi & Kumar, 1986). 
The restriction enzyme HindIII, which recognizes a six base pair restriction site, 
was used for the purpose of our experiment. The plasmid pCMV~ has one HindIII site 
which represents 0.084% of the whole plasmid length. Using agarose gel electrophoresis, 
the products of endpoint PCR amplification were observed for the samples spiked with 
high EtBr concentrations. This observation indicated that EtBr spiking caused an 
incomplete digestion of pCMV~ by HindIII, allowing the amplification to occur. HindIII 
digestion of the pDNA spiked with other contaminants, even when EtBr was combined 
with CsCl, prevented subsequent PCR amplifications (as no bands were visible on the 
gel). This indicated that these contaminants do not compromise the sequence accuracy of 
the delivered DNA. 
To quantify the occurrence of mutations introduced by EtBr, we carried out qPCR 
on the same EtBr-spiked samples before and after digestion (Figure 3.10). EtBr spiking 
induced mutations in 9.8% of HindIII recognition sites. This is a very high proportion 
considering that the screening was based on only 0.084% of the total plasmid length. As 
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previously mentioned, EtBr accumulates on 57% of base pairs in a single DNA molecule 
at a concentration of I mM EtBr (Hayashi & Harada, 2007). This experiment validated 
the accuracy and sensitivity of the mutation detection method through high-throughput 
screemng. 
CsCl reduced the transfection efficiency by interfering with the interaction of 
pDNA and calcium phosphate, while endotoxin spiking reduced the ability of the cells to 
take up pDNA. We used the calcium phosphate transfection method, first introduced by 
Graham & Van der Eb in 1973 and later optimized by Jordan et al. in 1996, where pDNA 
co-precipitates with calcium phosphate. Jordan et al. (1996) tested the effect of 
phosphate and calcium concentrations on DNA transfections and showed the importance 
of these parameters on this process. The high salt concentration, which results from 
spiking with CsCl, may be the main reason for the decreased transfection efficiency. 
Cesium is very reactive and is the highest electropositive metal, even more positive 
than sodium or potassium (Patnaik, 2003). The presence of cesium in the transfection 
reaction may lead to a side reaction that reduces the amount of precipitated DNA or 
disrupts the optimal transfection pH. CsCI may also reduce DNA transfection efficiency 
by directly interacting with the DNA and thus protecting it against the mutagenic effect 
of EtBr when a combination of EtBr and CsCI was used for spiking DNA. CsCl shielded 
the DNA molecule from interacting with the mutagen EtBf. 
It is generally accepted that transfection efficiency is negatively affected by the 
presence of an endotoxin in the transfection mixture (Sambrook et al., 1989). This was 
confirmed when we spiked the DNA with different concentrations of endotoxin. 
Although we did not have a completely endotoxin-free DNA, as our control contained 
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0.32 EU/Ilg DNA, increasing endotoxin concentrations caused a significant drop in 
transfection efficiency. We cannot refer to any cellular effect that might directly cause 
such a reduction since mammalian cells are not sensitive to endotoxin (Wright et aI., 
2003). Endotoxin interaction with DNA and/or the cell membrane may reduce 
transfection. The presence of endotoxin in the transfection mixture may decrease DNA 
precipitation which in tum will decrease transfection efficiency. Also, the 
lipopolysaccharide nature of an endotoxin may increase the cellular resistance to 
transfection by interacting with the cellular membrane. 
The interactions of the contaminants used in this study with pDNA are reversible, 
as demonstrated by the DNA cleaning procedures that restored transfection efficiencies 
and trans gene expression rates that were comparable to that of non-spiked controls 
(Figures 3.6 & 3.7). Cleaning of pDNA spiked with CsCl, EtBr/CsCl and endotoxin 
improved transfection efficiency (increased copy number), verifying that these 
contaminants acted to lower the efficiency of trans gene delivery to the cells. The 
cleaning of EtBr spiked samples did not have an effect on the efficiency of transfection, 
nevertheless, an improved trans gene (LacZ) expression was observed. This indicated that 
EtBr affects the DNA structure and function inside the cell and does not interfere with 
the efficiency of trans gene delivery. 
All of the investigated contaminants, except EtOH, had reversible, negative effects 
on DNA delivery or expression. EtBr affected expression through its mutagenic effect. In 
contrast, CsCl and endotoxins affected the efficiency of DNA transfection by calcium 
phosphate, with no mutagenesis. More studies are needed to understand the nature and 
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the mechanisms of the interactions between CsCI and the transfection process or 
endotoxin with the DNA and the cell membrane. 
4.2- ADENOVIRAL TPL EXONS AND El REGION 
To achieve active gene expression from exogenous DNA, we tried to mimic the late 
viral protein production of the adenovirus. The different elements that were incorporated 
in the plasmid pEl, such as the MLP and the TPL, are either directly related to gene 
expression or, as in the case of adenoviral El genes, they act indirectly to enhance and 
regulate the expression process. ITRs were incorporated to serve as origins of replication 
and provide plasmid stability by preventing the dilution ofpDNA by mitosis. 
4.2.1- TPL exons 
The TPL used in the plasmid construction was based on joined exon sequences 
without introns. The plasmid stability in CRO cells was not affected by the presence of 
different TPL exon combinations (exon 1, exons 1+2 and the complete TPL). Plasmid 
DNA reached its highest concentration inside the cells 12 hours post-transfection, the 
first point to be measured after transfection. Plasmid copy number decreased after this 
point, reaching less than half of the copy numbers at 24 hours post-transfection. Plasmid 
DNA can be diluted by mitotic division (Pauletti et al., 1990) and degradation by 
nucleases (Wilson et al., 1992) or by integrating into the cellular genome by homologous 
recombination (Bollag et al., 1989). Dilution and degradation are the most likely 
mechanisms by which the plasmid copy numbers decreased in our experiment, as 
plasmid integration may be excluded due to the short time period of the experiments. 
Cellular division by mitosis was the main cause of plasmid dilution, since the average 
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CHO doubling time in some reports is 12 hours (Chang & Little, 1991) and 19.1 hours in 
other papers (Parham et af., 1998). The average plasmid copy numbers per cell varied 
between different transfections due to the inconsistency of the calcium phosphate 
transfection method (Liu et al., 2004). 
Transgene mRNA transcription rates are directly subject to transgene copy numbers 
and therefore, variations in transfection efficiencies introduced bias in the assessments of 
transgene expression. To minimize the transfection efficiency bias, transgene 
transcription was measured and reported as mRNA copy number per plasmid per cell. 
The transcription of the different TPL exon combinations, including the complete TPL, 
cloned in the 5' untranslated region (UTR) upstream of the green fluorescence protein 
(GFP) mRNA, was confirmed for all plasmid constructs. The maximum amount of 
expressed GFP mRNA was measured 24 hours post-transfection. This result did not 
coincide with the maximum plasmid copy numbers which were observed 12 hours post-
transfection, reflecting the time required for trans gene transcription and the accumulation 
of mRNA. Inclusions of TPL ex on I or the complete TPL in the 5' UTR did not affect 
trans gene transcription, while the inclusions of both exons I and 2 significantly reduced 
GFP transcription. These results indicate that different TPL exons and even the complete 
TPL do not enhance mRNA transcription. This finding is in accordance with Mansour et 
af. (1986) who reported that transcription enhancement from the MLP by the TPL 
occurred through the downstream binding site (DBS) present within the first intron, but 
not through the TPL exons themselves. 
The effect of TPL exon 1 was more pronounced on transgene mRNA transport 
(from the nucleus to the cytoplasm) than on transgene transcription because its inclusion 
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in the transcript significantly decreased the accumulation of GFP mRNA in the 
cytoplasm. Based on the observed nuclear accumulation of GFP mRNA, it suggests that 
TPL exon 1, the shortest TPL exon, could not form the secondary structure required for 
TPL functionality. 
The inclusions of TPL exons 1 and 2 and even the complete TPL sequence did not 
have an effect on the transport of GFP mRNA from the nucleus to the cytoplasm. While 
the addition of these sequences did not decrease mRNA transport, as was the case when 
only TPL ex on 1 was used, it is clear that the activity of the TPL was severely 
diminished by the absence of viral proteins, specifically the E1B 55k (Horridge & 
Leppard, 1998) and the E4 orf6 (Dobbelstein et al., 1997) proteins, which interact with 
the TPL. Once this occurs, the TPL serves as a linker for the viral mRNA, rather than a 
leader, while the E1B 55k and the E4-ofr6 are the actual "leaders" of the mRNA. 
4.2.2- ITRs-El 
The presence ofITRs and E1 in the pEl plasmid did not have any effect on plasmid 
stability relative to the pMTGA plasmid (Figure 3.21). The difference in copy numbers 
(average number of plasmids per cell) between the two plasmids was a consequence of 
their different molecular weights, since equal masses were transfected into eHO cells. 
Twenty-four hours post-transfection, the ratio between their copy numbers (pEl : 
pMTGA = 1 : 2.8) was close to the ratio between their sizes (8481 bp : 3716 bp = 2.3 : 1, 
respectively). As expected, the copy number of pEl did not increase because the ITRs 
cannot function as an origin of replication in the absence of adenoviral E2 proteins 
(Rekosh et ai., 1977 and Hay et al., 1995). Without the ability to replicate, pEl was not 
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maintained in transfected cells. The increase in GFP mRNA transcripts and GFP 
intensity in the presence of ITRs and E 1 was likely a result of the transactivation of the 
MLP by the E1 proteins (Parks & Shenk, 1997). 
4.2.3- Cellular background 
In order to investigate the effect of cellular background on MLP activity and the 
functionality of adenoviral elements that are used to enhance the expression from the 
MLP, we studied the stability and activity of the pEl plasmid in both CRO and human 
embryonic kidney (REK) 293 cells. The results show that CRO cells exhibited seven 
folds higher transfection efficiency than REK 293 cells. The difference in transfection 
efficiencies can be attributed to the transfection agent that was used in this experiment 
(Lipofectamine 2000) as well as the growth rates of these two cell lines. Transfection 
with Lipofectamine 2000 is cell cycle dependent and is more efficient with dividing than 
non-dividing cells. Thus, the transfection efficiency with cells in the S or G2 phase is up 
to 500 fold greater than with cells in the G 1 phase (Brunner et a/., 2000). Since CRO 
cells have approximately two and a half fold faster doubling time than REK 293 cells 
(Parham et al., 1998), more CRO cells will be dividing during the transfection period and 
hence, take up the plasmid more efficiently. Although Preuss et al. (1999) reported that 
HEK 293 cells exhibited higher transfection efficiencies than CHO cells, they used the 
calcium phosphate transfection method in their experiments, which accounts for the 
contradictory data. 
Despite their lower transfection efficiency, REK 293 cells produced significantly 
more GFP transcripts than CRO cells. Therefore, HEK 293 cells exhibited higher 
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transcription efficiency than eRO cells, since on-average, they produced more OFP 
mRNA copies per plasmid DNA per cell than eRO cells. Liu et al. (2008), who 
investigated and optimized the factors that affect transient transfection in REK 293 and 
eRO cells, showed that both cell lines exhibited similar OFP productivities. Since 
cellular background did not directly influence OFP production, our data demonstrated 
that the difference in transgene mRNA expression between the two cell lines was due to 
the cell line-dependent differential activity of the MLP. Namely, REK 293 cells offer a 
more favourable environment for the activity of the MLP promoter. They have more 
adenoviral E1 proteins, which are continually expressed from their integrated E1 genes, 
and they are a cell line derived from the natural host of Adenovirus serotype 5 (AdS) 
(human) (Aiello et aI., 1979). eRO cells have a similar reduction of MLP activity as 
human cells which were previously reported for adenovirus 12 late RNAs in eRO cells 
expressing AdS E1 genes (Klimkait & Doerfler, 1985 and 1987). 
4.3- CELL LINE CONSTRUCTION 
The low stability of the pEl plasmid and the relatively low expression of the 
transgene (OFP) led to the conclusion that the elements encoded on pEl were not enough 
to attain high expression levels in eRO cells. In the next step of the study, the effects of 
introducing additional adenoviral components (to complement the elements that were 
already encoded on the plasmid) on plasmid stability and OFP expression were 
investigated. Three different methods were devised and implemented for this purpose. 
The first method was co-transfection with another plasmid, pE2; the second required the 
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development of a specific cell line which enhanced pE 1 stability and expression; and the 
third method was adenoviral super-infection. 
4.3.1- Co-transfection 
The pE2 plasmid encodes Ad5 E2 genes and the MLP-driven viral protease gene, 
all of which were successfully transcribed post-transfection in HEK 293 cells. However, 
transfection of the same plasmid into CHO cells resulted in the expression of only the 
viral protease. Transactivation of the E2 promoter in HEK 293 cells was facilitated by 
the expression of Ad5 E1 genes that are integrated into the host cell genome. eHO cells 
lack these E 1 genes and could not activate the E2 promoter. Therefore, transcription did 
not take place. However, the viral protease was expressed in CHO cells, as its 
transcription was driven by the MLP present on the strand complementary to the E2 
genes, and did not require primary activation. 
Co-transfection of various molar ratios of pEl and pE2 into CHO cells did not 
result in the cellular retention of either of the two plasmids. Neither of the plasmids was 
affected by the presence of the other and both were lost from the cells three days after the 
transfection. According to Shenk & Flint, 1991; Swaminathan & Thimmapaya, 1995 and 
Brehm et aI., 1998, the expected interaction between the two plasmids and their products 
would predict that the expression of EIA would activate the E2 promoter to express E2 
proteins, and the presence of E2 proteins would allow the replication at the circular ITRs 
(Graham et al., 1989). However, as mentioned previously, none of the obtained results 
suggested that pE2 co-transfection facilitated pE 1 replication. 
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The transcription of GFP from pEl was detected only when the highest amount of 
pEl was transfected into CRO cells. The fast growth rate of these cells may, in part, be 
responsible for the lack of any detectable trans gene transcription with lower plasmid 
concentrations. This is because episomal DNA is quickly diluted out by mitosis. 
Transcription of any of the E2 genes from pE2 was undetectable, even when the highest 
amount of pE2 was transfected into the cells. The only detected transcription from pE2 
was the viral protease and, similarly to GFP, was only observed with the highest amount 
of plasmid used. There are two possible explanations for this result. First, the amount of 
expressed El genes was not enough to transactivate the E2 promoter in CRO cells, 
unlike in the REK 293 cells where the El genes are integrated and continually expressed. 
Second, the success of co-transfections depends mainly on the coexistence of both 
plasmids in the same cell. Although both plasmids were detected after transfection, the 
simultaneous presence of both plasmids inside the same cell remains unknown. 
4.3.2- CHO cell lines 
As neither pEl nor pE2 plasmids were maintained after their co-transfection into 
CRO cells, the next step was to construct a new CRO cell line with integrated Ad5 E2 
and viral protease genes (CRO-E2 cell line). After transfecting linearized pE2 into CRO 
cells, followed by selection procedures, five different foci with G4l8 resistance (left end 
of the linearized plasmid) were isolated and that were confirmed to carry the right end of 
the linearized pE2. Linearized pE2 was used because the integration of linearized DNA is 
more probable than the integration of circular forms (Brinster et aI., 1985) and it is also 
used to control the linearization site so that it does not interfere with coding or regulatory 
sequences or their order within the DNA construct (Nagy et al. , 2003). 
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The presence of the four viral genes encoded on pE2 was confirmed by PCR 
performed on DNA isolated from all five cell line constructs. Although this is not the 
ideal selection or detection method, it was the only feasible way to select for the presence 
of these genes. A better selection method should have focused on the expression of these 
genes, so that foci that actively express all of the genes could be discriminated from foci 
with integrated, but inactive genes. This selection method is suited for genes whose 
expression is driven by constitutive or simple inducible promoters, however, the 
adenoviral E2 promoter is transactivated only in the presence of E1A proteins (Shenk & 
Flint, 1991; Swaminathan & Thimmapaya, 1995 and Brehm et ai., 1998). 
The circular form of the plasmid was detected in three of these five CHO-E2 cell 
lines (CHO-E2-2, CHO-E2-4 and CHO-E2-5) (Figure 3.42). These are interesting 
results, since the stock linearized plasmid that was used for the construction of all the cell 
lines was confirmed by PCR (detecting for the circular form) to be linearized completely. 
A possible explanation for this finding is that the linearized plasmids re-ligated inside the 
cells after the transfection. Mammalian cells are able to ligate linear DNA, especially 
when its ends are cohesive. The detection of circular forms of the adenoviral genome 
early after infection and before the initiation of viral genome replication, supports this 
assumption (Ruben et aI., 1983 and Graham, 1984). Additionally, non-homologous end-
joining ligation, detected between co-transfected plasmids, can occur as a result of 
double strand breaks in the foreign DNA (Ishikawa et ai., 2004). The ends of two DNA 
molecules can be ligated in the cells, regardless of the degree of homology between them 
(Wake et aI., 1984). Thus, non-homologous end-joining was the mechanism by which 
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circularization of linear plasmids occurred, after transfection (Kabotyanski et aI., 1998 
and Smith et a!., 2003). 
All five CHO-E2 cell lines were transfected with pEl and expressed GFP, detected 
by confocal microscopy (Figure 3.43), twenty-four hours post-transfection. However, 
there were no major differences in expression efficiency between the cell lines. In 
addition, pEl was not maintained in any of the new cell lines, as it was lost two days 
post-transfection in four of the five cell lines and after three days in the fifth one (CHO-
E2-3). Unaltered CHO cells retained the pEl plasmid for three days. The stability of pEl 
was dependent on the initial transfection efficiency, as the starting plasmid copy number 
dictated the amount of time it took for any given cell line to lose the plasmid by DNA 
degradation or dilution by mitosis. None of the constructed CHO-E2 cell lines were able 
to maintain pEl because replication from the ITRs did not occur. This finding also 
indicated that E2 proteins, which are essential for replication initiation from the ITRs, 
were lacking or present in insufficient amounts (Flint & Shenk, 1997). 
The transfection of pEl into the constructed CHO-E2 cell lines was supposed to 
provide the E1 proteins required for the transactivation of the E2 promoters (Shenk & 
Flint, 1991; Swaminathan & Thimmapaya, 1995 and Brehm et a!., 1998). However, 
expression of any of the E2 genes was not detected. In three of the five cell lines, the 
viral protease gene, which is under the control of the MLP and encoded on the 
complementary strand of the E2 genes, was expressed, as detected by qPCR. The MLP 
promoter is constitutive and does not require transactivation to initiate the expression of 
the viral protease. This explains why the viral protease was expressed and the E2 genes 
were not, despite being encoded on the same DNA molecule, but on opposite strands. 
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As stated above, only three cell lines (CHO-E2-1, CHO-E2-3 and CHO-E2-5) 
transcribed the viral protease gene. The other two cell lines (CHO-E2-2 and CHO-E2-4) 
did not express detectable amounts of the viral protease mRNA. Interestingly both of 
these cell lines screened positive for the presence of the circular form of pE2. As it is 
highly unlikely that these cells maintained pE2 as an episome, it was assumed that in 
these cells, the linearized pE2 was initially re-ligated (circularised) and subsequently 
linearized at a different site prior to integration into the host genome. This reorganization 
may have separated the viral protease gene from its promoter, accounting for the 
complete absence of viral protease expression in these cell lines. Although the cell line 
CHO-E2-5 tested positive for the presence of the circular form of pE2, it was able to 
express the viral protease gene. This indicated that pE2 most likely linearized at a site 
that did not interfere with the viral protease cassette. The lack of transcription of the E2 
genes in the three cell lines where the circular forms of the plasmid were detected may 
also be the result of disrupting the order of the E2 cassette (which constitutes 69.5% of 
plasmid length). 
In summary, the constructed cell lines did not express E2 genes, neither 
constitutively nor upon induction, and thus, were unable to facilitate the replication of 
episomal DNA. Furthermore, the lack of a complete genome sequence of CHO cells 
made it impossible to precisely determine the sites of integration of pE2. This also 
prevented the screening of homologous sequences (possibly present in the plasmids) that 
may have influenced the sites of integration. These findings emphasize the suggestion 
made by Griffin et al. (2007) that the availability of such genome sequence data will 
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enable the development of other tools such as microarrays that are useful in the genomic 
and transcriptomic analysis of the newly constructed CHO cell lines. 
4.4- INDUCTION OF GENE EXPRESSION BY ADENOVIRUS SUPER-INFECTION 
4.4.1- Stability and transcription from pMTGA in HEK 293 and CHO cells super-
infected with adenovirus 
Initially, the super-infection experiments were performed in both HEK 293 and 
CHO cells. The pMTGA plasmid, which encodes the complete TPL upstream of the GFP 
trans gene, was transfected into both cell lines and then super-infected with the wild type 
adenovirus d1309. Adenoviral infection did not enhance the stability of the transgenes 
despite the presence of the viral DNA binding protein (DBP), whose function is to 
protect single and double-stranded DNA from cellular DNases (Nass & Frenkel, 1978 
and 1980 and Frenkel & Horan, 1983). Therefore, it was assumed that dilution by 
mitosis, rather than DNA degradation by DNases, was the main force determining the 
stability or instability of the plasmid. 
The observed differences in trans gene expression efficiencies between CHO cells 
and HEK 293 cells (Figures 3.53 & 3.54) can be explained by examining the progression 
of the adenoviral life cycle in each of them. HEK 293 cells were lysed early after the 
super-infection, while CHO cells appeared unaffected. Although the adenoviral genome 
is replicated with equivalent efficiencies in CHO and HeLa cell lines, adenovirus-
infected CHO cells produce approximately 6,000 fold fewer virions than adenovirus-
infected HeLa cells (Longiaru & Horwitz, 1981). However, the adenovirus infection of 
CHO cells resulted in the synthesis of most viral proteins as well as active replication of 
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the viral genome, but not in complete virions. Similarly, studies that investigated 
infections of BHK21 hamster cells by adenovirus serotype 12 reported that these cells 
did not support the completion of the adenoviral life cycle (Doerfler, 1991). Although 
supplementing adenovirus 12 with the E1 region of Ad5 resulted in the replication of the 
viral genome and the transcription of late genes, virion production still did not occur. 
Adenoviruses are unable to complete their life cycles in hamster cells because the hexon 
and fibre proteins, which are essential for virion assembly, are not produced in these cells 
(Schiedner et aI., 1994 and Hosel et al., 2003). The increased transgene transcription 
efficiency in super-infected eHG cells, relative to super-infected HEK 293 cells, was 
therefore a consequence of their increased tolerance to adenovirus infection. This was 
due to the inability of the adenovirus to initiate cell lysis in eHG cells. 
4.4.2- Gene expression from different plasmids in CHO cells super-infected with 
adenovirus at MOl of 10 PFU/cell 
Although super-infection with the wild type adenovirus d1309 increased transgene 
transcription levels in both cell lines, the use of eHG cells was favoured over the use of 
HEK 293 cells in subsequent super-infection experiments. This decision was made based 
on the observation that eHG cells were more resistant to rapid lysis initiated by the viral 
infection, while still allowing complementation with the viral proteins that were required 
for improved efficiency of exogenous gene expression. The effects of the adenovirus 
super-infections on the efficiencies of transgene expression were elevated from different 
constructs, including incomplete and complete TPL sequences as well as the plasmid 
pE 1. These constructs yielded valuable information about the regulation of trans gene 
expression in mammalian cells. 
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Adenovirus super-infection was unable to improve the intracellular stability of 
plasmids that were not encoded for the ITRs and the E1. However, a significant increase 
in the copy number of pEl (which encoded the ITRs and the El) was measured 1.5 days 
post-transfection in super-infected cells (Figure 3.56). This indicated that this episomal 
vector replicated in the presence of adenoviral proteins. This data agrees with previous 
findings that show that the replication of circular adenoviral genomes, containing 
incomplete ligated ITRs, is able to produce linear genome copies and subsequently 
infectious viral particles (Graham et aI., 1989). The circular ITRs used in the 
construction of the pEl plasmid were derived from such circular, replication competent 
adenoviral genomes. Therefore, the adenovirus super-infection should provide the viral 
proteins required for replication and also induced the S-phase in host cells (Hay et aI., 
1995). The replication of pEl coincided with peak adenoviral DNA replication, which 
occurs five to eight hours post-infection (Berk, 2007). Despite the increase in pEl copy 
number in super-infected CHO cells that were measured 1.5 days post-transfection, 
mRNA transcription did not increase accordingly. This finding reflected the strength of 
the super-infection, as expression of viral proteins placed an overwhelming demand on 
the cellular gene expression machinery. 
The copy number of pEl in CHO cells dropped significantly 3.5 days, I>ost-
transfection (three days after the super-infection). This was accompanied by high levels 
of cellular detachment from the monolayer. This phenomenon, where the infected cells 
start to round and then detach from the monolayer, is common at the late stages of viral 
infection and is a hallmark of the cytopathic effect (CPE) (Flint, 1984). In adenovirus 
infected CHO cells, the CPE is slower to appear as these cells are not the natural host of 
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human adenoviruses. This effect was observed about 3 days post-infection. Vital staining 
showed that the majority of the detached cells were still alive. The investigation of pE 1 
activity in both attached and detached cells revealed that detached cells contained 
significantly higher amounts of the plasmid. In addition, there was more GFP mRNA and 
higher efficiencies of transgene transcription in the detached cells relative to adhered 
cells. 
The adenovirus super-infection did not increase the efficiency of GFP mRNA 
transcription from the pMGA and pMT,GA constructs. Both of these constructs lacked 
the complete TPL sequence. The data suggests that, even in the presence of viral 
proteins, an incomplete or missing TPL structure negatively affected mRNA stability and 
subsequently lowered transcription efficiency. The significant improvement of transgene 
transcription efficiency, measured when the complete TPL was used, indicated that all 
TPL exons are required for TPL functionality. The TPL sequence must be complete in 
order to interact with viral proteins EIB 55k and E4 orf6 (Dobbelstein et al., 1997 and 
Horridge & Leppard, 1998). GFP intensity was used as a direct measurement of 
trans gene expression at the protein level and was also negatively affected by the 
exclusion of the TPL from the construct. However, even when the complete TPL 
sequence was part of the trans gene expression construct, no significant increase in the 
intensity was observed relative to transfected but non-super-infected cells. This indicated 
that translational competition existed between the GFP transgene and the viral genes 
when the cells were super-infected with wild type adenovirus dl309 at an MOl of 10 
PFU/cel1. 
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To summanze, cellular detachment was a characteristic event in all adenoviral 
infections, including infections of control CHO cells that did not contain plasmid DNA. 
Therefore, our experiments showed that adenoviral infection of CHO cells caused 
cellular detachment and not complete cellular lysis, which began two to three days post-
infection. Active pEl replication occurred only in adenovirus infected cells, explaining 
why pE 1 copy numbers were significantly increased in detached cells, relative to 
monolayer cells. Furthermore, detached cells (from the super-infected pEl) had 
significantly increased trans gene transcription efficiency relative to attached cells. 
Despite an increase in plasmid pEl copy number, adenovirus super-infection did not 
improve transgene expression, relative to transfected but non-super-infected cells. We 
assumed that the use of an MOl of 10 PFU/cell overloaded the cellular expression 
machinery and also biased it towards processing other mRNAs that have the TPL 
sequence. This was indicated by a decrease in GFP intensity when the TPL sequence was 
excluded from the trans gene construct. 
4.4.3- Optimization of viral MOl in CHO cells 
MOl optimization was performed for infections of CHO cells transfected with pEl. 
MOl did not have a measurable effect on transgene/plasmid stability. Furthermore, pEl 
copy numbers did not increase at any of the used MOls, including an MOl of 10 
PFU/cell. This is an interesting finding since, in the previous experiment, a transient 
increase in pEl copies was observed at an MOl of 10 PFU/cell. Although the experiment 
was not repeated again, these differing results can be explained by a variable efficiency 
of replication from the circular ITR forms. In particular, replication from the circular ITR 
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forms appears to be inefficient compared to the linear forms, especially at the early 
stages of the replication cycle. 
The adenovirus replicates its genome through a strand displacement mechanism 
starting at the ITRs that serve as an origin of replication (Brenkman et al., 2002) (Figure 
1.3). Graham et al. (1989) proposed a model for viral DNA replication from circular 
molecules (See the appendix). In their model, replication takes place at the junction of 
virallTRs to produce linear forms of the viral DNA. Cellular background may be another 
factor that affected replication from circular ITRs. The complete circular viral genome 
can complete the virus life cycle in human cells and produce new infectious viruses. 
However, in the super-infected CHO cells, replication from circular ITRs may not have 
been as efficient as replication from the linear viral genome. 
Decreasing the MOl caused an enhancement of GFP mRNA levels, transgene 
transcription efficiency and translation levels (Figures 3.62-3.64). At an MOl of I 
PFU/cell, transgene transcription efficiency and GFP intensity were significantly higher 
than at an MOl of 10 PFU/cell. These results concurred with our previous observations 
of cellular vitality and monolayer attachment. The cells remained attached at an MOl of 
1 PFU/cell, similarly to the non-infected control cells, but further increases of MOl 
resulted in proportional detachment of cells from the monolayer. 
These findings indicated that the strength of viral infection and expression directly 
affected transgene expression inside the cells. At higher MOls, it appears that the 
competition between viral and trans gene mRNA translation lowered trans gene 
expression, while high viral loads severely affected host cells. This was in accordance 
with previously published data obtained from adenovims infected HEK 293 cells. The 
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data showed that further increases of the MOl over 5 PFU/cell did not elevate viral 
production (Ferreira et aI., 2005), as cellular machinery had reached its saturation point 
and could no longer produce more viruses. Similarly, at an MOl of 10 PFU/cell in our 
experiment, trans gene expression was lowered by competing viral proteins, whose 
expression overtaxed the cellular expression machinery and affected other cellular 
processes. Therefore, it was concluded that use of lower MOl is more suitable for both 
transgene expression and cellular vitality. 
4.4.4- Gene expression from different plasmids in CHO cells super-infected with 
adenovirus at MOl of 1 PFU/cell 
The use of an MOl of 1 PFU/cell did not severely affect cellular activity and 
attachment. Therefore, we were able to extend DNA, RNA and protein collection times 
which provided us with more detailed results. As expected from the previous 
optimization experiment, adenovirus super-infection did not affect plasmid stability over 
time. At low MOls, it appears that viral proteins were not produced in quantities required 
to force active replication from the circular ITRs construct. Low viral yield at an MOl of 
1 PFU/cell was also reported by Ferreira et al. (2005), who showed that viral yield was 
lower by 104 compared to an MOl of 5 PFU/cell. 
The presence of viral proteins had a positive effect on transgene transcription from 
the MLP, as GFP mRNA copy numbers increased after the super-infection (Figure 3.66). 
The direct effect of the viral infection on MLP activity was clearly demonstrated with the 
use of the constructs lacking the TPL sequence. However, the gradual increase in 
trans gene transcript copies with the addition of TPL exons in the expression constructs 
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indicated an additive effect, which was mainly exerted on transgene mRNA stability. 
Although the inclusion of TPL exons in the expression cassette enhanced trans gene 
mRNA expression in non-infected cells, this effect was more pronounced in adenovirus 
super-infected cells. 
In contrast to the other four plasmids (pMGA, pMT1GA, pMT1,2GA and pMTGA), 
transgene transcription efficiency from pEl was significantly higher after super-infection 
(Figure 3.67). The only difference between the pEl and pMTGA plasmids was that pEl 
encoded the ITRs-EI fragment, while pMTGA did not. Therefore, the increased 
trans gene transcription efficiency of pE I, relative to pMTGA, was most likely caused by 
the inclusion of this fragment. In a previous experiment, it was demonstrated that the 
ITRs-EI fragment enhanced transgene transcription efficiency in the absence of viral 
super-infection. Most notably, the EIA proteins, which were encoded by the ITRs-EI 
fragment, play a major role in the transactivation of transcription from the MLP. 
Although the wild type adenovirus d1309 also encoded the E I region and the ITRs, 
enhanced transgene expression from pMTGA did not reach same levels as pEl after 
super-infection. This indicated that an excess amount of EIA proteins enhances 
trans gene transcription efficiency. The pEl plasmid increased the abundance of these 
prot~ins by increasing their gene copy number and hence, GFP expression from this 
construct was significantly higher than from pMTGA. 
The translation of GFP mRNA also increased after viral infection, most likely as a 
result of the viral encoded EIB 55k and E4 orf6 proteins (Babiss et aI., 1985; Pilder et 
al., 1986b; Leppard & Shenk, 1989 and Bridge & Ketner, 1990). The only exception was 
GFP mRNA translation from the pMGA plasmid, which did not increase after super-
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infection. This result was expected, since the TPL sequence was absent from this 
transgene expression construct. On the other hand, the constructs that contained the 
complete TPL structure (pMTGA and pE 1) showed a significant increase in GFP 
intensity after super-infection. This demonstrates the importance of the EIB 55k and E4 
orf6 viral proteins. In addition, the intensity of GFP expressed from pEl was 
significantly higher than that from pMTGA, mainly because of the higher transgene 
transcription efficiency from pE 1. 
CONCLUSION 
Based on the data presented in this thesis, one can conclude the following: 
1- Contaminants have a major negative effect on DNA delivery and gene expression by 
either affecting transfection efficiency or mutating the trans gene coding region. 
Among the contaminants tested in this study, only EtBr appeared to cause mutations 
in the DNA sequence. Using a new, ultrasensitive, PCR-based mutation detection 
method, developed in this study, it was possible to detect very low mutation 
frequencies. 
2- Five plasmids were engineered and contained an ~xpression cassette with a common 
promoter (MLP) and incomplete or complete TPL exons. The ITRs-EI fragment was 
included in one construct. The TPL exons 2 and 3 are essential for the TPL 
functionality. The incorporation of the Ad5 EI region or the use of HEK 293 cells 
enhanced trans gene expression. 
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3- The constructed eHO cell lines showed no expression of the AdS E2 genes, neither 
constitutively nor upon induction, and thus, were unable to facilitate the replication 
of episomal DNA. 
4- Adenovirus super-infection enhanced transgene expressIOn when the MOl was 
optimized for gene expression and cellular vitality. The MLP, as well as the TPL, 
showed higher activity under the super-infection. However, there was no conclusive 
evidence of trans gene replication at the optimized MOL 
In summary, this study emphasized the importance of DNA quality for transgene 
delivery and expression. However, the use of adenoviral elements to enhance exogenous 
gene expression was successful only when the complementary viral proteins and 
sequences were present. Active expression of the adenoviral proteins did not depend 
solely on the presence of a few major regulatory elements, but rather on the specific 
combination of different elements that work in cis or trans to activate gene expression. 
177 
LITERA TURE CITED 
Abdallah, B.; Hassan, A.; Benoist, C.; Goula, D.; Behr, J. P. and Demeneix, B. A. (1996). A 
powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: 
polyethylenimine. Hum. Gene Ther. 7: 1947-1954. 
Acheson, N . (2007). Fundamentals of molecular virology. p 123-133. John Wiley & Sons. 
Adam, S. A. and Dreyfuss, G. (1987). Adenovirus proteins associated with rnRNA and hnRNA 
in infected HeLa cells. J Viral. 61: 3276-3283. 
AIm, H. H.; Lee, J. H.; Kim, K. S.; Lee, J. Y.; Kim, M. S.; Khang, G.; Lee, I. W. and Lee, H. B. 
(2008). Polyethyleneimine-mediated gene delivery into human adipose derived stem cells. 
Biomaterials 29: 2415-2422. 
Aiello, L.; Guilfoyle, R; Huebner, K.; and Weinmann, R (1979). Adenovirus 5 DNA sequences 
present and RNA sequences transcribed in transformed human embryonic kidney cells 
(HEK-Ad-5 or 293). Virology 94: 460-469. 
Andersen, D. C. and KlUmmen, L. (2002). Recombinant protein expression for therapeutic 
applications. Curro Opin. Biotechnol. 13 : 117-123 
Asian, H.; Zilberman, Y.; Arbeli, V.; Sheyn, D.; Matan, Y.; Liebergall, M.; Li, J. Z.; Helm, G. 
A.; Gazit, D. and Gazit, Z. (2006). Nucleofection-based ex vivo nonviral gene delivery to 
human stem cells as a platfonn for tissue regeneration. Tissue Eng. 12: 877-889. 
Atchison, M. L. (1988). Enhancers: mechanisms of action and cell specificity. Annu. Rev. Cell. 
Bioi. 4: 127-153. 
Babiss, L. E. and Ginsberg, H. S. (1984). Adenovirus type 5 early region lB gene product is 
required for efficient shutoff of host protein synthesis. J Virol. 50: 202-212. 
Babiss, L. E.; Ginsberg, H. S. and Darnell, J. E. (1985). Adenovirus ElB proteins are required for 
accumulation of late viral mRNA and for effects on cellular rnRNA translation and 
transport. Mol. Cell. Bioi. 5: 2552-2558. 
Bablanian, R and Russell, W. C. (1974). Adenovirus polypeptide synthesis in the presence of 
non-replicating poliovirus. J Gen. Virol. 24: 261-279. 
Baez, J.; Olsen, D. and Polarek, J. W. (2005). Recombinant microbial systems for the production 
of human collagen and gelatin. Appl. Microbiol. Biotechnol. 69: 245-252 . 
Baird, S. D.; Turcotte, M.; Korneluk, R G. and Ho1cik, M. (2006). Searching for IRES. RNA 12: 
1755-1785. 
Balaban, A. T. and Ilies, M. A. (2001). Recent developments in cationic lipid-mediated gene 
delivery and gene therapy. Expert Opin. Ther. Patents 11: 1729-1752. 
Banerjee, A. K. (1980). 5'-tenninal cap structure in eucaryotic messenger ribonucleic acids . 
Bacteriol. Rev. 44: 175-205. 
178 
Literature citea 
Banerji, J.; Olson, L. and Schaffner, W. (1983). A lymphocyte-specific cellular enhancer is 
located downstream of the joining region in immunoglobulin heavy chain genes. Cell 33: 
729-740. 
Banerji, J.; Rusconi, S. and Schaffner, W. (1981). Expression ofa ~-globin gene is enhanced by 
remote SV40 DNA sequences. Cell 27: 299-308. 
Barrett, J. W.; Sun, Y.; Nazarian, S. H.; Belsito, T. A.; Brunetti, C. R. and McFadden, G. (2006). 
Optimization of codon usage of poxvirus genes allows for improved transient expression in 
mammalian cells. Virus Genes 33: 15-26. 
Basu, J. and Willard, H. F. (2005). Artificial and engineered chromosomes: nonintegrating 
vectors for gene therapy. Trends Mol. Med. 11: 251-258. 
Bates, S.; Phillips, A. C.; Clark, P. A.; Stott, F.; Peters, G.; Ludwig, R. L. and Vousden, K. H. 
(1998). p14ARF links the tumour suppressors RB and p53. Nature 395: 124-125. 
Beattie, E.; Tartaglia, J. and Paoletti, E. (1991). Vaccinia virus-encoded eIF-2a homolog 
abrogates the antiviral effect of interferon. Virology 183: 419-422. 
Bechler, K. (1997). Influence of Capping and Polyadenylation on mRNA Expression and on 
Antisense RNA Mediated Inhibition of Gene Expression. Biochem. Biophys. Res. 
Commun. 241: 193-199. 
Behr, J. P. (1996). The proton sponge, a means to enter cells viruses never thought of. MlS-Med 
Sci. 12: 56-58. 
Beitz, G. A. and Flint, S. J. (1979). Inhibition of HeLa cell protein synthesis during adenovirus 
infection . .J Mol. BioI. 131: 353-373. 
Benko, M.; Harrach, B. and Russell, W. C. (1999). Adenoviridae. In: van Regenmortel, M. H. V.; 
Fauquet, C. M. and Bishop, D. H. L. (eds.), Virus Taxonomy, Seventh Report of the 
International Committee on Taxonomy of Viruses. Academic Press, San Diego, pp. 227-
238. 
Berget, S. M.; Moore, C. and Sharp, P. (1977). Spliced segments at the 5' terminus of Ad2 late 
mRNA. Proc. Nat!. Acad. Sci. USA 74: 3171-3175. 
Berk, A. J. (2007). Adenoviridae: The Viruses and Their replication. In: Knipe, D. M. David, M., 
Howley, P. M. and Peter M. (eds.), Fields Virology. Lippincott Williams & Wilkins: 
Philadelphia, PA, pp. 2356-2394. 
Berk, A. J.; Lee, F.; Harrison, T.; Williams, J. and Sharp, P. A. (1979). Pre-early adenovirus 5 
gene product regulates synthesis of early viral messenger RNAs. Cell 17: 935-944. 
Berkner, K. E. and Sharp, P . A. (1985). Effect of tripartite leader on synthesis of a non-viral 
protein in a adenovirus 5' recombinant. Nucleic Acids Res. 13: 841-857. 
Bernstein, P. and Ross, J. (1989). Poly(A), poly(A) binding protein and the regulation ofmRNA 
stability .. Trends Biochem. Sci. 14: 373-377. 
179 
Literature cited 
Bemstein, P. L.; Herrick, D. J.; Prokipcak, R. D. and Ross, J. (1992). Control of c-myc mRNA 
half-life in vitro by a protein capable of binding to a coding region stability determinant. 
Genes Dev. 6: 642-654. 
Bimstiel, M. L., Busslinger, M. and Strub, K. (1985). Transcription termination and 3' 
processing: the end is in site!. Cell 41 : 349-359. 
Blasey, H. D.; Aubry, J. -P.; Mazzei, G. J. and Bemard, A. R. (1996). Large scale transient 
expression with COS cells. Cytotechnology 18: 138-142. 
Boam, D. S. W.; Davidson, I. and Chambon, P. (1995). A TATAless promoter containing 
binding sites for ubiquitous transcription factors mediates cell type-specific regulation of 
the gene for transcription enhancer factor-1 (TEF-1). J. Bioi. Chern. 270: 19487-19494. 
Boettner, M.; Prinz, B.; Holz, C.; Stahl, U. and Lang, C. (2002). High-throughput screening for 
expression of heterologous proteins in the yeast Pichia pastoris. J. Biotechnol. 99: 51-62. 
Bollag, R. J.; Waldman, A. S. and Liskay, R. M. (1989). Homologous Recombination in 
mammalian cells. Annual Reviews of Genetics 23: 199-225. 
Bolster, D. R.; Vary, T. C.; Kimball, S. R. and Jefferson, L. S. (2004). Leucine regulates 
translation initiation in rat skeletal muscle via enhanced eIF4G phosphorylation. J. Nutr. 
134: 1704-1710. 
Bos, J. L.; Polder, L. J.; Bemards, R.; Schrier, P. I.; van den Elsen, P. J.; van der Eb, A. J. and 
van Ormondt, H. (1981). The 2.2 kb EIB mRNA of human adenovirus 12 and adenovirus 
5 codes for two tumor antigens starting at different AUG triplets. Cell 27: 121-131. 
Bosher, J.; Robinson, E. C. and Hay, R. T. (1990). Interactions between the adenovirus type 2 
DNA polymerase and the DNA binding domain of nuclear factor I. New Bioi. 2: 1083-
1090. 
Botting, C. H. and Hay, R. T. (1999). Characterisation of the adenovirus preterminal protein and 
its interaction with the POU hom eo domain ofNFIII (Oct-I). Nucleic Acids Res. 27: 2799-
2805. 
Boussif, 0.; Lezoualch, F.; Zanta, M. A.; Mergny, M. D.; Scherman, D.; Demeneix, B. and Behr, 
J. P. (1995). A versatile vector for gene and oligonucleotide transfer into cells in culture 
and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 92: 7297-7301. 
Brand, S. R.; Kobayashi, R. and Mathews, M. B. (1997). The Tat protein of human 
immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally 
activated protein kinase, PKR. J. Bioi. Chern. 272: 8388-8395. 
Brawermann, G. (1981). The Role of the poly(A) sequence in mammalian messenger RNA. Crit. 
Rev. Biochern. 10: 1-38. 
Brehm, A.; Miska, E. A.; McCance, D. J.; Reid, J. L.; Bannister, A. J. and Kouzarides, T. (1998). 
Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391: 
597-601. 
180 
Literature citea 
Brenkman, A. B.; Breure, E. C. and van der Vliet, P. C. (2002). Molecular architecture of 
adenovirus DNA polymerase and location of the protein primer. J. Virol. 76: 8200-8207. 
Brenkman, A. B.; Heideman, M. R.; Truniger, V.; Salas, M. and van der Vliet, P. C. (2001). The 
(IN)XGG motif of adenovirus DNA polymerase affects template DNA binding and the 
transition from initiation to elongation. J. BioI. Chern. 276: 29846-29853. 
Bridge, E. and Ketner, G. (1990). Interaction of adenoviral E4 and Elb products in late gene 
expression. Virology 174: 345-353. 
Brinster, R. L.; Chen, H. Y.; Trumbauer, M. E.; Yagle, M. K; Palmiter, R. D. (1985). Factors 
affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. 
Proc. Natl. Acad. Sci. USA 82: 4438-4442. 
Brunner, S.; Sauer, T.; Carotta, S.; Cotton, M.; Saltik. M, and Wagner, E (2000). Cell cycle 
dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther. 
7: 401-407 
Burton, E. A.; Fink, D. 1. and Glorioso, 1. C. (2002). Gene delivery using herpes simplex virus 
vectors. DNA Cell BioI. 21 :915-936 
Bushell, M. E.; Rowe, M.; Avignone-Rossa, C. A. and Wardell, J. N. (2003). Cyclic fed-batch 
culture for production of human serum albumin in Pichia pastoris. Biotech. Bioeng. 82: 
678-683. 
Butler, M. (2005). Animal cell cultures: recent achievements and perspectives in the production 
ofbiopharmaceuticals. Appl. MicrobioI. Biotechnol. 68: 283-29l. 
Caput, D.; Beutler, B.; Hartog, K; Thayer, R.; Brown-Shimer, S. and Cerami, A. (1986). 
Identification of a common nucleotide sequence in the 39- untranslated regions of mRNA 
molecules specifying inflammatory mediators. Proc. Nat!. Acad. Sci. USA 83: 1670-1674. 
Carter, K; Bowman, D.; Canington, W.; Fogarty, K; McNeil, A.; Fay, F. S. and Lawrence, 1. B. 
(1993). A three-dimensional view of precursor messenger RNA metabolism within the 
mammalian nucleus. Science 259: 1330-1335. 
Cassan, M. and Rousset, 1. P. (2001). VAG readthrough in mammalian cells: Effect of 
upstreamand downstreamstop codon contexts reveal different signals. BMC Mol. BioI. 2: 3. 
Chang, L. S. and Shenk, T. (1990). The adenovirus DNA-binding protein stimulates the rate of 
transcription directed by adenovirus and adenoassociated virus promoters. J. Virol. 64: 
2103-2109. 
Chang, W. P. and Little, 1. B. (1991). Delayed reproductive death in X-irradiated Chinese 
hamster ovary cells. Int. J. Radiat. BioI. 60: 483-496. 
Chao, D. and Korsmeyer, S. (1998). BCL-2 family: regulators of cell death. Annu. Rev. Irnrnunol. 
16: 395-419. 
Chatton, B.; Bocco, 1. L.; Gaire, M.; Hauss, C.; Reimund, B.; Goetz, 1. and Kedinger, C. (1993). 
Transcriptional activation by the adenovirus larger EIA product is mediated by members 
181 
Literature citea 
of the cellular transcription factor ATF family which can directly associate with E1 A. Mol. 
Cell. Bioi. 13: 561-570. 
Chen, C. Y.; Gherzi, R.; Ong, S. E.; Chan, E. L.; Raij makers , R.; Pmijn, G. l; Stoecklin, G.; 
Moroni, c.; Mann, M . and Karin, M. (2001). AU binding proteins recmit the exosome to 
degrade ARE-containing mRNAs. Cell 107: 451-464. 
Chen, F.; MacDonald, C. C. and Wilusz, l (1995). Cleavage site determinants in the mammalian 
polyadenylation signal. Nucleic Acids Res. 23: 2614-2620. 
Chen, M.; Mermod, N. and Horwitz, M. S. (1990). Protein-protein interactions between 
adenovims DNA polymerase and nuclear factor I mediate formation of the DNA 
replication preinitiation complex. J. Bioi. Chern. 265: 18634-18642. 
Chou, T. W.; Biswas, S. and Lu, S. (2004). Gene delivery using physical methods, an overview. 
Methods in Molecular Biology 245 : 147-165. 
Chou, Z. F.; Chen, F. and Wilusz, J. (1994). Sequence and position requirements for uridylate-
rich downstream elements of polyadenylation signals. Nucleic Acids Res. 22: 2525-2531. 
Chow, L. T. and Broker, T. R. (1994). Papillomavims DNA replication. Intervirology 37: 150-
158. 
Chow, L. T.; Roberts, l M.; Lewis, l B. and Broker, T. R. (1977). A map of cytoplasmic RNA 
transcripts from lytic adenovims type 2, determined by electron microscopy ofRNA:DNA 
hybrids. Cell 11 : 819-836. 
Chung, J. H.; Whiteley, M. and Felsenfeld, G. (1993). A 50 element of the chicken beta-globin 
domain serves as an insulator in human erythroid cells and protects against position effects 
in Drosophila. Cell 74: 505-514. 
Chung, J.; Ahn, H.; Lim, S.; Sung, Y.; Koh, Y.; Park, S. and Lee, G. (2003). Development of 
recombinant Chinese hamster ovary cell lines producing human thrombopoietin or its 
analog. Journal of Microbiology and Biotechnology 13: 759-766. 
Clark, D. P. (2005). Processing of RNA. In: Molecular Biology: Understanding the Genetic 
Revolution. Elsevier Academic Press, San Diego. 
Cleat, P. H. and Hay, R. T. (1989). Co-operative interactions between Nfl and the adenovims 
DNA binding protein at the adenovims origin of replication. Elv1BO J. 8: 1841-1848. 
Cleghon, V.; Voelkerding, K.; Morin, N.; Delsert, C. and Klessig, D. F. (1989). Isolation and 
characterization of a viable adenovims mutant defective in nuclear transpOli of the DNA-
binding protein. J. Virol. 63: 2289-2299. 
Cohen, S. N.; Chang, A. C. Y. and Hsu, L. (1972). Nonchromosomal antibiotic resistance in 
bacteria: Genetic transformation of Escherichia coli by R-factor DNA. Proc. Natl. Acad. 
Sci. USA 69: 2110-2114. 
Coller, l and Parker, R. (2004). Eukaryotic mRNA decapping. Annu. Rev. Biochem. 73: 861-890. 
182 
Literature citea 
Conese, M.; Auriche, C. and Ascenzioni, F. (2004). Gene therapy progress and prospects: 
episomally maintained self-replicating systems. Gene Ther. 11: 1735-1741. 
Conti, E. and Izaurralde, E. (2001). Nucleocytoplasmic transport enters the atomic age. Curro 
Opin. Cell Bioi. 13: 310-319. 
Coura Rdos, S. and Nardi, N. B. (2008). The state of the ali of adeno-associated virus-based 
vectors in gene therapy. Virol. J 4: 99. 
Crick, F. (1970). Central Dogma of Molecular Biology. Nature 227: 561-563. 
Crick, F. H. C. (1958). On Protein Synthesis. Symp. Soc. Exp. Bioi. 12: 138-163. 
Cuesta, R; Xi, Q. and Schneider, R J. (2000). Adenovirus-specific translation by displacement 
of kinase Mnk1 from cap-initiation complex eIF4F. EMBO J 19: 3465-3474. 
Culp, J. S.; Webster, L. C.; Friedman, D. J.; Smith, C. L.; Huang, W-J.; Wu, F. Y-H.; Rosenberg, 
M. and Ricciardi, R P. (1988). The 289-amino acid E1A protein of adenovirus binds zinc 
in a region that is important for trans-activation. Proc. Natl. Acad. Sci. USA 85: 6450-6454. 
Dalby, B.; Cates, S.; Harris, A; Ohki, E. C.; Tilkins, M. L.; Price, P. J. and Ciccarone, V. C. 
(2004). Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, 
and high-throughput applications. Methods 33: 95-103. 
de Jong, R. N. and van der Vliet, P. C. (1999). Mechanism of DNA replication in eukaryotic 
cells: cellular host factors stimulating adenovirus DNA replication. Gene 236: 1-12. 
Debbas, M. and White, E. (1993). Wild-type p53 mediates apoptosis by E1A, which is inhibited 
by ElB. Genes Dev. 7: 546-554. 
Dekker, J.; Kanellopoulos, P. N.; Loonstra, A. K.; van Oosterhout, J. A; Leonard, K.; Tucker, P. 
A and van der Vliet, P. C. (1997). Multimerization of the adenovirus DNA-binding protein 
is the driving force for ATP-independent DNA unwinding during strand displacement 
synthesis. EMBOJ. 16: 1455-1463. 
Deshpande, M. C. and Prausnitz, M. R (2007). Synergistic effect of ultrasound and PElon DNA 
transfection in vitro. J Control Release 118: 126-135. 
Dillon, N. (2004). Heterochromatin structure and function. Bioi. Cell. 96: 631-637. 
Dillon, N. and Festenstein, R (2002). Unravelling heterochromatin: competition between 
positive and negative factors regulates accessibility. Trends Genet. 18: 252-258. 
Dinnis, D. M. and James, D. C. (2005). Engineering mammalian cell factories for improved 
recombinant monoclonal antibody production: Lessons from nature? Biotechnol. Bioeng. 
91: 180-189. 
Disbrow, G. L.; Sunitha, I.; Baker, C. C.; Hanover, J. and Schlegel, R. (2003). Codon 
optimization of the HPV-16 E5 gene enhances protein expression. Virology 311: 105-114. 
183 
-Literature citea 
Dobbelstein, M.; Roth, J.; Kimberly, W. T.; Levine, A. J. and Shenk, T. (1997). Nuclear export 
of the ElB 55-kDa and E4 34-kDa adenoviral oncoproteins mediated by a rev-like signal 
sequence. EMBO J. 16: 4276-4284. 
Dobner, T.; Horikoshi, N.; Rubenwolf, S. and Shenk, T. (1996). Blockage by adenovirus E40rf6 
of transcriptional activation by the p53 tumor suppressor. Science 272: 1470-1473. 
Doerfler, W. (1991). The abortive infection and malignant transformation by adenoviruses: 
integration of viral DNA and control of viral gene expression by specific patterns of DNA 
methylation. Adv. Virus Res. 39: 89-128. 
Dolph, P. J.; Huang, J. and Schneider, R. J. (1990). Translation by the adenovirus tripartite 
leader: elements which determine independence from cap-binding protein complex. J. 
Virol. 64: 2669-2677. 
Dolph, P. J.; Racaniello, V.; Villamarin, A.; Palladino, F. and Schneider, R. J. (1988). The 
adenovirus tripartite leader eliminates the requirement for cap-binding protein during 
translation initiation. J. Virol. 62: 2059-2066. 
Douglas, J. T. (2008). Adenoviral vectors for gene therapy. Molecular Biotechnology 36: 71-80. 
Du, M.; Ye, L.; Liu, J.; Liu, J. and Yang, L. (2008). Enhancement ofGFP expression by Kozak 
sequence +4G in HEK293 cells. Chinese Journal of Biotechnology 24: 491-494. 
Edmonds, M. (2002). A history of poly A sequences: from formation to factors to function. Prog 
Nucleic Acid Res. Mol. Bioi. 71: 285-389. 
Esche, H.; Mathews, M. B. and Lewis, J. B. (1980). Proteins and messenger RNAs of the 
transforming region of wild-type and mutant adenoviruses. J. Mol. Bioi. 142: 399-417. 
Evans, R. M.; Fraser, N.; Ziff, E.; Weber, J.; Wilson, M. and Darnell, J. E. (1977). The initiation 
sites for RNA transcription in Ad2 DNA. Cell 12: 733-739. 
Farr, C. J.; Stevanovic, M.; Thomson, E. J.; Goodfellow, P. N. and Cooke, H. J. (1992). 
Telomere-associated chromosome fragmentation: applications in genome manipulation and 
analysis. Nat. Genet. 2: 275-282. 
FeIgner, P. L. and Ringold, G. M. (1998). Cationic lip os orne-mediated transfection. Nature 337: 
387-388. 
FeIgner, P. L.; Gadek, T. R.; Holm, M.; Roman, R.; Chan, H. W.; Wenz, M.; Northrop, J. P.; 
Ringold, G. M. and Danielsen, M. (1987). Lipofection: a highly efficient, lipid-mediated 
DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84: 7413-7417. 
Ferreira, T. B.; Alves, P. M.; Gon((alves, D. and Carrondo, M. J. T. (2005). Effect of MOl and 
Medium Composition on Adenovirus Infection Kinetics. In: GOdia, F. and Fussenegger, M. 
(eds.), Animal cell technology meets genomics. Springer Netherlands, pp. 329-332. 
Field, J.; Gronostajski, R. M. and Hurwitz, J. (1984). Properties of the adenovirus DNA 
polymerase. J. Bioi. Chern. 259: 9487-9495. 
184 
Literature citea 
Flint, J. and Shenk, T. (1997). Viral transactivating proteins. Annu. Rev. Genet. 31: 177-212. 
Flint, K. J. and Jones, N. C. (1991). Differential regulation of three members of the ATF/CREB 
family of DNA-binding proteins. Oncogene 6: 2019-2026. 
Flint, S. J. (1984). Adenovirus cytopathology. Compr. Virol. 19: 297-358. 
Flint, S. J. and Gonzalez, R. A. (2003). Regulation of mRNA production by the adenoviral ElB 
55-kDa and E4 Orf6 proteins. Curro Top. Microbiol. Immunol. 272: 287-330. 
Fort, P.; Rech, J.; Vie, A.; Piechaczyk, M.; Bonnieu, A. ; Jeanteur, P. and Blanchard, J.-M. 
(1987). Regulation of c-fos gene expression in hamster fibroblasts: initiation and 
elongation of transcription and mRNA degradation. Nucleic Acids Res. 15 : 5657-5667. 
Francastel, c.; Walters, M. C.; Groudine, M. and Martin, D. 1. (1999). A functional enhancer 
suppresses silencing of a transgene and prevents its localization close to centrometric 
heterochromatin. Cell 99: 259-69. 
Frenkel, G. D. and Horan, K. (1983). DNase inhibition by the adenovirus DNA-binding protein 
exhibits specificity for the enzyme but not for the secondary structure of the DNA. 
Biochem. Biophys. Res. Commun. 110: 443-448. 
Frenkel, P. A.; Chen, S.; Thai, T.; Shohet, R. V. and Graybull1, P. A. (2002). DNA-loaded 
albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med. 
Bioi. 28: 817-822 
Freyer, G. A.; Katoh, Y. and Roberts, R. J. (1984). Characterization of the major mRNAs from 
adenovirus 2 early region 4 by cDNA cloning and sequencing. Nucleic Acids Res. 12: 
3503-3519. 
Furuichi, Y.; LaFiandra, A. and Shatkin, A. J. (1977). 5'-Terminal structure and mRNA stability. 
Nature 266: 235-239. 
Gale, M. Jr., Blakely, C. M.; Kwieciszewski, B.; Tan, S. -L.; Dossett, M.; Korth, M. J.; Polyak, 
S. J.; Gretch, D. R. and Katze, M. G. (1998). Control ofPKR protein kinase by hepatitis C 
virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol. Cell. Bioi. 
18: 5208-5218. 
Gale, M. Jr.; Korth, M. J.; Tang, N. M.; Tan, S. -L.; Hopkins, D. A.; Dever, T. E.; Polyak, S. J.; 
Gretch, D. R. and Katze, M. G. (1997). Evidence that hepatitis C virus resistance to 
interferon is mediated through repression of the PKR protein kinase by the nonstructural 
5A protein. Virology 230: 217-227. 
Gale, M. Jr.; Kwieciszewski, B.; Dossett, M.; Nakao, H . and Katze, M. G. (1999). Anti-apoptotic 
and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral 
repression of the PKR protein kinase . .J. Virol. 73: 6506-6516. 
Gallie, D. R.; Feder, J. N.; Schimke, R. T. and Walbot, V. (1991). Post-transcriptional regulation 
in higher eukaryotes: the role of the reporter gene in controlling expression. Mol. Gen. 
Genet. 228: 258-264. 
185 
Literature cited 
Gao, X. and Huang, L. (1995). Cationic liposome-mediated gene transfer. Gene Ther. 2: 710-722. 
GalTick, D., Fiering, S., Martin, D. I. and Whitelaw, E. (1998). Repeat-induced gene silencing in 
mammals. Nat. Genet. 18: 56-59. 
Gemgross, T. U. (2004). Advances in the production of human therapeutic proteins in yeasts and 
filamentous fungi. Nat. Biotechnol. 22: 1409-1414. 
Gilardi, P. and PelTicaudet, M. (1986). The E4 promoter of adenovirus type 2 contains an ElA 
dependent cis-acting element. Nucleic Acids Res. 14: 9035-9049. 
Glover, D. 1.; Lipps, H. J. and Jans, D. A. (2005). Towards safe, non-viral therapeutic gene 
expression in humans. Nat. Rev. Genet. 6: 299-310. 
Godbey, W. T.; Wu, K. K. and Mikos, A. G. (1999). Poly(ethylenimine) and its role in gene 
delivery. J. Control Release 60: 149-160. 
Goeddel, D.; Kleid, D.; Bolivar, F.; Heyneker, H.; Yansura, D.; Crea, R.; Hirose, T.; Kraszewski, 
A.; Itakura, K. and Riggs, A. (1979). Expression in Escherichia coli of chemically 
synthesized genes for human insulin. Proc. Natl. Acad. Sci. USA 76: 106-110. 
Gonzalez, R. A. and Flint, S. 1. (2002). Effects of mutations in the adenoviral EIB 55-kilodalton 
protein coding sequence on viral late mRNA metabolism. J. Virol. 76: 4507-4519. 
Goodrich, J. A.; Cutler, G. and Tjian, R. (1996). Contacts in context: Promoter specificity and 
macromolecular interactions in transcription. Cell 84: 825-830. 
Gorlach, M.; Burd, C. G. and Dreyfuss, G. (1994). The mRNA poly(A)-binding protein: 
localization, abundance, and RNA-binding specificity. Exp. Cell Res. 211: 400-407. 
Gorlich, D. and Kutay, U. (1999). Transport between the cell nucleus and the cytoplasm. Annu. 
Rev. Cell Dev. Bioi. 15: 607-660. 
Graber, 1. H.; Cantor, C. R.; Mohr, S. C. and Smith, T. F. (1999). In silico detection of control 
signals: mRNA 3'-end-processing sequences in diverse species. Proc. Natl. Acad. Sci. USA 
96: 14055-14060. 
Graessmann, M. and Graessmann, A. (1983). Microinjection of tissue culture cells. Methods 
Enzymol. 101: 482-492. 
Graham, F. L. (1984). Covalently closed circles of human adenovirus DNA are infectious. 
EMBOJ. 3: 2917-2922. 
Graham, F. L. and van der Eb, A. 1. (1973). A new technique for the assay of infectivity of 
human adenovirus 5 DNA. Virology 52: 456-467. 
Graham, F. L. ; Rudy, 1. and Brinkley, P. (1989). Infectious circular DNA of human adenovirus 
type 5: regeneration of viral DNA termini from molecules lacking telTllinal sequences. 
EMBO J. 8: 2077-2085. 
186 
-Literature citea 
Graham, F. L.; Smiley, 1.; Russell, W. C. and Nairn, R. (1977). Characteristics of a human cell 
line transformed by DNA from human adenovirus type 5. J. Gen Virol. 36: 59-72. 
Granados, R. R. and Federici, B. A. (1986). The Biology of Baculoviruses. CRC Press, Boca 
Raton, Florida. 
Grand, R. J.; Parkhill, J.; Szestak, T.; Rookes, S. M.; Roberts, S. and Gallimore, P. H. (1999). 
Definition of a major p53 binding site on Ad2ElB58K protein and a possible nuclear 
localization signal on the Adl2ElB54K protein. Oncogene 18: 955-965. 
Gregory, T. R. (2005). Animal Genome Size Database. http://www.genomesize.com. 
Griffin, T. 1.; Seth, G.; Xie, H.; Bandhakavi, S. and Hu, W. S. (2007). Advancing mammalian cell 
culture engineering using genome-scale technologies Trends in Bioteclmology 25: 401-
408. 
Groner, A. (1986). Specificity and safety of baculoviruses. In: Granados, R. R. and Federici, B. 
A. (eds.), The Biology ofBaculoviruses. CRC Press, Boca Raton, Florida, p. 177. 
Grosjean, F.; Batard, P.; Jordan, M. and Wurm, F. (2002). S-phase synchronized CHO cells show 
elevated transfection efficiency using CaPi. Cytotechnology 38: 57-62. 
Grosveld, F.; van Assendelft, G. B.; Greaves, D. R. and Kollias, G. (1987). Position-independent, 
high-level expression of the human beta-globin gene in transgenic mice. Cell 51 : 975-985. 
Halbert, D. N.; Cutt, 1. R. and Shenk, T. (1985). Adenovirus early region 4 encodes functions 
required for efficient DNA replication, late gene expression, and host cell shutoff. J. Virol. 
56: 250-257. 
Hall, T. M. (2002). Poly(A) tail synthesis and regulation: recent structural insights. Curro Opin. 
Struct. BioI. 12: 82-88. 
Hamm, J. and Mattaj, I. W. (1990). A cap binding protein that may mediate nuclear export of 
RNA polymerase II-transcribed RNAs. Cell 63: 109-118. 
Han, 1.; Sabbatini, P.; Perez, D.; Rao, L.; Mohda, D. and White, E. (1996). The ElB 19K protein 
blocks apoptosis by interacting with and inhibiting the p53- inducible and death-promoting 
Bax protein. Genes Dev. 10: 461-477. 
Hans, H. and Alwine, 1. C. (2000). Functionally significant secondary structure of the simian 
virus 40 late polyadenylation signal. Mol. Cell BioI. 20: 2926-2932. 
Hardwick, J. M.; von Sprecken, R. S.; Yielding, K. L. and Yielding, L. W. (1984). Ethidium 
binding sites on plasmid DNA determined by photo affinity labelling. J. BioI. Chem. 259: 
11090-11097. 
Harrington, 1. 1.; van Bokkelen, G.; Mays, R. W.; Gustashaw, K. and Willard, H. F. (1997). 
Formation of de novo centromeres and construction of first-generation human artificial 
microchromosomes. Nat. Genet. 15: 345-355. 
187 
-Literature cited 
Hay, R. T.; Freeman, A.; Leith, I.; Monaghan, A. and Webster, A. (1995). Molecular interactions 
during adenovirus DNA replication. In: Doerfler, W. and Bohm, P. (eds.), The Molecular 
Repertoire of Adenoviruses. Berlin: Springer, pp. 31-48. 
Hayashi, M. and Harada, Y. (2007). Direct observation of the reversible unwinding of a single 
DNA molecule caused by the intercalation of ethidium bromide. Nucleic Acids Res. 35: 
e125-e125. 
Helin, K. and E. Harlow. (1994). Heterodimerization ofthe transcription factors E2F-1 and DP-1 
is required for binding to the adenovirus E4 (ORF6/7) protein. J. Virol. 68: 5027-5035. 
Hillemann, M. R. and Werner, J. R. (1954). Recovery of a new agent from patients with acute 
respiratory illness. Proceedings of the Society for Experimental Biology and Medicine 85, 
183-188. 
Herisse, J.; Rigolet, M.; de Dinechin, S. D. and Galibert, F. (1981). Nucleotide sequence of 
adenovirus 2 DNA fragment encoding for the carboxylic region of the fiber protein and the 
entire E4 region. Nucleic Acids Res. 9: 4023-4042. 
Hinnebusch, A. G. (2000). Mechanism and regulation of initiator methionyl-tRNA binding to 
ribosomes. In: Sonenberg, N., Hershey, J. W. B. & Mathews, M. B. (eds.), Translational 
Control of Gene Expression. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 
NY, pp. 185-243. 
Horkoshi, N.; Maguire, K. J.; Kralli, A.; Maldonado, E.; Reinberg, D. and Weimnann, R. (1991). 
Direct interaction between adenovirus E1A protein and the TATA box binding 
transcription factor lID. Proc. Natl. Acad. Sci. USA 88: 5124-5128. 
Horridge, J. J. and Leppard, K. N. (1998). RNA-binding activity of the EIB 55-kilodalton protein 
from human adenovirus type 5. J. Virol. 72: 9374-9379. 
Horwitz, M. S. (2001). Adenovirus immunoregulatory genes and their cellular targets. Virology 
279: 1-8. 
Hosel, M.; Webb, D.; Schroer, J. and Doerfler, W. (2003). The abortive infection of Syrian 
hamster cells with human adenovirus type 12. Curro Top. Microbiol. lmmunol. 272: 415-
440. 
Hseih, P. and Robbins, P. W. (1984). Regulation of asparagine-linked oligosaccharide 
processing: Oligosaccharide processing in Aedes albopictus mosquito cells. J. Bioi. Chem. 
259: 2375-2382. 
Huang, W. B.; Wong, J. M. and Bateman, E. (1996). TATA elements direct bi-directional 
transcription by RNA polymerases II and III. Nucleic Acids Res. 24: 1158-1163. 
Hunt, I. (2005). From gene to protein: a review of new and enabling technologies for multi-
parallel protein expression. Protein Expression and Purification 40: 1-22. 
Hurley, L. H. (2002). DNA and its associated processes as targets for cancer therapy. Nat. Rev. 
Cancer 2: 188-200. 
188 
Literature cited 
Ikemura, T. (1985). Codon usage and tRNA content in unicellular and multicellular organisms. 
Mol. Bioi. Evo/. 2: 13-34. 
Imperiale, M. J.; Akusjarvi, G. and Leppard, K. N. (1995). Post-transcriptional control of 
adenovirus gene expression. Curro Top. Microbiol. Immunol. 199: 139-171. 
Inoue, H.; Nojima, H. and Okayama, H. (1990). High efficiency transformation of Escherichia 
coli with plasmids. Gene 96: 23-28. 
Ishikawa, T.; Lee, E. J. and Jameson, J. L. (2004). Nonhomologous end-joining ligation transfers 
DNA regulatory elements between cointroduced plasmids. Mol. Cell Bioi. 24: 8323-8331. 
Iyer, M.; Wu, L.; Carey, M. ; Wang, Y.; Smallwood, A. and Gambhir, S. S. (2001). Two-step 
transcriptional amplification as a method for imaging reporter gene expression using weak 
promoters. Proc. Natl. Acad. Sci. USA 98: 14595-14600. 
Jackson, D. A.; Symons, R. H. and Berg, P. (1972). Biochemical method for inserting new 
genetic information into DNA of Simian Virus 40: circular SV40 DNA molecules 
containing lambda phage genes and the galactose operon of Escherichia coli. Proc. Natl. 
Acad. Sci. USA 69: 2904-2909. 
Jackson, R. J. and Kaminski, A. (1995). Intemal initiation of translation in eukaryotes: the 
picomavirus paradigm and beyond. RNA 1: 985-1000. 
Jacobson, A. (1996). Poly(A) metabolism and translation: the closed loop model. In: Hershey, J. 
W.; Mathews, M. B. and Sonenberg, N. (eds.), Translational Control. Cold Spring Harbor 
Press, pp. 451-480. 
Jang, S. K., Kra"usslich, H. -G.; Nicklin, M. 1. H.; Duke, G. M.; Palmenberg, A. C. and Wimmer, 
E. (1988). A segment of the 59 nontranslated region of encephalomyocarditis virus RNA 
directs intemal entry of ribosomes during in vitro translation. J. Virol. 62: 2636-2643. 
Jang, S.; Davies, M.; Kaufman, R. and Wimmer, E. (1989). Initiation of protein synthesis by 
intemal entry of ribosomes into the 5' nontranslated region of encephalomyocarditis virus 
RNA in vivo. J. Virol. 63: 1651-1660. 
Jaskiewicz, E.; Jedynak, A. and Ziolo, E. (2005). Expression of recombinant forms of human 
21.5 kDa myelin basic protein and proteolipid protein in CHO cells. Acta Biochimica 
Polonica 52: 863-866. 
Jefferson, L. S. and Kimball, S. R. (2003). Amino acids as regulators of gene expression at the 
level ofmRNA translation. J. Nutr. 133: 2046S-2051S. 
Jenkins, N.; Murphy, L. and Tyther, R. (2008). Post-translational modifications of recombinant 
proteins: significance for biopharmaceuticals. Mol. Biotechnol. 39: 113-118. 
Jones, N. and Shenk, T. (1979). Isolation of adenovirus type 5 host range deletion mutants 
defective for transformation of rat embtyo cells. Cell 17: 683-689. 
Jordan, M.; Kohne, C. and WUlm, F. M. (1998). Calcium-phosphate mediated DNA transfer into 
HEK-293 cells in suspension: control of physicochemical parameters allows transfection in 
189 
Literature cited 
stilTed media: Transfection and protein expression in mammalian cells. Cytotechnology 26: 
39-47. 
Jordan, M.; Schallhom, A. and Wurm, F. W. (1996). Transfecting mammalian cells: 
Optimization of critical parameters affecting calcium-phosphate precipitate fOlmation. 
Nucleic Acids Res. 24: 596-601. 
Kabotyanski, E. B.; Gomelsky, L.; Han, J. -0.; Stamato, T. D. and Roth, D . B. (1998). Double-
strand break repair in Ku86- and XRCC4-deficient cells. Nucleic Acids Res. 26: 5333-
5342. 
Kaczmarczyk, S. J. and Green, J. E. (2001). A single vector containing modified cre recombinase 
and LOX recombination sequences for inducible tissue-specific amplification of gene 
expression. Nucleic Acids Res. 29: E56-66. 
Kang, c.Y., (1988). Baculovirus for expression of foreign genes. Adv. Virus Res. 35: 177-192. 
Kaufman, R. J. (1990). Vectors used for expression in mammalian cells. Methods Enzymol. 185: 
487-511. 
Kaufman, R. J. (1999). Double-stranded RNA-activated protein kinase mediates virus-induced 
apoptosis: a new role for an old actor. Proc. Nat/. Acad. Sci. USA 96: 11693-11695. 
Kaufman, R. J. (2000). Overview of vector design for mammalian gene expression. Mol. 
Biotechnol. 16: 151-160. 
Kawagishi-Kobayashi, M.; Silverman, J. B.; Ung, T. L. and Dever, T. E. (1997). Regulation of 
the protein kinase PKR by the vaccinia virus pseudosubstrate inhibitor K3L is dependent 
on residues conserved between the K3L protein and the PKR substrate eIF-2a. Mol. Cell. 
BioI. 17: 4146-4158. 
Keblusek, P.; Dorsman, J. C.; Teunisse, A. F.; Teunissen, H.; van der Eb, A. J. and Zantema, A. 
(1999). The adenoviral ElA oncoproteins interfere with the growth-inhibiting effect of the 
cdk-inhibitor p21CIP"/WAF". Journal a/General Virology 80: 381-390. 
Kichler, A.; Erbacher, P. and Behr, J. P. (1995). Polyethylenimines: a family of potent polymers 
for nucleic acid delivery. In: Huang, L.; Hung, M. and Wagner, E. (eds.), Non-Viral 
Vectors for Gene Therapy. San Diego, CA, USA: Academic press. 
Kim, C. H.; Oh, Y. and Lee, T. H. (1997). Codon optimization for high-level expression of 
human erythropoietin (EPO) in mammalian cells. Gene 199: 293-301. 
King, A. J. and van der Vliet, P. C. (1994). A precursor terminal proteintrinucleotide intermediate 
during initiation of adenovirus DNA replication: regeneration of molecular ends in vitro by 
a jumping back mechanism. EMBO J. 13: 5786-5792. 
King, A. J.; Teertstra, W. R. and van der Vliet, P. C. (1997a). Dissociation of the protein primer 
and DNA polymerase after initiation of adenovirus DNA replication. J. BioI. Chem. 272: 
24617-24623. 
190 
Literature cited" 
King, A J.; Teelistra, W. R.; Blanco, L.; Salas, M. and van der Vliet, P. C. (1997b). Processive 
proofreading by the adenovirus DNA polymerase. Association with the priming protein 
reduces exonucleolytic degradation. Nucleic Acids Res. 25: 1745-1752. 
Klann, E. and Dever, T. E. (2004). Biochemical mechanisms for translational regulation in 
synaptic plasticity. Nature Reviews Neuroscience 5: 931-942. 
Klimkait, T. and Doerfler, W. (1985). Adenovirus types 2 and 5 functions elicit replication and 
late expression of adenovirus type 12 DNA in hamster cells. J. Virol. 55: 466-474. 
Klirnkait, T. and Doerfler, W. (1987). EIB functions of type C adenoviruses playa role in the 
complementation of blocked adenovirus type 12 DNA replication and late gene 
transcription in hamster cells. Virology 161: 109-120. 
Koch, S.; Pohl, P.; Cobet, U. and Rainov, N. G. (2000). Ultrasound enhancement of liposome-
mediated cell transfection is caused by cavitation effects. Ultrasound Med. BioI. 26: 897-
903 . 
Kollmar, R.; Sukow, K. A.; Sponagle, S. K. and Farnham, P. J. (1994). Start site selection at the 
TATA-Iess carbamoyl-phosphate synthase (glutamine-hydrolyzing)/aspartate 
carbamoyltransferase dihydroorotase promoter. J. Bioi. Chern. 269: 2252-2257. 
Kost, T. A; Condreay, J. P. and Jarvis, D. (2005). Baculovirus as versatile vectors for protein 
expression in insect and mammalian cells. Nat. Biotechnol. 23: 567-575. 
Kozak, M. (1987). At least six nucleotides preceding the AUG initiator codon enhance 
translation in mammalian cells. J. Mol. Bioi. 196: 947-950. 
Kozak, M. (1997). Recognition of AUG and alternative initiator codons is augmented by G in 
position +4 but is not generally affected by the nucleotides in positins +5 and +6. EMBO J. 
16: 2482-2492. 
Kriegler, M. (1990). Assembly of enhancers, promoters, and splice signals to control expression 
oftransfen'ed genes. Methods Enzyrnol. 185: 512-527. 
Krugh, T. R. and Reinhardt, C. G. (1975). Evidence for sequence preferences in the intercalative 
binding of ethidium bromide to dinucleoside monophosphates. J. Mol. BioI. 97: 133-162. 
Labatmoleur, F.; Steffan, A M.; Brisson, C. ; Perron, H.; Feugeas, 0.; Furstenberger, P.; 
Oberling, F.; Brambilla, E. and Behr, J. P. (1996). An electron microscopy study into the 
mechanism of gene transfer with lipopolyamines. Gene Ther. 3: 1010-1017. 
Leclmer, R. L. and Kelly, T. J. J. (1977). The structure of replicating adenovirus 2 DNA 
molecules. Cell 12: 1007-1020. 
Lee, T. G.; Tang, N.; Thompson, S.; Miller, J. and Katze, M. G. (1994). The 58,000-dalton 
cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase 
(PKR) is a member of the tetratricopeptide repeat family of proteins. Mol. Cell. Bioi. 14: 
2331-2342. 
191 
Literature cited 
Lee, T. I. and Young, R. A. (2000). Transcription of eukatyotic protein-coding genes. Annu. Rev. 
Genet. 34: 77-137 
Lee, W. S.; Kao, C.; Bryant, G. 0.; Liu, X. and Berk, A 1. (1991). Adenovirus EIA activation 
domain binds the basic repeat in the TATA box transcription factor. Cell 67: 365-376. 
Lemkine, G. F. and Demeneix, B. A (2001). Polyethylenimines for in vivo gene delivery, Curro 
Opin. Mol. Ther. 3: 178-182. 
Leppard, K. N. and Shenk, T. (1989). The adenovirus ElB 55 kD protein influences mRNA 
transport via an intranuclear effect on RNA metabolism. EMBO J 8: 2329-2336. 
Lichtenstein, D. L. and Wold W. S. M. (2004). Experimental infections of humans with wild-type 
adenoviruses and with replication-competent adenovirus vectors: replication, safety, and 
transmission. Cancer Gene Ther. 11: 819-829. 
Lichy,1. H.; HOlwitz, M. S. and Hurwitz, J. (1981). Formation of a covalent complex between 
the 80,000-dalton adenovirus terminal protein and 5'-dCMP in vitro . Proc. Nat!. Acad. Sci. 
USA 78: 2678-2682. 
Lieberman, A. P.; Pitha, P. M. and Shin, M. L. (1992). Poly(A) removal is the kinase-regulated 
step in tumor necrosis factor mRNA decay. J Bioi. Chem. 267: 2123-2126. 
Lipps, H. 1.; Jenke, A. C.; Nehlsen, K.; Scinteie, M. F.; Stehle, I. M. and Bode, 1. (2003). 
Chromosome-based vectors for gene therapy. Gene 304: 23-33 . 
Liu, C.; Dalby, B.; Chen, W.; Kilzer, J. M. and Chiou, H. C. (2008). Transient transfection 
factors for high-level recombinant protein production in suspension cultured mammalian 
cell. Mol. Biotechnol. 39: 141-153. 
Liu, D.; Chiao, E. F. and Tian, H. (2004). Chemical methods for DNA delivery: an overview. 
Methods Mol. Bioi. 245 : 3-24. 
Liu, F. and Green, M. R., (1994). Promoter Targeting by Adenovirus-Ela through Interaction 
with Different Cellular DNA-Binding Domains. Nature 368: 520-525. 
Lodish, H.; Berk, A ; Kaiser, C. A.; Krieger, M. ; Scott, M. P.; Bretscher, A.; Ploegh, H. and 
Matsudaira, P. (2007). Molecular Cell Biology, 6th edition. W.H. Freeman and Company, 
New York. 
Logan, J. and Shenk, T. (1984). Adenovirus tripartite leader sequence enhances translation of 
mRNAs late after infection. Proc. Natl. Acad. Sci. USA 81: 3655-3659. 
Longiaru, M. and Horwitz, M. S. (1981). Chinese hamster ovary cells replicate adenovirus 
deoxyribonucleic acid. Mol. Cell Bioi. 1: 208-215. 
Lowe, S. W. and Ruley, H. E. (1993). Stabilization of the p53 tumor suppressor is induced by 
adenovirus 5 EIA and accompanies apoptosis. Genes Dev. 7: 535-545. 
192 
Literature cited" 
Loyter, A ; Scangos, G.; Juricek, D.; Keene, D. and Ruddle, F. H. (1982). Mechanisms of DNA 
entry into mammalian cells. II. Phagocytosis of calcium phosphate DNA co-precipitate 
visualized by electron microscopy. Exp. Cell Res. 139: 223234. 
Lucas, B.; Giere, L. ; DeMarco, R.; Shen, A ; Chisholm, V. and Crowley, C. (1996). High-level 
production of recombinant proteins in CHO cells using a dicistronic DHFR intron 
expression vector. Nucleic Acids Res. 24: 1774-1779. 
Luckow, V. A. and Summers, M. D. (1988). Trends in the development of baculovirus 
expression systems. Bio/Technology (NY) 6: 47-55. 
Lutz, P. and Kendinger, C. (1996). Properties of the adenovirus IVa2 gene product, an effector of 
late-phase-dependent activation of the major late promoter. J. Virol. 70: 1396-1405. 
Lutz, P.; Rosa-Calatrava, M. and Kedinger, C. (1997). The product of the adenovirus 
intermediate gene IX is a transcriptional activator. J. Viral. 71: 5102-5109. 
Macauley-Patrick, S.; Fazenda, M. L.; McNeil, B. and Harvey, L. M. (2005). Heterologous 
protein production using the Pichia pastoris expression system. Yeast 22: 249-270. 
Maeda, S. (1989). Expression of foreign genes in insects using baculovirus vectors. Annu. Rev. 
Entomol. 34: 351-372. 
Makrides, S. C. (1999). Components of vectors for gene transfer and expression in mammalian 
cells. Protein Expr. Purif. 17: 183-202. 
Malone, R. W.; Felgner, P. L.; Venna, I. M. (1989). Cationic liposome-mediated RNA 
transfection. Prac. Natl. Acad. Sci. USA 86: 6077-6081. 
Mansour, S. L.; Grodzicker, T. and Tjian, R. (1986). Downstream sequences affect transcription 
initiation from the adenovirus major late promoter. Mol. Cell Bioi. 6: 2684-2694. 
Markrides, S.C. (1999). Components of vectors for gene transfer and expression in mammalian 
cells. Protein Expression and Purification. 17: 183-202. 
Martinez-Salas, E.; Pacheco, A; Serrano, P. and Fernandez, N. (2008). New insights into internal 
ribosome entry site elements relevant for viral gene expression. J. Gen. Viral. 89: 611-626. 
Marzluff, W. F. and Pandey, N. B. (1988). Multiple regulatory steps control histone mRNA 
concentrations. Trends Biochem. Sci. 13: 49-52. 
Maston, G. A ; Evans, S. K. and Green, M. R. (2006). Transcriptional Regulatory Elements in the 
Human Genome. Annu. Rev. Genomics Hum. Genet. 7: 29-59. 
Matsuki, N.; Ishikawa, T.; Imai, Y. and Yamaguchi, T. (2008). Low voltage pulses can induce 
apoptosis. Cancer Lett. 269: 93-100. 
Mattaj, I. W. and Englmeier, L. (1998). Nucleocytoplasmic transp0l1: The soluble phase. Annu. 
Rev. Biochem. 67: 265-306. 
193 
Literature citea 
McCrae, M. A and Woodland, H. R. (1981). Stability of non-polyadenylated viral mRNAs 
injected into frog oocytes. Eur. J. Biochem. 116: 467-470. 
McMillan, N. A J.; Chun, R. F.; Siderovski, D. P.; Galabru, J.; Toone, W. M.; Samuel, C. E.; 
Mak, T. W.; Hovanessian, A G.; Jeang, K. -T. and Williams, B. R. G. (1995). HIV-l Tat 
directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, 
PKR. Virology 213: 413-424. 
Michael, S. F. (1994). Mutagenesis by incorporation of a phosphorylated oligo during PCR 
amplification. Biotechniques 16: 410-412. 
Miller, L.K. (1988). Baculoviruses as gene expression vectors. Annu. Rev. Microbio!. 42: 177-
199. 
Miyamoto, N. G.; Moncolin, V.; Egly, J. M. and Chambon, P. (1985). Specific interaction 
between a transcription factor and the upstream element of the adenovirus-2 major late 
promoter. The EMBO Journal 4: 3563-3570. 
Mockey, M.; Gons;alves, C.; Dupuy, F. P.; Lemoine, F. M.; Pichon, C. and Midoux, P. (2006). 
mRNA transfection of dendritic cells: synergistic effect of ARCA mRNA capping with 
Poly(A) chains in cis and in trans for a high protein expression level. Biochem. Biophys. 
Res. Commun. 340: 1062-1068. 
Moghimi, S. M.; Symonds, P.; MUlTay, J. C.; Hunter, A C.; Debska, G. and Szewczyk, A. 
(2005). A two-stage poly( ethylenimine )-mediated cytotoxicity: implications for gene 
transfer/therapy. Mol. Ther. 11: 990-995. 
Molla, A; Jang, S.; Paul, A; Reuer, Q. and Wimmer, E. (1992). Cardioviral internal ribosomal 
entry site is functional in a genetically engineered dicistronic poliovirus. Nature 356: 255-
257 . 
Monaco, L.; Tagliabue, R.; Giovanazzi, S.; Bragonzi, A and Soria, M. (1996). Expression of 
recombinant human granulocyte colony-stimulating factor in CHO dhfr - cells: new insights 
into the in vitro amplification expression system. Gene 180: 145-150. 
Montell, C.; Fisher, E. F.; Caruthers, M. H. and Berk, A. J. (1984). Control of adenovirus ElB 
mRNA synthesis by a shift in the activation of RNA splice sites. Mol. Cell. BioI. 4: 966-
972. 
Moore, M. A. and T. Shenk. (1988). The adenovirus tripartite leader sequence can alter nuclear 
and cytoplasmic metabolism of a non-adenovirus mRNA within infected cells. Nucleic 
Acids Res. 16: 2247-2262. 
Mossadegh, N.; Gissmann, L.; Muller, M.; Zentgraf, H.; Alonso, A and Tomakidi, P. (2004). 
Codon optimization of the human papillomavirus 11 (HPV 11) L 1 gene leads to increased 
gene expression and formation of virus-like particles in mammalian epithelial cells. 
Virology 326: 57-66. 
Mukherjee, D.; Gao, M.; O'Connor, J. P.; Raijmakers, R.; Pruijn, G.; Lutz, C. S. and Wilusz, J. 
(2002). The mammalian exosome mediates the efficient degradation of mRNAs that 
contain AU-rich elements. EMBO J. 21: 165-174. 
194 
Literature cited 
Mul, Y. M. and van der Vliet, P. C. (1992). Nuclear factor I enhances adenovirus DNA 
replication by increasing the stability of a preinitiation complex. EMBO J 11: 751-760. 
Mul, Y. M.; Verrijzer, C. P. and van der Vliet, P. C. (1990). Transcription factors NFl and 
NFIII/oct-1 function independently, employing different mechanisms to enhance 
adenovirus DNA replication. J Virol. 64: 5510-5518. 
Mullis, K.; Faloona, F.; Scharf, S.; Saiki, R.; Hom, G. and Erlich, H. (1986). Specific enzymatic 
amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harbor 
Symposium on Quantitative Biology 51 Part 1: 263-273. 
Nadeau, I. and Kamen, A. (2003). Production of adenovirus vectors for gene therapy. 
Biotechnology advances 20: 475-489. 
Nadeau, I.; Jacob, D.; Perrier, M. and Kamen, A. (2000a). 293SF metabolic flux analysis during 
cell growth and infection with an adenoviral vector. Biotechnol. Prog. 16: 872-884. 
Nadeau, I.; Sabatie, J.; Koehl, M.; Perrier, M. and Kamen, A. (2000b). Human 293 cell 
metabolism in low glutamine-supplied culture: interpretation of metabolic changes through 
metabolic flux analysis. Metab. Eng. 2: 277-292. 
Nadeau, I.; Seanez, G. and Wu, F. (2001). Adenovirus production in 293 cells: a comparative 
study between a suspension cell and an adherent cell process. The 17th ESACT Meeting, 
Tylosand, Sweden, June 10-14. 
Nagata, T.; Uchijima, M.; Yoshida, A.; Kawashima, M. and Koide, Y. (1999). Codon 
optimization effect on translational efficiency of DNA vaccine in mammalian cells: 
analysis of plasmid DNA encoding a CTL epitope derived from microorganisms. Biochem. 
Biophys. Res. Comm. 261: 445-451. 
Nagy, A.; Gertsenstein, M.; Vintersten, K. and Behringer, R . (2003). Manipulating the mouse 
embryo, a laboratory manual: Production of transgenic mice. pp. 289-358, cold spring 
harbour laboratory press. 
Najjar, S. M., and Lewis, R. E. (1999). Persistent expression of foreign genes in cultured 
hepatocytes: Expression vectors. Gene 230: 41-45 . 
Nakamura, S.; Watanabe, S.; Ohtsuka, M.; Maehara, T.; Ishihara, M.; Yokomine, T. and Sato, M. 
(2008). Cre-IoxP system as a versatile tool for conferring increased levels of tissue-specific 
gene expression from a weak promoter. Mol. Reprod. Dev. 75: 1085-1093. 
Namy, 0.; Hatin I. and Rousset J. P. (2001). Impact of the six nucleotides downstreamofthe stop 
codon on translation termination. EMBO Rep. 2: 787-793 . 
Nass, K. and Frenkel, G. D. (1978). Adenovirus-induced inhibition of cellular DNase. J Virol. 
26: 540-543. 
Nass, K. and Frenkel, G. D. (1980). Adenovirus-specific DNA-binding protein inhibits the 
hydrolysis of DNA by DNase in vitro. J Virol. 35: 314-319. 
195 
Literature citea 
Neill, S. D.; Hemstrom, C.; Virtanen, A. and Nevins, J. R. (1990). An adenovirus E4 gene 
product trans-activates E2 transcription and stimulates stable E2F binding through a direct 
association with E2F. Proc. Natl. Acad. Sci. USA 87: 2008-2012. 
Nettelbeck, D. M.; Jerome, V. and Muller, R. (1998). Astrategy for enhancing the transcriptional 
activity of weak cell type-specific promoters. Gene Ther. 5: 1656-1664. 
Nevels, M.; Rubenwolf, S.; Spruss, T.; Wolf, H. and Dobner, T. (1997). The adenovirus E40rf6 
protein can promote E1A1ElB-induced focus formation by interfering with p53 tumor 
suppressor function. Proc. Natl. Acad. Sci. USA 94: 1206-1211. 
Nevins, J. R. and Darnell, J. E. (1978). Groups of adenovirus type 2 mRNAs derived from a large 
primary transcript: probable nuclear origin and possible common 3' ends. J. Virol. 25: 811-
823. 
Nevins, J. R., and Wilson, M. C. (1981). Regulation ofadenovirus-2 gene expression at the level 
of transcriptional termination and RNA processing. Nature 290: 113-118. 
Nicolas, J C.; Samow, P.; Girard, M. and Levine, A. J (1983). Host range temperature-
conditional mutants in the adenovirus DNA binding protein are defective in the assembly 
of infectious virus. Virology 126: 228-239. 
Novina, C. D. and Roy, A. L. (1996). Core promoters and transcriptional control. Trends Genet. 
12: 351-355. 
Nuno-Gonzalez, P.; Chao, H. and Oka, K. (2005). Targeting site-specific chromosome 
integration. Acta Biochirnica Polonica 52: 285-291. 
O'Neill, E. A.; Fletcher, C.; Burrow, C. R.; Heintz, N.; Roeder, R. G. and Kelly, T. J (1988). 
Transcription factor OTF-l is functionally identical to the DNA replication factor NF-Ill. 
Science 241: 1210-1213. 
Oker-Blom, C.; Petersson, R. F. and Summers, M. D. (1989). Baculovirus polyhedrion promoter 
directed expression of rubella virus envelope glycoproteins, El and E2, in Spodoptera 
Jrugiperda cells. Virology 172: 82-91. 
Olafsdottir, G.; Svansson, V.; Ingvarsson, S.; Marti, E. and Torsteinsdottir, S. (2008). In vitro 
analysis of expression vectors for DNA vaccination of horses: the effect of a Kozak 
sequence. Acta Vet. Scand. 50: 44. 
Olofsson, J; Levin, M.; Stromberg, A.; Weber, S. G.; Ryttsen, F. and Orwar, O. (2007). 
Scanning electroporation of selected areas of adherent cell cultures. Anal. Chern. 79: 4410-
4418. 
Olofsson, J.; Nolkrantz, K.; Ryttsen, F.; Lambie, B. A.; Weber, S. G. and Orwar, O. (2003). 
Single-cell electroporation. Curro Opin. Biotechnol. 14: 29-34. 
Onishi, Y. and Kikuchi, Y. (2003). Study of the complex between DNA and DEAEdextran. 
Kobunshi Ronbunshu 60: 359-364. 
196 
Literature citea 
Onishi, Y. and Kikuchi, Y. (2004). Study of the complex between RNA and DEAEdextran. 
Kobunshi Ronbunshu 61: 139-143. 
Oosterom-Dragon, E. A. and Ginsberg, H. S. (1980). Purification and preliminary immunological 
characterization of the type 5 adenovirus, non-structural 100,000-dalton protein. J Virol. 
33: 1203-1207. 
Ornelles, D. A. and Shenk, T . (1991). Localization of the adenovirus early region lB 55-
kilodalton protein during lytic infection: association with nuclear viral inclusions requires 
the early region 4 34-kilodalton protein. J Virol. 65: 424-429. 
Orrantia, E. and Chang, P. L. (1990) . Intracellular distribution of DNA internalized tlu'ough 
calcium phosphate precipitation. Exp. Cell Res. 190: 170-174. 
Papadakis, E. D.; Nicklin, S. A.; Baker, A. H. and White, S. J. (2004). Promoters and control 
elements: designing expression cassettes for gene therapy. Curro Gene Ther. 4: 89-113. 
Parham, 1. H.; Iannone, M. A.; Overton, L. K. and Hutchins, 1. T. (1998).Optirnization of 
transient gene expression in mammalian cells and potential for scale-up using flow 
electroporation. Cytotechnology 28: 147-155. 
Parker, E. J.; Botting, C. H.; Webster, A. and Hay, R. T. (1998). Adenovirus DNA polymerase: 
domain organisation and interaction with preterminal protein. Nucleic Acids Res. 26: 1240-
1247. 
Parker, R . and Song, H. (2004). The enzymes and control of eukaryotic mRNA turnover. Nat. 
Struct. Mol. Bioi. 11: 121-127. 
Parks, C. L. and Shenk, T. (1997). Activation of the adenovirus major late promoter by 
transcription factors MAZ and Spi. J Viral. 71: 9600-9607. 
Patel, D. and Butler, 1. S. (1992). Conditional defect in mRNA 39 end processing caused by a 
mutation in the gene for poly(A) polymerase. Mol. Cell. Bioi. 12: 3297-3304. 
Patnaik, P. (2003). Handbook of inorganic chemicals. The McGraw-Hill Companies, Inc., NY. 
Pauletti, G.; Lai, E. and Attardi, G. (1990). Early appearance and long-term persistence of the 
submicroscopic extrachromosomal elements (amplisomes) containing the amplified DHFR 
genes in human cell lines. Proc. Natl. Acad. Sci. USA 87: 2955-2959. 
Pautz, G. E.; Yang, Z. Y.; Wu, B. Y.; Gao, X.; Huang, L. and Nabel, G. 1. (1993). 
Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc. Natl. Acad. Sci. 
USA 90: 4645-4649. 
Pelletier, J. and Sonenberg, N. (1988). Internal initiation of translation of eukaryotic mRNA 
directed by a sequence derived from poliovirus RNA. Nature 334: 320-325. 
Peltz, S. W., and Jacobson, A. (1992). mRNA stability: in trans-it. Curro Opin. Cell Bio!. 4: 979-
983. 
197 
Literature citea 
Peltz, S. W.; Brewer, G.; Kobs, G. and Ross, 1. (1987). Substrate specificity of the exonuclease 
activity that degrades H4 histone mRNA. J. Bioi. Chern. 262: 9382-9388. 
Peppel, K and Baglioni, C. (1991). Deadenylation and turnover of interferon-b mRNA. J. Bioi. 
Chern. 266: 6663-6666. 
Peroni, c.; Soares, C.; Gimbo, E.; Morganti, L.; Ribela, M. and Bartolini, P. (2002). High-level 
expression of human thyroid-stimulating hormone in Chinese hamster ovary cells by co-
transfection of dicistronic expression vectors followed by a dual-marker amplification 
strategy. Biotechnology and Applied Biochemistry 35: 19-26. 
Pesole, G., Mignone, F. , Gissi, C., Grillo, G., Licciulli, F. and Liuni, S. (2001). Structural and 
functional features of eukaryotic mRNA untranslated regions. Gene 276: 73-81. 
Philpott, N. J. and Thrasher, A. J. (2008). Use of nonintegrating lentiviral vectors for gene 
therapy. Hum. Gene Ther. 18: 483-489. 
Phi-Van, L. von Kries, 1. P.; Ostertag, W. and Stratling, W. H. (1990). The chicken lysozyme 50 
matrix attachment region increases transcription from a heterologous promoter in 
heterologous cells and dampens position effects on the expression of transfected genes. 
Mol. Cell. Bioi. 10: 2302-2307. 
Pilder, S.; Leppard, K; Logan, 1. and Shenk, T. (1986a). Functional analysis of the adenovirus 
EIB 55K polypeptide. Cancer Cells 4: 285-290. 
Pilder, S. ; Logan, J. and Shenk, T. (1984). Deletion of the gene encoding the adenovirus 5 early 
region I b 21,000-molecular-weight polypeptide leads to degradation of viral and host cell 
DNA. J. Virol. 52: 664-67l. 
Pilder, S.; Moore, M.; Logan, 1. and Shenk, T. (1986b). The adenovirus EIB- 55K transforming 
polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. 
Mol. Cell. Bioi. 6: 470-476. 
Preuss, A. K; Connor, J. A. and Vogel, H. (2000). Transient transfection induces diVerent 
intracellular calcium signaling in CHOKI versus HEK293 cells. Cytotechnology 33: l39-
145. 
Preuss, A. K; Pick, H. M.; Wurm, F. and Vogel, H. (1999). Transient transfection induces early 
cytosolic calcium signaling in CHO-Kl cells. In: Ikura, K; Nagao, M.; Masuda, S. and 
Sasaki, R. (eds.), Animal Cell Technology: Challenges for the 21 st Century. Kluwer 
Academic Publishers, Dordrecht, pp. 17-21. 
Prives, C. (1998). Signaling to p53: breaking the MDM2-p53 circuit. Cell 95: 5-8. 
Ptushkina, M.; von der Haar, T.; Karim, M. M.; Hughes, 1. M. X. and McCarthy, 1. E. G. (1999). 
Repressor binding to a dorsal regulatory site traps human elF4E in a high cap-affinity state. 
EMBO J. 18: 4068-4075. 
Puck, T. T.; Cieciura, S. 1. and Robinson, A. (1958). Genetics of somatic mammalian cells: iii. 
Long-term cultivation of euploid cells from human and animal subjects. J. Exp. Med. 108: 
945-956. 
198 
Literature citea 
Querido, E.; Marcellus, R c.; Lai, A.; Charbonneau, R.; Teodoro, J. G.; Ketner, G. and Branton, 
P. E. (1997a). Regulation of p53 levels by the EIB 55-kilodalton protein and E40rf6 in 
adenovirus-infected cells. J. Virol. 71: 3788-3798. 
Querido, E.; Teodoro J. G. and Branton, P. E. (1997b). Accumulation of p53 induced by the 
adenovirus ElA protein requires regions involved in the stimulation of DNA synthesis. J. 
Virol. 71: 3526-3533. 
Rabussay D. (2008). Applicator and electrode design for in vivo DNA delivery by 
electroporation. Methods Mol. BioI. 423: 35-59. 
Rao, L.; Debbas, M.; Sabbatini, P.; Hockenbery, D.; Korsmeyer, S. and White, E. (1992). The 
adenovirus EIA proteins induce apoptosis, which is inhibited by the EIB 19-kDa and Bel-
2 proteins. Proc. Natl. Acad. Sci. USA 89: 7742-7746, Erratum in: 89: 9974. 
Recillas-Targa, F. (2004). Gene transfer and expression in mammalian cell lines and transgenic 
animals. Methods Mol. BioI. 267: 417-433. 
Reed, R and Hurt, E. A. (2002). Conserved mRNA export machinery coupled to pre-mRNA 
splicing. Cell 108: 523-531. 
Reed, Rand Magni, K. A. (2001). A new view of mRNA export: Separating the wheat from the 
chaff. Nat. Cell Bioi. 3: E201-E204. 
Rekosh, D. M.; Russell, W. C.; Bellet, A. J. and Robinson, A. J. (1977). Identification of a 
protein linked to the ends of adenovirus DNA. Cell 11 : 283-295. 
Rhoads, R. E. (1988). Cap recognition and the entry of mRNA into the protein synthesis 
initiation cycle. Trends Biochem. Sci. 13: 52-56. 
Ridgway, P. J.; Hall, A. R; Myers, C. J. and Braithwaite, A. W. (1997). p53/Elb58kDa complex 
regulates adenovirus replication. Virology 237: 404-413. 
Riley, D. and S. J. Flint. (1993). RNA-binding properties of a translational activator, the 
adenovirus L4 100-kilodalton protein. J. Virol. 67: 3586-3595. 
Ross, J. (1995). mRNA stability in mammalian cells. Microbiological Reviews 59: 423-450. 
Roth, J.; Konig, C.; Wienzek, S.; Weigel, S.; Ristea, S. and Dobbelstein, M. (1998). Inactivation 
of p53 but not p73 by adenovirus type 5 EIB 55-kilodalton and E4 34-kilodalton 
oncoproteins. J. Viral. 72: 8510-8516. 
Rowe, W. P.; Huebner, R. 1.; Gilmore, L. K.; Parrot, R H. and Ward, T. G. (1953). Isolation of a 
cytopathic agent from human adenoids undergoing spontaneous degradation in tissue 
culture. Proceedings of the Society for Experimental Biology and Medicine 84: 570-573. 
Rowlett, R M.; Chrestensen, C. A.; Schroeder, M. J.; Harp, M. G.; Pelo, J. W.; Shabanowitz, J.; 
DeRose, R.; Hunt, D. F.; Sturgill, T. W. and Worthington, M. T. (2008). Inhibition of 
tristetraprolin deadenylation by poly(A) binding protein. Am. J. Physiol. Gastrointest Liver 
Physiol. 295: G421-G430. 
199 
Literature cited 
Ruben, M.; Bacchetti, S. and Graham, F. (1983). Covalently closed circles of adenovirus 5 DNA. 
Nature 301: 172-174. 
Russell WC. (2000). Update on adenovirus and its vectors. J Gen. Viral. 81: 2573-2604. 
Sabbattini, P.; Han, J. H.; Chiou, S. -K. .; Nicholson, D. and White, E. (1997). Interleukin 1 b 
converting enzyme-like proteases are essential for p53-mediated transcriptionally 
dependent apoptosis. Cell Grawth Diff 8: 643-653. 
Sachs, A. (1990). The role of poly(A) in the translation and stability of mRNA. Curro Opin. Cell 
Bial. 2: lO92-lO98. 
Sachs, A. B. (1993). Messenger RNA degradation in eukalyotes. Cell 74: 413-421. 
Sambrook, 1.; Fritsch, E. F. and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, 
2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 
Samow, P.; Ho, Y.; Williams, 1. and Levine, A. (1982). Adenovirus Elb-58kd tumor antigen and 
SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in 
transformed cells. Cell 28: 387-394. 
Schatzlein, A. G. (2001). Non-viral vectors in cancer gene therapy principles and progress. 
Anticancer Drugs 12: 275-304. 
Schiedner, G.; Schmitz, B. and Doerfler, W. (1994). Late transcripts of adenovirus type 12 DNA 
are not translated in hamster cells expressing the E1 region of adenovirus type 5. J Viral. 
68: 5476-5482. 
Schumperli, D. (1988). Multilevel regulation of replication-dependent histone genes. Trends 
Genet. 4: 187-191. 
Shatkin, A. 1. (1985). mRNA cap binding proteins: essential factors for initiating translation. Cell 
40: 223-224. 
Shaw, A. R. and Ziff, E. B. (1980). Transcripts from the adenovirus-2 major late promoter yield a 
single early family of3' coterminal mRNAs and five late families. Cell 22: 905-916. 
Shaw, G. and Kamen, R. (1986). A conserved AU sequence from the 39 untranslated region of 
GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659-667. 
Shaw-Jackson, C. and Michiels, T. (1999). Absence of intemal ribosome entry site-mediated 
tissue specificity in the translation of a bicistronic transgene. J Viral. 73 : 2729-2738. 
Shenk, T. and Flint, J. (1991). Transcriptional and transforming activities of the adenovirus E1A 
proteins. Adv. Cancer Res. 57: 47-85. 
Shenk, T. (2001). Adenaviridae: the virus and their replication. In: Knipe, D. M. and Howley, P. 
M. (eds.), Fundamental Virology, 4th ed. Philadelphia: Lippincott Williams and Wilkins, 
pp. lO53-1088. 
200 
Literature cited 
Shenk, T.; Jones, N.; Colby, W. and Fowlkes, D. (1980). Functional analysis of adenovirus-5 
. host-range deletion mutants defective for transformation of rat embryo cells. Cold Spring 
Harb. Symp. Quant. Bioi. 44: 367-375. 
Shimotohno, K; Kodama, Y.; Hashimoto, 1. and Miura, K (1977). Importance of 59-terminal 
blocking structure to stabilize mRNA in eukaryotic protein synthesis. Proc. Natl. Acad. 
Sci. USA 74: 2734-2738. 
Shyu, A. -B.; Belasco, 1. G. and Greenberg, M. E. (1991) . Two distinct destabilizing elements in 
the c-fos message trigger deadenylation as a first step in rapid mRNA decay. Genes Dev. 5: 
221-231. 
Smart, 1. E. and Stillman, B. W. (1982). Adenovirus terminal protein precursor. Partial amino 
acid sequence and the site of covalent linkage to virus DNA. J. BioI. Chem. 257: 13499-
13506. 
Smith, J., Riballo, E.; Kysela, B.; Baldeyron, C.; Manolis, K; Masson, C.; Lieber, M. R.; 
Papadopoulo, D. and Jeggo, P. (2003). Impact of DNA ligase IV on the fidelty of end 
joining in human cells. Nucleic Acids Res. 31: 2157-2167. 
Song, B.; Hu, S. -L.; Darai, G.; Spindler, K R. and Young, C. S. H. (1996). Conservation of 
DNA sequences in the predicted major late promoter region of selected mastadenoviruses. 
Virology 220: 390-401. 
Steegenga, W. T.; Riteco, N.; Jochemsen, A. G.; Fallaux, F. 1. and Bos, 1. L. (1998). The large 
ElB protein together with the E40rf6 protein target p53 for active degradation in 
adenovirus infected cells. Oncogene 16: 349-357. 
Stein, R. W.; COlTigan, M.; Yaciuk, P.; Whelan, P. and Moran, E. (1990). Analysis of EIA-
mediated growth regulation functions: binding of the 300-kilodalton cellular product 
cOlTelates with EIA enhancer repression function and DNBA synthesis-inducing activity. 
J. Virol. 64: 4421-4427. 
Stephens, C. and Harlow, E. (1987). Differential splicing yields novel adenovirus 5 ElA mRNAs 
that encode 30 kd and 35 kd proteins. EMBO J. 6: 2027-2035. 
Stepinski, J.; Waddell, C.; Stolarski, R.; Darzynkiewicz, E. and Rhoads, R. E. (2001). Synthesis 
and properties of mRNAs containing the novel "anti-reverse" cap analogs 7-methyl(3'-O-
methyl)GpppG and 7-methyl (3'-deoxy)GpppG. RNA 7: 1486-1495. 
Stillman, B. (2005). Origin recognition and the chromosome cycle. FEBS Lett. 579: 877-884. 
Stuiver, M. H. and van der Vliet, P. C. (1990). Adenovirus DNA-binding protein forms a 
multimeric protein complex with double-stranded DNA and enhances binding of nuclear 
factor I. J. Virol. 64: 379-386. 
Sun, J.; Chen, M.; Xu, J. and Luo, J. (2005). Relationships among stop codon usage bias, its 
context, isochores, and gene expression level in various eukaryotes. J. Mol. Evol. 61 : 437-
444. 
201 
Literature cited 
Sutherland, H. G.; Martin, D. I. and Whitelaw, E. (1997). A globin enhancer acts by increasing 
the proportion of erythrocytes expressing a linked transgene. Mol. Cell. Bioi. 17: 1607-
1614. 
Swaminathan, S. and Thimmapaya, B. (1995). Regulation of adenovirus E2 transcription unit. In: 
Doerfler, W. and Bohm, P. (eds.), The Molecular Repertoire of Adenoviruses, vol. III. 
Springer-Verlag, Berlin, Germany, pp. 177-194. 
Szutorisz, H.; Dillon, N. and Tora, L. (2005). The role of enhancers as centres for general 
transcription factor recruitment. Trends Biochem. Sci. 30: 593-99. 
Tai, C. K and Kasahara N . (2008). Replication-competent retrovirus vectors for cancer gene 
therapy. Front Biosci. 13: 3083-3095. 
Tang, Y. M.; Ning, B. T.; Cao, J.; Shen, H. Q. and Qian, B. Q. (2007). Construction and 
expression of single-chain antibody derived from a new clone of monoclonal antibody 
against human CD14 in CHO cells. Immunopharmacol Immunotoxicol. 29: 375-386. 
Temperley, S. M. and Hay, R. T. (1992). Recognition of the adenovirus type 2 origin of DNA 
replication by the virally encoded DNA polymerase and preterminal proteins. The EMBO 
J. 11: 761-768. 
Tripathi, A. K and Kumar, H. D. (1986). Mutagenesis by ethidium bromide, proflavine and 
mitomycin C in the cyanobacterium Nostoc sp. Mutation Research Letters 174: 175-178. 
Ulfendahl, P. J.; Linder, S.; Kreivi, J. P.; Nordqvist, K; Sevensson, c.; Hultberg, H. and 
Akusjarvi, G. (1987). A novel adenovirus-2 EIA mRNA encoding a protein with 
transcription activation properties. EMBO J. 6: 2037-2044. 
UlIu, E. and Tschudi, C. (1991). Trans splicing in trypanosomes requires methylation of the 5' 
end of the spliced leader RNA. Proc. Natl. Acad. Sci. USA 88: 10074-10078. 
Unger, E. C.; McCreery, T. and Sweitzer, R. H. (1997). Ultrasound enhances gene expression of 
liposomal transfection. lnvest. Radiol. 32: 723-727. 
van Breukelen, B.; Brenkman, A. B.; Holthuizen, P. E. and van der Vliet, P. C. (2003). 
Adenovirus Type 5 DNA Binding Protein Stimulates Binding of DNA Polymerase to the 
Replication Origin. J. Viral. 77: 915-922. 
van Breukelen, B.; Kanellopoulos, P. N.; Tucker, P. A. and van der Vliet, P. C. (2000). The 
formation of a flexible DNA-binding protein chain is required for efficient DNA 
unwinding and adenovirus DNA chain elongation. J. BioI. Chem. 275: 40897-40903. 
van der Vliet, P. C. (1995). Adenovirus DNA replication. Curro Top. Microbiol. Immunol. 199:1-
30. 
van Leeuwen, H. C.; Rensen, M. and van der Vliet, P. C. (1997). The Oct-l POU homeodomain 
stabilizes the adenovirus pre initiation complex via a direct interaction with the priming 
protein and is displaced when the replication fork passes. J. BioI. Chem. 272: 3398-3405. 
202 
Literature citea 
Verma, R; Boleti, E. and George, A (1998). Antibody engineering: comparison of bacterial, 
yeast, insect and mammalian expression systems. Journal of Immunological Methods 216: 
165-18l. 
Vilar, J. M. and Saiz, L. (2005). DNA looping in gene regulation: from the assembly of 
macromolecular complexes to the control of transcriptional noise. Curro Opin. Genet. Dev. 
15: 136-44. 
Virtanen, A.; Gilardi, P.; Naslund, A; LeMoullec, J. M.; Pettersson, U. and Perricaudet, M . 
(1984). mRNAs from human adenovirus 2 early region 4. J Virol. 51: 822-83l. 
Waggoner, S. A and Liebhaber, S. A (2003). Regulation of alpha-globin mRNA stability. Exp. 
Bioi. Med. (Maywood) 228: 387-395. 
Wahle, E. and Ruegsegger, U. (1999). 3'-end processing of pre-mRNA in eukaryotes. FEMS 
Microbiol. Rev. 23: 277-295. 
Wake, C. T.; Gudewicz, T.; Porter, T.; White, A and Wilson, 1. H. (1984). How damaged is the 
biologically active subpopulation oftransfected DNA? Mol. Cell Bioi. 4: 387-398. 
Walsh, G. and Jefferis, R (2006). Post-translational modifications in the context of therapeutic 
proteins. Nature Biotechnology 24: 1241-1252. 
Walters, M. C.; Fiering, S.; Eidemiller, 1.; Magis, W.; Groudine, M. and Martin, D. I. (1995). 
Enhancers increase the probability but not the level of gene expression. Proc. Natl. Acad. 
Sci. USA 92: 7125-7129. 
Walters, M. C.; Magis, W.; Fiering, S.; Eidemiller, 1.; Scalzo, D.; Groudine, M. and Martin, D. I. 
(1996). Transcriptional enhancers act in cis to suppress position-effect variegation. Genes 
Dev. 10: 185-195. 
Wang, X.; Kiledjian, M.; Weiss, I. M. and Liebhaber, S. A (1995). Detection and 
characterization of a 3_ untranslated region ribonucleoprotein complex associated with 
human alpha-globin mRNA stability. Mol. Cell. Bioi. 15: 1769-1777. 
Wang, Z. R. and Kiledjian, M. (2001). Functional link between the mammalian exosome and 
mRNA decapping. Cell 107:751-762. 
Watanabe, H.; Imai, T.; Sharp, P. A and Handa, H. (1988). Identification of two transcription 
factors that bind to specific elements in the promoter of the adenovirus early-region 4. Mol. 
Cell. BioI. 8: 1290-1300. 
Weaver, F. R. and Hedrick, P. W. (1992). Genetics, 2nd edition. Wm. C. Brown, Dubuque. 
Webster, L. C. and Ricciardi, R P. (1991). trans-dominant mutants of EIA provide genetic 
evidence that the zinc finger of the trans-activating domain binds a transcription factor. 
Mol. Cell. Bioi. 11: 4287-4296. 
Webster, L. C.; Zhang, K.; Chance, B.; Ayene, I.; Culp, 1. S.; Huang, W. -1.; Wu, F. Y. -H. and 
Ricciardi, R. P. (1991). Conversion of the ElA Cys4 zinc finger to a nonfunctional 
203 
Literature cited' 
His2,Cys2 zinc finger by a single point mutation. Proc. Nat!. Acad. Sci. USA 88: 9989-
9993. 
Weiss, I. M. and Liebhaber, S. A. (1995). Elythroid cell-specific mRNA stability elements in the 
alpha 2-g10bin 3_ nontranslated region. Mol. Cell. Bioi. 15: 2457-2465. 
White, E.; Grodzicker, T. and Stillman, B. W. (1984). Mutations in the gene encoding the 
adenovirus early region 1B 19,000-molecular-weight tumor antigen cause the degradation 
of chromosomal DNA. J. Virol. 52: 410-419. 
Whyte, P.; Williamson, N. M. and Harlow, E. (1989). Cellular targets for transformation by the 
adenovirus E1A proteins. Cell 56: 67-75. 
Williams, l; Karger, B. D.; Ho, Y. S.; Castaglia, C. L.; Mann, T. and Flint, S. J. (1986). The 
adenovirus EIB 495R protein plays a role in regulating the transp011 and stability of the 
viral late messages. Cancer Cells 4: 275-284. 
Wilson, l M.; Grossman, M.; Cabrera, l A.; Wu, C. H. and Wu, G. Y. (1992). A novel 
mechanism for achieving transgene persistence ·in vivo after somatic gene transfer into 
hepatocytes. J. Bioi. Chern. 267: 11483-11489. 
Wimmer, E.; Hellen, C. U. and Cao, X. (1993). Genetics of poliovirus. Annu. Rev. Genet. 27: 
353-436. 
Woodcock, D. M.; Cowther, P. l; Dohe11y, J.; Jefferson, S.; DeCruz, E.; Noyer-Weidner, M.; 
Smith, S. S.; Michael, M. Z. and Graham, M. W. (1989). Quantitative evaluation of 
Escherichia coli host strains for tolerance to cytosine methylation in plasmid and phage 
recombinants. Nucleic Acids Res. 17: 3469-3478. 
Worgall, S. (2005). A realistic chance for gene therapy in the near future . Pediatr. Nephrol. 20: 
118-124. 
Wright, J. L.; Jordan, M. and Wurm, F. M. (2003). Transfection of partially purified plasmid 
DNA for high-level transient protein expression in HEK293-EBNA cells. J. Biotechnol. 
102: 211-221. 
Wu, C. and Alwine, l C. (2004). Secondary structure as a functional feature in the downstream 
region of mammalian polyadenylation signals. Mol. Cell Bioi. 24: 2789-2796. 
Wu, l M.; Lin, l C.; Chieng, L. L.; Lee, C. K. and Hsu, T. A. (2003). Combined use of GAP and 
AOXI promoter to enhance the expression of human granulocyte-macrophage colony-
stimulating factor in Pichia pastoris. Enz. Microb. Technol. 33 : 453-459. 
Wurm, F. M. (2004). Production of recombinant protein therapeutics in cultivated mammalian 
cells. Nat. Biotechnol. 22: 1393-1398. 
Wurm, F. M. and Bernard, A. (1999). Large-scale transient expression in mammalian cells for 
recombinant protein production. Curro Opin. Biotechnol. 313: 156-159. 
Xi, Q.; Cuesta, R. and Schneider, R. l (2004). Tethering of eIF4G to adenoviral mRNAs by lOOk 
protein drives ribosome shunting. Genes Dev. 18: 1997-2009. 
204 
Literature cited 
Xi, Q.; Cuesta, R. and Schneider, R. J. (2005). Regulation of translation by ribosome shunting 
through phosphotyrosine-dependent coupling of adenovirus protein lOOk to viral mRNAs. 
J. Virol. 79: 5676-5683. 
Xia, X. (2007). The +4G site in Kozak consensus is not related to the efficiency of translation 
initiation. PLoS ONE 2: e188. 
Xiang, W. K.; Paul, A. V. and Wimmer, E. (1997). RNA signals in entero- and rhinovirus 
genome replication. Semin. Virol. 8: 256-273. 
Yang, G.; Zhou, H.; Lu, Y.; Lin, Y. and Zhou, S. (2004). Comparing expression of different 
forms of human DNA topoisomerase I in Pichia pastoris. Enz. Microb. Technol. 34: 139-
146. 
Yang, N. S.; Burkholder, J.; McCabe, D.; Neumann, V. and Fuller, D. (2001). Particle-mediated 
gene delivery in vivo and in vitro. Curro Protoc. Hum. Genet. Chapter 12: Unit 12.6. 
Yang, T. -T.; Cheng, L. and Kain, S. R. (1996). Optimized codon usage and chromophore 
mutations provide enhanced sensitivity with the green fluorescent protein. Nucleic Acids 
Res. 24: 4592-4593. 
Yew, N. S.; Wysokenski, D. M.; Wang, K. x.; Ziegler, R. J .; Marshall , J.; McNeilly, D. ; Cherry, 
M.; Osbum, W. and Cheng, S. H. (1997). Optimization of plasmid vectors for high-level 
expression in lung epithelial cells. Hum. Gene Ther. 8: 575-584. 
Young, C. S. H. (2003). The structure and function of the adenovirus major late promoter. 
Current Topics in Microbiology and Immunology 272: 213-249. 
Yueh, A. and Schneider, R. J. (1996). Selective translation initiation by ribosome jumping in 
adenovirus-infected and heat-shocked cells. Genes Dev. 10: 1557-1567. 
Yueh, A. and Schneider, R. J. (2000). Translation by ribosome shunting on adenovirus and hsp70 
mRNAs facilitated by complementarity to 18S rRNA. Genes Dev. 14: 414-421. 
Zhang, D. Y.; Yang, S.; Lli, S. J.; Yan, J. D. and Zhu, T. H. (2006). Expression, characterization 
and biological activity analysis of recombinant human bone morphogenetic protein 2 in 
CHO cells. Sheng Wu Gong Cheng Xue Bao. 22: 968-972. 
Zhang, G.; Budker, V. G.; Ludtke, J. J. and Wolff, J. A. (2004). Naked DNA Gene Transfer in 
Mammalian Cells. Methods Mol BioI. 245 : 251-264. 
Zhang, Y. and Yu, L. C. (2008). Single-cell microinjection technology in cell biology. Bioessays 
30: 606-610. 
Zhang, Y.; Dolph, P. J. and Schneider, R. J. (1989). Secondaty Structure Analysis of Adenovirus 
Tripartite Leader. J. Bioi Chem. 264: 10679-10684. 
Zhang, Y.; Feigenblum, D. and Schneider, R. J. (1994). A late adenovirus factor induces eIF-4E 
dephosphorylation and inhibition of cell protein synthesis. J. Virol. 68: 7040-7050. 
205 
Literature citea 
Zhang, Y.; Xiong, Y. and Yarbrough, W. G. (1998). ARF promotes mdm2 degradation and 
stabilises p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression 
pathways. Cell 92: 725-734. 
Zhao, J.; Hyman, L. and Moore, C. (1999). Formation of mRNA 3' ends in eukaryotes: 
mechanism, regulation, and interrelationships with other steps in mRNA synthesis. 
Microbial. Mol. BioI. Rev. 63: 405-445. 
Ziff, E. and Fraser, N. (1978). Adenovirus type 2 late mRNAs: structural evidence for 3'-
cotenninal species. J. Viral. 25: 897-906. 
Ziff, E. B. and Evans, R. M. (1978). Coincidence of the promoter and capped 5' telminus of RNA 
from the adenovirus 2 major late transcription unit. Cell 15: 1463-1475. 
Zijderveld, D. C.; d'Adda di Fagagna, F.; Giacca, M.; Timmers, H. T. and van der Vliet, P. C. 
(1994). Stimulation of the adenovirus major late promoter in vitro by transcription factor 
USF is enhanced by the adenovirus DNA binding protein. J. Viral. 68: 8288-8295. 
Zolotukhin, S.; Potter, M.; Hauswirth, W. W.; Guy, J. and Muzyczka, N. (1996). A "humanized" 
green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J. 
Viral. 70: 4646-4654. 
206 
APPENDIX 
A- Effect of CsCl, EtBr/CsCl, endotoxin and EtOH on mutation frequency 
Undigested 
Digested 
700 bp 
600 bp 
700 bp 
600 bp 
Figure A.I: PCR amplification before and after HindIII digestion of DNA isolated from cells 
transfected with pCMV~ spiked with CsC\. The amplicon size of 677 bp and CsCl spiking 
concentrations are shown on the Figure. The DNA ladder (L) used is Norgen's PCRSizer. 
Undigested 
Digested 
L 010 2.2/0.51 2215.1 220/51 nM/~M 
700 bp 
600 bp 
700 bp 
600 bp 
Figure A.2: PCR amplification before and after HindIII digestion of DNA isolated from cells 
transfected with pCMV~ spiked with EtBr/CsC!. The amplicon size of 677 bp and EtBr/CsCl 
spiking concentrations are shown on the Figure. The DNA ladder (L) used is Norgen's PCRSizer. 
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Undigested 
Digested 
L 0.32 4 40 400 EU L 
700 bp 
600 bp 
700 bp 
600 bp 
Figure A.3: PCR amplification before and after HindIII digestion of DNA isolated from cells 
transfected with pCMV~ spiked with endotoxin. The amplicon size of 677 bp and endotoxin 
spiking concentrations are shown on the Figure. The DNA ladder (L) used is Norgen's PCRSizer. 
Undigested 
Digested 
L o 0.1 0.5 1% 
700 bp 
600 bp 
700 bp 
600 bp 
Figure A.4: PCR amplification before and after HindIII digestion of DNA isolated from cells 
transfected with pCMV~ spiked with EtOH. The amplicon size of 677 bp and EtOH spiking 
concentrations are shown on the Figure. The DNA ladder (L) used is Norgen's PCRSizer. 
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L o 250nM EtBr 56j.JM CsCI 220/51 nM/lJM L 400 EU 1% EtOH 
EtBr/CsCI 
Figure A.S: PCR amplification before and after HindlII digestion of DNA isolated from cells 
transfected with pCMV~ spiked with the highest contaminant concentrations and cleaned before 
transfection. The amplicon size of 677 bp and the spiking conditions and concentrations are 
shown on the Figure. The DNA ladder (L) used is Norgen's PCRSizer. 
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B- Construction of pEl 
8 8 ~R. GFP-SV40 poly(A) 42 
Restriction endonuclease EC19~ 
(RE) digestion & gel 410ning 
extraction 
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Cloning 
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&PCR 
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Figure A6: Overall construction strategy of pE 1 plasmid. Numbers shows the flow of the 
construction steps. 
3.2.1.1- Construction ofpUC19-GA 
The plasmid pCG contains GFP (AcGFPl: derived from the jellyfish Aequorea 
coerulescens) and SV40 poly(A). It was used as a template in a PCR reaction to amplify 
a fragment of 969 bp and contains the gene and poly(A) using the GA specific primer set. 
The reaction was performed using the Plu DNA polymerase enzyme to reduce the 
mutation probability and also to create a product with blunt ends needed for downstream 
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cloning. An agarose gel was used to run the reaction product and the amplified DNA 
fragment was extracted from the gel. The amplification strategy and the gel picture of the 
amplification are shown in Figures A7 and A8, respectively. 
---<cmVie 
peG 
4379bp 
GFP 
\ 
GFP-SV40 poly(A) 
1005 bp 
SV40 poly(A 
\ I 
Figure A7: Strategy ofPCR amplification ofGFP-SV40 poly(A) from pCMV-GFP. Red arrows 
represent the annealing sites of the two PCR primers. 
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bp 
2000 
1500 
1000 
750 
500 
300 
150 
50 
L 2 
Figure AS: PCR amplification of GFP-SV40 poly(A) using pCMV-GFP as a template. Lane 1 
shows the amplification product of969 bp, lane 2 is the negative control and lane L is Norgen's 
FastRunner DNA ladder. The bp sizes of the ladder bands are shown on the left side. 
pUC19 was digested with the restriction enzyme HincH (blunt ends) and 
subsequently cleaned to remove salts and enzymatic residuals. The cleaned GFP-SV 40 
poly(A) fragment was then cloned into the HindI digested and cleaned pUC19 using T4 
DNA ligase and later transformed into DH5a cells. The obtained plasmid was designated 
pUC19-GA. The construction strategy is seen in Figure A9 and the restriction enzyme 
digestion pattern and the digestion picture are shown in Table Al and Figure AIO, 
respectively. 
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GFP SV40 poly(A 
........ \ ........ 1... 
GFP-SV40 poly(A) 
1005 bp 
Gel extracted PCR product P(BlA~ ~AlPHA , HincH (432) )?( P(LAC) 
APr 
pUC19 
2686bp 
HincH digestion & 
gel extraction 
Ligation 
'---------------,,----------------
P(BlA) 
~ 
pUC1KA 
g(ffiq, 
J 
ORI 
~ 
Figure A9: pUC19-GA construction strategy. The PCR product was extracted from the gel and 
cloned into the HindI site ofpUC19. 
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Table AI: Restriction enzyme analysis ofpUCI9-GA. 
Restriction enzyme 
Fragment size(s) (bp) 
bp 
5000 
4000 
3000 
2500 
2000 
1500 
1000 
700 
500 
300 
L 
HindIII 
3655 
1 
ApaI 
3655 
2 3 
BamHI EcoOl09I 
3449 2249 
206 736 670 
4 L 
Figure AIO: Restriction enzyme analysis of pUC 19-GA. Lanes 1-4: plasmid DNA digested with 
HindIII, ApaI, BamBI and EcoOl09I, respectively. Lanes L: Norgen' s MidRanger DNA ladder. 
The bp sizes of the ladder bands are shown on the left side. 
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3.2.1.2- Construction ofpUCI9-GA-ITRs-EI 
The adenoviral backbone plasmid pFG 173 (36731 bp) was digested with AvrIl and 
MfeI to obtain the ITRs-EI fragment (4384 bp). The fragment was extracted from the gel 
and it has the two sticky ends of Avril and MfeL On the other hand, pUC19GA was 
digested with EeaRI and XbaI to produce two fragments of 27 bp and 3628 bp. Gel 
extraction was used to obtain the large fragment of 3628 bp which has EeaR! and MfeI 
sticky ends~ MfeI and EeaRI have complementary sticky ends and since the sticky ends 
of Avril and XbaI can complement with each other, it was possible to clone the ITRs-EI 
fragment into the pUCI9-GA. The resulting plasmid was designated pUCI9-GA-ITRs-
El. The construction strategy is seen in Figure All and the restriction enzyme digestion 
pattern and picture are shown in Table A2 and Figure AI2, respectively. 
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Figure All: pUC19-GA-ITRs-El construction strategy. 
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Table A2: Restriction enzyme analysis ofpUCI9-GA-ITRs-El. 
Restriction enzyme Xbal Sphl Neol Pvull 
2364 
3598 1862 Fragment size(s) 8012 5108 2951 1530 (bp) 2904 1463 1310 775 
171 
Ll 2 3 4 L2 
Figure A12: Restriction enzyme analysis of pUCI9-GA-ITRs-El. Lanes 1-4: plasmid DNA 
digested with Xbal, SphI, Neol and PvuII, respectively. Lane Ll: Norgen's HighRanger DNA 
ladder and lane L2: Norgen's MidRanger DNA ladder. The bp sizes of the ladder bands are 
shown on the side of the picture. 
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3.2.1.3- Construction ofpUC19-GA-ITRs-El-MCS 
The cloning of the MLP-TPL fragment into the pUC19-GA-ITRs-El plasmid will 
require additional restriction enzyme sites. In this step, a multi-cloning site (MCS) 
containing all the necessary sites for the downstream cloning was designed to have a 
sticky complementary ends to EcoRI and Agel. This was created by the annealing of two 
synthesized oligonucleotides. pUC19-GA-ITRs-El was digested with SbjI and Agel, 
yielding two fragments of 7970 bp and 42 bp in size. An agarose gel was run to separate 
the two fragments and the large fragment was extracted. The MCS is then ligated to the 
pUC19-GA-ITRs-EI backbone since EcoRI and SbjI have complementary sticky ends. 
The resulting plasmid was designated pUC 1 9-GA-ITRs-E I-MCS. The construction 
strategy is shown in Figure A13. Table A3 contains the restriction enzyme digestion 
pattern and Figure A14 shows the digestion picture. 
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Table A3: Restriction enzyme analysis ofpUCI9-GA-ITRs-EI-MCS. 
Restriction enzyme NheI HindIII Pvull 
2364 
1862 
Fragment size(s) 8012 4245 1530 (bp) 3755 1310 
763 
171 
L1 2 3 L2 
Figure A14: Restriction enzyme analysis of pUCI9-GA-ITRs-EI-MCS. Lanes 1-3: plasmid 
DNA digested with NheI, HindIII and PvuII, respectively. Lane L1: Norgen's HighRanger-2500 
DNA ladder and lane L2: Norgen's MidRanger DNA ladder. The bp sizes of each ladder band 
are shown on the sides of the picture. 
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3.2.1.4- Construction ofMLP-TPLfragment 
The MLP sequence was obtained from the work done by Parks & Shenk (1997). 
The sequence was aligned to the adenovirus 5 genome obtained from the National Center 
for Biotechnology Information (NCB!) genome browser 
(http://www.ncbi.nlm.nih.gov/sites/Cl1trez?Db=genome&Cmd=ShowDetaiIView&TcrmT 
oSearch=20000(8). Alignment of the adenovirus 5 genome to the TPL exon sequences 
obtained by Zhang et al. (1989) was used to determine the exact TPL sequence. 
The MLP-TPL fragment (493 bp) was then built up by gene construction 
procedures. The fragment contains the MLP and TPL in addition to restriction enzyme 
linkers for downstream cloning. The reverse and forward strands were divided into 
oligonucleotides of 47 bases in length, except for the terminal 5' oligonucleotides that 
have a size of 23 bases and can be used as primers in PCR amplification of the whole 
fragment. Oligonucleotides were designed so that they will have a 23 bp and 24 bp 
overlap with the complementary oligonucleotides with a single strand break in between 
(Table A4). 
First, the 22 oligonucleotides were phosphorylated using T4 polynucleotide kinase, 
which adds a phosphate group to the hydroxyl of the 5' end. Next, the phosphorylated 
oligonucleotides were annealed together to form the primary non-ligated MLP-TPL 
fragment containing single strand breaks between the adjacent oligonucleotides. Taq 
DNA ligase was then used to ligate the neighbouring oligonucleotides followed by PCR 
amplification of the whole fragment using Plu DNA polymerase and the terminal primers 
MT-FI and MT-Rl. The construction strategy and the gel picture of the amplified 
221 
Jlppenaix.. 
constructed fragment are shown in Figures A15 and A16, respectively. The fragment was 
gene cleaned and cloned into the HincH site ofpUCl9 to construct pUC19-MLP-TPL. 
Table A4: Nucleotide Sequences of oligonucleotides used in MLP-TPL DNA fragment 
construction. 
Name Nucleotide sequence 
lForward oligonucleotides: 
MT-Fl 5'ATAAGAGCCAAGTTCCAGCGTCC3' 
MT-F2 5'TGCAGGGCCCACTCTGAGACAAAGGCTCGCGTCCAGGCCAGCACGAA3' 
MT-F3 5'GGAGGCTAAGTGGGAGGGGTAGCGGTCGTTGTCCACTAGGGGGTCCA3' 
MT-F4 5'CTCGCTCCAGGGTGTGAAGACACATGTCGCCCTCTTCGGCATCAAGG3' 
MT-F5 5'AAGGTGATTGGTTTGT AGGTGT AGGCCACGTGACCGGGTGTTCCTGA3' 
MT-F6 5'AGGGGGGCTATAAAAGGGGGTGGGGGCGCGTTCGTCCTCACTCTCTT3' 
MT-F7 5'CCGCATCGCTGTCTGCGAGGGCCAGCTGTTGGGCTCGCGGTTGAGGA3' 
MT-F8 5'CAAACTCTTCGCGGTCTTTCCAGTACTCTTGGATCGGAAACCCGTCG3' 
MT-F9 5 'GCCTCCGAACGGTACTCCGCCGCCGAGGGACCTGAGCGAGTCCGCAT3 , 
MT-FIO 5'CGACCGGATCGGAAAACCTCTCGAGAAAGGCGTCTAACCAGTCACAG3' 
MT-Fll 5'TCGCACTAGTGAATTCGGGCCCACCGGTATCGCAAGCCACAGGT ATT3' 
Reverse oligonucleotides: 
MT-Rl 5 'AATACCTGTGGCTTGCGATACCG3 , 
MT-R2 5'GTGGGCCCGAATTCACTAGTGCGACTGTGACTGGTTAGACGCCTTTC3' 
MT-R3 5'TCGAGAGGTTTTCCGATCCGGTCGATGCGGACTCGCTCAGGTCCCTC3' 
MT-R4 5'GGCGGCGGAGTACCGTTCGGAGGCCGACGGGTTTCCGATCCAAGAGT3' 
MT-R5 5'ACTGGAAAGACCGCGAAGAGTTTGTCCTCAACCGCGAGCCCAACAGC3' 
MT-R6 5'TGGCCCTCGCAGACAGCGATGCGGAAGAGAGTGAGGACGAACGCGCC3' 
MT-R7 5'CCCACCCCCTTTTATAGCCCCCCTTCAGGAACACCCGGTCACGTGGC3' 
MT-R8 5'CT ACACCT ACAAACCAA TCACCTTCCTTGATGCCGAAGAGGGCGACA3' 
MT-R9 5'TGTGTCTTCACACCCTGGAGCGAGTGGACCCCCTAGTGGACAACGAC3' 
MT-RIO 5'CGCTACCCCTCCCACTTAGCCTCCTTCGTGCTGGCCTGGACGCGAGC3' 
MT-Rll 5'CTTTGTCTCAGAGTGGGCCCTGCAGGACGCTGGAACTTGGCTCTTA T3' 
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Figure A15: Strategy ofMLP-TPL DNA fragment construction. 
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Figure A16: PCR amplification of MLP-TPL fragment after annealing and ligation of the 
different oligonucleotides. Lane 1 shows the amplification product of 493 bp, lane 2 is the 
negative control and lane Lis Norgen's PCRSizer DNA ladder with its band sizes on the left side 
of the picture. 
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3.2.1.5- Cloning of MLP-TPL into pUC19-GA-ITRs-EI-MCS 
This is the final step in the construction of the pEl plasmid. In this step, the 494 bp 
fragment containing MLP-TPL was obtained from pUC19-MLP-TPL by Xbal and Agel 
digestion and subsequently extracted from an agarose gel. The fragment was then ligated 
to the Nhel and Agel-digested pUC19-GA-ITRs-El-MCS, since Xbal and Nhel have 
complementary sticky ends. The resulting plasmid was named pEl (8481 bp) and it 
contains the complete expression cassette (MLP-TPL-GFP-SV40 poly(A)) in addition to 
the adenoviral ITRs and El region. The strategy of this step is shown in Figure A17 and 
the restriction enzyme digestion pattern is listed in Table A5 with the agarose gel picture 
visualized in Figure A18. 
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Figure AI7: pEl construction strategy. 
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Table AS: Restriction enzyme analysis of pEl. 
Restriction enzyme EcoRl Seal HindIII HindI Pvull 
2364 
4049 1862 
Fragment size(s) 6374 4726 2334 1530 8481 1310 (bp) 2107 3755 2037 732 61 512 
171 
L1 2 3 4 5 L2 
Figure A18: Restriction enzyme analysis of pEl. Lanes 1-5: plasmid DNA digested with EcoRl, 
Seal, HindIII, HindI and PvuII, respectively. Lanes L1 is Norgen's HighRanger-2500 DNA 
ladder and L2 is Norgen's MidRanger DNA ladder. The bp size of each ladder band is shown on 
the sides of the picture. 
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C- Construction of plasmids with incomplete and complete TPL exons 
The effect of the complete and incomplete TPL on mRNA transport and stability 
was investigated using four different plasmids. pE I was the backbone plasmid in the 
construction of all the four plasm ids which share the same promoter and reporter gene 
(GFP) in addition to SV40 poly(A). The four plasmids contain either: no TPL exons 
(pMGA), TPL exon 1 (pMTIGA), TPL exons 1,2 (pMTI,2GA) or the entire TPL 
(pMTGA). The overall construction strategy is shown in Figure A 19. 
Ligation to synthetic ~ 
,-_D_N_A_f~--,ag=-m_e_nt_B_. 
ITR-EI deletion & 
ligation to synthetic RE Ligation to Synthetic ~ DNA fragment A ~ digestion DNA fragment C 
-----=:;1---·· --.,;..=,;,,;..;.,;..-+----3-=----+ 
Ligation to PCR product 
ofTPLexons 1&2 
4 
Figure A19: Overall construction strategy of the complete and incomplete TPL exons plasmids. 
Numbers show the flow of the construction steps. RE: Restriction endonuclease. 
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3.2.3.1.1- Construction ofpMTGA 
pMTGA contains the complete TPL sequence and it was constructed from pE 1 by 
the deletion of the ITRs-El fragment. First, pEl was digested with NdeI and MfeI to split 
the plasmid into two fragments of 4652 bp and 3829 bp in size. The smaller fragment 
contains the MLP, the complete TPL, GFP, SV40 poly(A), the ampicillin resistant gene 
and the origin of bacterial replication. An agarose gel was used to separate the two 
fragments and the smaller one was extracted from the gel. Two synthesized 
oligonucleotides were annealed to produce a short DNA fragment (synthetic DNA 
fragment A) with NdeI and MfeI sticky ends, and then ligated to the extracted DNA 
fragment. The obtained plasmid was designated pMTGA (3716 bp) and was used to 
construct the other three plasmids by deleting a part from the MLP and the entire TPL. 
Different DNA fragments, either oligonucleotides or PCR amplification products, were 
used to complement the MLP and introduce the desired TPL exons. The construction 
strategy of pMTGA is shown in Figure A20. Sequences of the two oligonucleotides that 
forms the DNA fragment A and the restriction enzyme digestion pattern are contained in 
Tables A6 and A7, respectively. The agarose gel picture is displayed in Figure A21. 
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Table A6: Sequences of the oligonucleotides forming the synthetic DNA fragment A. 
Sticky end Sequences Sticky end 
5' tatcgaattctagcatcgatcattactagtcattggcgcgccacgaatttaaatcttac 3' 
NdeI MfeI 
3' agcttaagatcgtagctagtaatgatcagtaaccgcgcggtgcttaaatttagaatgttaa 5' 
Table A7: Restriction enzyme analysis ofpMTGA. 
Restriction enzyme EeoRI Neal & HindIII Pvull 
Fragment size(s) 2935 3358 2644 732 (bp) 953 530 512 
L 2 3 L 
Figure A21: Restriction enzyme analysis of pMTGA. Lanes 1-3: plasmid DNA digested with 
EeoRI, double digestion with Neal & HindlII and PvuII , respectively. Lanes L are Norgen's 
MidRanger DNA ladder. The bp size of each ladder band is shown on the left side of the picture. 
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3.2.3.1.2- Construction ofpMGA and pMT,GA 
pMTGA was used to construct the TPL-free plasmid as well as a plasmid with only 
the first TPL exon. First, pMTGA was digested with PmlI (blunt end) and Agel to erase a 
280 bp fragment containing the entire TPL with some of the MLP. The rest of the 
plasmid (3608 bp) was then cleaned by gel extraction and used to construct pMGA and 
pMT,GA plasmids by cloning synthetic DNA fragments obtained by annealing two 
oligonucleotides having both the PmlI and Agel complementary ends. DNA fragment B 
contains part of the MLP however fragment C contains part of the MLP plus the first 
TPL exon. The ligation of fragments B to the 3608 bp fragment resulted in the plasmid 
designated pMGA (Figure A22) and pMT,GA resulted from fragment C being ligated to 
the 3608 bp fragment (Figure A24). Sequences of the oligonucleotides that form DNA 
fragments Band C are listed in Tables A8 and AlO, respectively. The pMGA restriction 
enzyme digestion patterns and agarose gel picture are shown in is shown in Table A9 and 
Figure A23, respectively. The digestion pattern of pMT,GA and its agarose gel picture 
are shown in Table All and Figure A2S, respectively. 
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Figure A22: pMGA construction strategy. 
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Table AS: Sequences of the oligonucleotides fonning the synthetic DNA fragment B. 
Sticky Sequences Blunt 
end end 
5' ccggatctagagaggacgaacgcgcccccacccccttttatagccccccttcaggaacacccggtcac 3' 
Agel PmlI 
3' tagatctctcctgcttgcgcgggggtgggggaaaatatcggggggaagtccttgtgggccagtg 5' 
Table A9: Restriction enzyme analysis of pMGA. 
Restriction enzyme EeoRi Neal & HindIII Pvull 
Fragment size(s) 3676 3358 2644 (bp) 318 1023 
L 2 3 L 
Figure A23: Restriction enzyme analysis of pMGA. Lanes 1-3: plasmid DNA digested with 
EeoRI, double digestion with Neal & HindIII and PvuII, respectively. Lanes L are Norgen's 
MidRanger DNA ladder. The bp size of each ladder band is shown on the left side of the picture. 
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Figure A24: pMT.GA construction strategy. 
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Table AIO: Sequences of the oligonucleotides forming the synthetic DNA fragment C. 
Sticky Sequences Blunt 
end end 
5' ccggatctagaccaacagctggccctcgcagacagcgatgcggaagagagtgaggacgaacgcg 
cccccacccccttttatagccccccttcaggaacacccggtcac 3' 
Agel PmlI 
3' tagatctggttgtcgaccgggagcgtctgtcgctacgccttctctcactcctgcttgcgcgggggtggg 
ggaaaatatcggggggaagtccttgtgggccagtg 5' 
Table All: Restriction enzyme analysis ofpMT1GA. 
Restriction enzyme EeaRl Neal & HindIII Pvull 
Fragment size(s) 3358 2644 3716 560 (bp) 358 512 
L 2 3 L 
Figure A25: Restriction enzyme analysis of pMT1GA. Lanes 1-3: plasmid DNA digested with 
EeaRl, double digestion with Neal & HindIII and PvuII, respectively. Lanes L are Norgen's 
MidRanger DNA ladder. The bp size of each ladder band is shown on the left side of the picture. 
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3.2.3.1.3- Construction ofpMT1,2GA 
We performed PCR amplification using specific primers and pMTGA as a template 
to obtain the DNA fragment that contains part of MLP and the first two exons of the 
TPL. The two primers were named TPLI,2-F and TPLI,2-R; the later contains extra 
nucleotides to introduce the Neal restriction enzyme site into the PCR product. Pfu DNA 
polymerase was used to amplify the fragment because it produces a blunt ended product. 
After that, the PCR product was cleaned and digested with Neal and the DNA was 
cleaned again. The digested PCR product was then ligated to a 3597 bp fragment 
obtained from PmlI and Neal-digested pMTGA and extracted from an agarose gel. The 
resulting plasmid was sequenced to verify the accuracy of its nucleotide sequence and 
was designated pMTl ,2GA. The construction strategy of this plasmid is displayed in 
Figure A26 and the restriction enzyme digestion pattern is shown in Table Al2 with the 
agarose gel picture in Figure A27. 
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Figure A26: pMT1,2GA construction strategy. 
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Table A12: Restriction enzyme analysis ofpMT1GA. 
Restriction enzyme EcoRI Neal & HindIII Pvull 
Fragment size(s) 3358 2644 3775 619 (bp) 417 512 
L 2 3 L 
Figure A27: Restriction enzyme analysis of pMT1 ,2GA. Lanes 1-3: plasmid DNA digested with 
EcoRI, double digestion with Neal & HindIII and PvuII, respectively. Lanes L are Norgen's 
MidRanger DNA ladder. The bp size of each ladder band is shown on the left side of the picture. 
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D- Construction of pE2 
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Figure A28: Overall construction strategy of pE2 plasmid. Numbers shows the flow of the 
construction steps. 
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3.3.1.1- Cloning of E2A and viral protease into pUC19neo 
The backbone plasmid of this construction step is pUC19neo which contains the 
neomycin resistant cassette cloned in pUC 19. The neomycin cassette provides resistance 
to neomycin and its chemical synthetic form, G418, in mammalian cells. First, E2A and 
viral protease are obtained from pBHGfrtdell ,3FLP by Sad digestion. The subsequent 
gel extraction of the 4581 bp fragment took place which contains both E2A and the viral 
protease. This fragment was then cloned into pUC19neo previously digested with the 
same enzyme. The resulted plasmid was designated pUCI9neo-E2A-protease. The 
construction strategy is outlined in Figure A29 and the restriction enzyme digestion 
pattern and picture are shown in Table A13 and Figure A30, respectively. 
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Figure A29: pUC19neo-E2A-Protease construction strategy. 
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Table A13: Restriction enzyme analysis ofpUCI9neo-E2A-Protease. 
Restriction enzyme EcoRI Seal DrdI Eco01091 
4721 5426 
1942 1868 Fragment size(s) 10188 5607 1869 1444 (bp) 4581 951 771 
705 561 118 
L1 2 3 4 L2 
Figure A30: Restriction enzyme analysis ofpUCI9neo-E2A-Protease. Lanes 1-4: plasmid DNA 
digested with EcoRI, Sad, DrdI and EcoOl091, respectively. Lane L1: Norgen's UltraRanger 
DNA ladder and lane L2: Norgen's HighRanger DNA ladder. The bp size of each ladder band is 
shown on the picture. 
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3.3.1.2- Cloning ofMCS into pUC19neo-E2A-Protease 
The downstream cloning of E2B required restriction enzymes that are not present in 
pUC 19neo-E2-Protease. Hence, we cloned an MCS in between the Ndel site and EcoRI 
site of the plasmid. The inserted MCS was designed so that the original Ndel and EcoRI 
sites of the plasmid were removed and replaced with a new EcoRI site inside the MCS to 
control the orientation during the subsequent E2B cloning. Another four enzymes were 
incorporated in the MCS including Clal, Spel, AscI and SwaI. The MCS was synthesized 
as two DNA oligonucleotides and was then annealed together. The annealed MSC 
contained complementary ends, just in the overhanging nucleotides but not in the entire 
sequence, to Ndel and EcoRI. The MCS was then ligated to pUC19neo-E2A-Protease 
previously digested with Ndel and EcoRl and extracted from an agarose gel. The 
resulting plasmid was designated pUC19neo-E2A-Protease-MCS. The construction 
strategy and the gel picture of the digested plasmid are shown in Figures A31 and A32, 
respectively. The restriction enzyme digestion pattern is listed in Table A14. 
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oligonucleotides 
;:! ~ ~ ~ ~ 
c ..s:! <u (,) :;.. ~u~-<~ 
Complementary _-----.-A---------_ Complementary 
to NdeI r- -- to EcoRi 
5' tatcgaattctagcatcgatcattactagtcattggcgcgccacgaatttaaatcttac 3' 
3' agcttaagatcgtagctagtaatgatcagtaaccgcgcggtgcttaaatttagaatgttaa 5' 
ORI~ 
NdeI (185) P(BLA) 
AP'~J I r----ECORI (397) 
\-protease 
PUC19neOOE2Aoproteaj e _ 
101881:p 
E2A 
Ndel & EcoRI 
Gel extraction 
of 9976 bp 
fragment 
Ligation 
'---------------~ ~----------------
OR! 
~ 
P(B1.~1 Apr~J 
Eco RI(190) ! aa I (an) I/. Spe I (210) 
r=:==~(221) 
Swal(~ 
\ ________ proteasE 
pUC19neoO E2A-Protease-MCS 
lOo35bp 
NeoR 
Figure A31: pUC19neo-E2A-Protease-MCS construction strategy. 
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Table A14: Restriction enzyme analysis ofpUC19neo-E2A-Protease-MCS. 
Restriction enzyme EcoRI AscI SacI DrdI 
4721 
Fragment size(s) 5454 1942 10035 10035 1869 (bp) 4581 951 
552 
L1 2 3 4 L2 
Figure A32: Restriction enzyme analysis of pUC 19neo-E2A-Protease-MCS. Lanes 1-4: plasmid 
DNA digested with EcoRI, AscI, SacI and DrdI, respectively. Lane L1: Norgen's HighRanger 
DNA ladder and lane L2: Norgen's UltraRanger DNA ladder. The bp size of each ladder band is 
shown on the picture. 
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3.3.1.3- Construction ofpUC19neo-E2-Protease 
The MCS of the pUCI9neo-E2A-Protease-MCS plasmid was used to clone the 
E2B. The plasmid was digested with EcoRI and AscI, and then the 10004 bp fragment 
was extracted from an agarose gel. Meanwhile, the adenoviral E2B was obtained from 
the pBHGfrtdell,3FLP plasmid by EcoRI and AscI digestion. The 12154 bp fragment 
that contains E2B was extracted from an agarose gel and cloned into the pre-digested 
pUCI9neo-E2A-Protease-MCS to create a plasmid that contains the entire viral E2 
region and named pUCI9neo-E2-Protease. The construction strategy of this plasmid is 
illustrated is Figure A33 and the restriction enzyme digestion pattern and the agarose gel 
picture are shown in Table A15 and Figure A34, respectively. 
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Figure A33: pUCI9neo-E2-Protease construction strategy. 
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Table A15: Restriction enzyme analysis of pUC 19neo-E2-Protease. 
Restriction enzyme 
Fragment size(s) 
(bp) 
8000 
6000 
5000 
4000 
3000 
2500 
2000 
1500 
1000 
700 
500 
300 
EcoRl Asci 
I 
I 
22158 22158 
L 2 
HindIII 
7140 
6605 
5322 
2081 
935 
75 
3 4 5 L 
Sacl DrdI 
5520 
4581 6963 3651 4721 2003 2035 1977 1942 1784 1869 957 1589 680 1581 671 951 234 506 73 
27 
Figure A34: Restriction enzyme analysis of pUC 19neo-E2-Protease. Lanes 1-5: plasmid DNA 
digested with EcoRl, Asci, HindIII, Sacl and DrdI, respectively. Lanes L: Norgen's UltraRanger 
DNA ladder. The bp size of each ladder band is shown on the picture. 
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3.3.1.4- Construction ofpUC19-MCS 
The final part that is missing in the pE2 constmction is the E2 promoters (early and 
late). Due to the relatively long size of the promoter fragment (2512 bp), we decided to 
use multistep cloning procedures rather than PCR to lower the probability of creating 
mutation within the sequence. First, pUC19 was modified by the insertion of a MCS 
containing restriction enzymes needed for the downstream cloning of the E2 promoter. In 
addition, the MCS contained more enzymes to add new restriction sites to the terminal 
ends of the fragment suitable for its subsequent cloning into pUC 19neo-E2-protease. The 
MCS was synthesized through the annealing of two oligonucleotides. The resulting MCS 
contained complementary terminal ends, just in the overhanging nucleotides but not in 
the entire sequence, to NdeI and SphI. Meanwhile, pUC19 was digested with NdeI and 
SphI and the 2425 bp fragment was extracted from an agarose gel. The MCS and the 
pUC19 fragment were ligated to generate the pUCI9-MCS plasmid. The constmction 
strategy of this plasmid is illustrated is Figure A35, and the restriction enzyme digestion 
pattern and the agarose gel picture are shown in Table A16 and Figure A36, respectively. 
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Figure A35: pUC19-MCS construction strategy. 
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NOOI('97) 
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IJ~/ Splt l (212) 
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---
OR) 
}!ppendf:( 
Table A16: Restriction enzyme analysis ofpUC19-MCS. 
Restriction enzyme Sail DrdI 
Fragment size(s) 2464 1896 (bp) 595 
L 2 
Figure A36: Restriction enzyme analysis ofpUCI9-MCS. Lanes 1 and 2: plasmid DNA digested 
with Sail and DrdI, respectively. Lane 1: Norgen's MidRanger DNA ladder. The bp size of each 
ladder band is shown on the left side of the picture. 
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3.3.1.5- Construction ofpUC19-E2promoters 
The adenoviral E2 genes are driven by different promoters during the early and late 
phases of the life cycle and both promoters were cloned in our construction. The E2 
promoter fragment of 3338 bp was obtained from pBHGfrtdell,3FLP by NdeI and SphI 
digestion and extracted from an agarose gel. Since both terminal restriction enzyme sites 
are not suitable for cloning the fragment into pUC 19neo-E2-Protease, the fragment 
needed new restriction enzyme sites that are suitable for the subsequent cloning to form 
the final plasmid pE2. For this purpose, we cloned the fragment into pUCI9-MCS after 
its digestion with NdeI and SphI and extraction from an agarose gel. The resulting 
plasmid was designated pUC19-E2promoters. The construction strategy of this plasmid 
is illustrated in Figure A37 and the restriction enzyme digestion pattern and the agarose 
gel picture are shown in Table Al7 and Figure A38, respectively. 
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Figure A37: pUC19-E2promoters construction strategy_ 
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Table A17: Restriction enzyme analysis of pUC 19-E2promoters. 
Restriction enzyme 
Fragment size(s) 
(bp) 
bp 
10000 
8000 
6000 
5000 
4000 
3000 
2500 
2000 
1500 
1000 
900 
800 
700 
600 
500 
400 
300 
200 
100 
NdeI 
5793 
L 
HindlII 
4541 
1252 
2 3 L 
Sad 
3404 
1465 
924 
Figure A38: Restriction enzyme analysis of pUC19-E2promoters. Lanes 1-3: plasmid DNA 
digested with Ndel. HindIII and Sad, respectively. Lanes L: Norgen's HighRanger Plus DNA 
ladder. The bp size of each ladder band is shown on the left side of the picture. 
254 
jlppentfix.. 
3.3.1.6- Construction ofpE2 
The cloned E2 promoters fragment in pUC19-E2promoters was digested by AvrIl 
and extracted from an agarose gel. Meanwhile, pUC19neo-E2-Protease was cut open by 
Xbal and cleaned afterwards through agarose gel extraction. Since AvrIl and Xbal have 
combatable sticky ends, it was possible to ligate both fragments. The orientation of the 
cloned E2 promoter fragment was then screened for through colony picking. When the 
proper orientation upstream from the E2A region was found, the plasmid was designated 
pE2. The construction strategy of this plasmid is illustrated in Figure A39 and the 
restriction enzyme digestion pattern and the agarose gel picture are shown in Table A18 
and Figure A40, respectively. 
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Figure A39: pE2 construction strategy. 
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Table A18: Restriction enzyme analysis ofpE2. 
Restriction enzyme 
Fragment size(s) 
(bp) 
bp 
10000 
8000 
6000 
5000 
4000 
3000 
2500 
2000 
1500 
1000 
900 
800 
700 
600 
500 
400 
300 
200 
100 
NdeI 
25511 
L 1 
MfeI 
11626 
5553 
4091 
2626 
1615 
2 3 
HindIII Sacl 
6347 
4581 
3651 
2003 
7821 1977 
7140 1784 
5322 1465 
2137 957 
2081 924 
935 680 
75 671 
234 
137 
73 
27 
4 L 
Figure A40: Restriction enzyme analysis ofpE2. Lanes 1-4: plasmid DNA digested with NdeI, 
MfeI, HindIII and Sacl, respectively. Lanes L: Norgen's HighRanger Plus DNA ladder. The bp 
size of each ladder band is shown on the left side of the picture. 
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E- Replication mechanism from circular adenoviral plasmids 
The replication mechanism of viral DNA from circular molecules was proposed by 
Graham et al. (1989): 
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"Model for replication of viral DNA from circular molecules. (A) Initiation of replication by 
protein priming. DNA at the junction of viral ITRs is assumed to form a cruciform with readily 
denaturable regions which facilitate initiation of viral DNA replication. The sequence of the 
template strand shown below is that determined for a hypothetical plasmid with one intact ITR 
(e.g. p141 or 142) and the shaded segment identifies the conserved decamer present near the ends 
of all human adenovirus genomes. See text for details. (B) Completion of the first round of viral 
DNA replication off a circular template. Synthesis (DNA indicated in black) has initiated as in 
(A) proceeded all the way around the circular genome by strand displacement replication, 
reaching the junction region (from the left in A) and terminating near the 5' pTP-blocked end of 
the newly made strand. (C) Generation of a panhandle. Annealing of newly made ITR sequences, 
or template switching as the 3' end of the growing chain progresses down the 'right' ITR, 
generates a duplex terminus similar in structure to the ends of viral DNA. If the ITR sequences at 
the 3' end of the newly synthesized strand are incomplete they can be repaired using the 5' 
sequences as a template." (Graham et al., 1989). 
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